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Abstract
Cigarette smoking is the major aetiological factor in the development of Chronic
Obstructive Pulmonary Disease (COPD), a collection of diseases encompassing chronic
bronchitis and emphysema. Emphysema is characterised by enlargement of the distal
airspaces in the lungs due to destruction of alveolar walls, and was initially thought to
be the result of matrix destruction from a protease-antiprotease and oxidant-antioxidant
imbalance, leading to detachment of alveolar cells. However, recently apoptosis has
been implicated in alveolar cell loss; increased numbers of apoptotic epithelial and
endothelial cells have been observed in the lungs of emphysema patients. Thus the
effect of cigarette smoke on apoptotic cell death was investigated.
Unexpectedly, cigarette smoke condensate (CSC) did not induce apoptosis in either an
alveolar epithelial type II cell line (A549) or primary human umbilical vein endothelial
cells (HUVECs), but instead it induced necrosis and inhibited staurosporine-induced
apoptosis. The anti-apoptotic, pro-necrotic, effect of CSC was reproduced in a model
system using Jurkat T cells, when either staurosporine or Fas ligation was used as an
apoptotic stimulus. Additional studies indicated that these effects might be oxidant-
mediated as the antioxidant compounds glutathione and dithiothreitol prevented CSC-
mediated apoptosis inhibition, and necrosis. Time course experiments revealed that
CSC inhibited an early step in the caspase cascade, whereby caspase-3 was not
activated. Moreover, reconstitution of the apoptosome in cytoplasmic extracts from
CSC-treated cells, by addition of cytochrome-c and dATP, did not result in activation of
caspases-3 or -9. Thus, smoke treatment may alter the levels of pro- and anti-
apoptogenic factors downstream of the mitochondria to inhibit active apoptosome
formation. Therefore these data demonstrate that CSC treatment did not induce
apoptosis as previously reported. More interestingly, CSC inhibited apoptosis by
preventing activation of caspases, resulting in necrotic cell death. Thus, cell death in
response to cigarette smoke by necrosis, and not apoptosis, may be responsible for the
loss of alveolar walls observed in emphysema.
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1.1. The Respiratory System
The body's requirement for oxygen is absolute, while we can survive a number of days
without food or water, a lack of oxygen results in death within a few minutes. The
primary function of the respiratory system is to enable oxygen to enter the blood and to
give carbon dioxide passage to the external environment.
The conducting airways begin at the larynx and then continue as the trachea, before
branching into the left and right primary bronchi. Each bronchus then subdivides into
the secondary bronchi, the tertiary bronchi, then the bronchioles, alveolar ducts and
alveolar sacs. The bronchi and the small terminal bronchioles form the conducting
portion of the lung, purely serving to passage air to the gas exchange portion, which
consists of respiratory bronchioles, alveolar ducts and alveolar sacs (Figure 1.1). The
acinus is defined as, the respiratory airspaces arising from a single terminal bronchiole
(Snider et al., 1985). The bronchi are supported by rings of cartilage, the numbers of
which gradually decrease with each successive division, such that airways of less than
1mm have no cartilaginous support. These small airways, and the alveolar sacs,
maintain their patency by means of attachments to the underlying connective tissue and
other airways and alveoli. This provides outward traction or elastic recoil on



















Figure 1.2. Schematic depicting alveolar airspaces.
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The epithelial cell population of the bronchiolar region is comprised of Clara cells,
ciliated cells, goblet cells, serous cell, endocrine cells and brush cells (Spurzem and
Rennard, 2002). The mucous, serous and ciliated cells in this region form the
mucociliary escalator, which traps any inhaled particles or microorganisms in the mucus
secreted by goblet cells; the movement of the cilia actively transports them upwards
towards the trachea, where they are removed by expectoration, or more commonly, by
swallowing.
1.1.1. The Alveoli
The alveoli are approximately 200pm in diameter, and through their walls run the
capillaries of the pulmonary circulation. The alveoli are supported by connective tissue
consisting of fibroblasts, smooth muscle cells and extracellular matrix proteins such as
collagen, elastin and fibronectin. Ninety percent of the alveolar surface consists of
large, elongated type I pneumocytes (type I alveolar epithelial cells), with the remainder
consisting of type II pneumocytes (type II alveolar epithelial cells). The lung
epithelium is the first line of defence against inhaled particles, gases and
microorganisms, thus tight cell junctions are present in the airway and alveolar
epithelium to provide an impenetrable barrier. The alveoli are the gas exchange region
of the lung and the thin type I pneumocyte layer lies alongside the thin capillary wall of
the pulmonary circulation, to enable maximum gas exchange. The alveolar spaces are
patrolled by alveolar macrophages that protect against inhaled micro-organisms and
particles, small enough to penetrate beyond the ciliated airways (Figure 1.2)
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1.1.1.1. Type Ipneumocytes
Type I pneumocytes are the terminally differentiated epithelial cells, which form the
main site for gas exchange. Their elongated flattened shape minimises the diffusion
distance between the alveolar space and the blood, 0.15pm at its narrowest point
(Corrin, 1981). Deoxygenated blood is brought to the lungs from the heart via the
pulmonary arteries, which divide to form the capillaries, reform as the post capillary
venules and then the oxygenated blood is taken back to the heart by the pulmonary
veins. The heart pumps the newly oxygenated blood through the systemic circulation to
the tissues.
Gas exchange occurs across the respiratory membrane, which consists of the alveolar
fluid, the flattened type I epithelial cell layer, the epithelial basement membrane,
interstitial space, the capillary basement membrane and the endothelial cell layer.
Inhaled oxygen diffuses from the airway, through the respiratory membrane into arterial
blood. Carbon dioxide diffuses from venous blood, across this air-blood barrier into the
airway, to be exhaled.
1.1.1.2. Type IIpneumocytes
Type II pneumocytes reside in alveolar "corners", are cuboidal in shape, and contain
numerous cytoplasmic organelles, including lamellar bodies. Type II cells fulfil a
variety of functions with the predominant two being: secretion of pulmonary surfactant
(Fehrenbach, 2001), and repopulation of the gas exchange layer by division and
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differentiation into type I cells (Adamson and Bowden, 1974). They also maintain the
alveolar fluid balance by regulating sodium transport across the epithelial layer and,
may contribute to host defence via the production and release of growth factors and
inflammatory mediators. Alveolar type II cells also produce, export and help maintain
high levels of glutathione (GSH) in lung lining fluid (discussed later).
1.1.2. Epithelial lining fluid (ELF)
The lung epithelium is bathed in the epithelial lining fluid (ELF) consisting of a mixture
of proteins and lipids. The ELF protects against invading pathogens, and inhaled
chemicals and oxidants. The ELF also aids the clearance of these foreign bodies, and
macrophages that have phagocytosed foreign bodies, by trapping them and facilitating
their removal from the lung by the mucociliary escalator (section 1.1). The exact
composition of ELF is unknown, however it is known to contain, surfactant proteins,
antioxidants (glutathione, superoxide dismutase (SOD), catalase, urea, and ascorbate),
antiproteases and mucus.
Surfactant
Surfactant is a mixture of approximately 90% lipid and 10% protein, which is
synthesised by the type II cell, and stored in cytoplasmic lamellar bodies prior to
secretion by exocytosis. The lipid fraction of surfactant consists mainly of
phospholipids while the protein fraction contains 50-90% of serum proteins and four
apoproteins, surfactant protein (SP)-A, SP-B, SP-C and SP-D. Pulmonary surfactant
coats the alveolar surface, reduces surface tension and thereby reducing the effort
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needed to inflate the lung. In addition, these proteins play a role in host defence against
infection (Frerking et ai, 2001).
Antioxidant defences
The lung is continually exposed to reactive oxygen and nitrogen species which, in
addition, may form free radicals. Formation of radicals occurs by several mechanisms
involving both endogenous and exogenous factors. Superoxide can leak from the
mitochondrial electron transport chain or from the NADPH oxidase enzymatic system.
The respiratory burst, utilised by inflammatory cells to combat invading pathogens, can
also lead to the production of reactive oxygen species, such as superoxide. Superoxide
can dismutate to produce hydrogen peroxide a weak oxidising agent that diffuses easily
through biological membranes. Nitric oxide is another easily diffusible compound that
is 'synthesised intracellularly by the enzyme nitric oxide synthase (NOS) and is involved
in a number of regulatory mechanisms. Nitric oxide can also be converted to nitrogen
dioxide (NO2), peroxynitrate (OO-NO2) and peroxynitrite (00-N=0) (section 1.3.3.1).
Reactive oxygen and nitrogen species can also derive from inhaled pollutants such as
cigarette smoke (discussed further in section 1.3.3.1).
The presence of free radicals at excessive levels may cause damage to cells and tissues.
The lung possesses a multitude of antioxidant defences to minimise the damage to
biological molecules (Table 1.1). These consist of enzymatic antioxidants (superoxide
dismutase, catalase, glutathione peroxidase) and expendable soluble antioxidants
(glutathione, vitamin E, vitamin C, and |3-carotene). Superoxide dismutase catalyses
the dismutation of superoxide to hydrogen peroxide. The hydrogen peroxide produced
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must be removed by other enzymes such as catalase or glutathione peroxidase (GPx).
Catalase is responsible for the conversion of hydrogen peroxide to water and oxygen,
whereas GPx catalyses the oxidation of GSH to GSSG (discussed later) at the expense
of hydroperoxides such as hydrogen peroxide. The non-enzymatic antioxidants react
directly with radical species and are sacrificed in the process. During this process the
antioxidants either themselves become oxidised, or become radical species. In breaking
the chain of lipid peroxidation, vitamin E becomes a tocopherol radical that is less
damaging than the peroxyl radical (Wang and Quinn, 1999). Vitamin C scavenges O2'
and -OH forming the dehydroascorbate radical (Chaudiere and Ferrari-Iliou, 1999). In
addition to its functions in the GSH system whereby GSH is oxidised to GSSG by GPx,
free GSH can scavange radicals such as O2' resulting in the formation of the thiyl
radical (GS) and H2O2 (Comhair and Erzurum, 2002). Nitrosation of free GSH by
ONNO- results in the formation of GSNO, which is liberated into free GSH and NO by
GPx (Comhair and Erzurum, 2002). The antioxidant network acts in synergy to
eradicate radical species and enables regeneration of the reducing compounds. The
regeneration of most, if not all, reducing cofactors is coupled to glutathione and/or
NADPH metabolism. For example, the tocopherol radical can be reduced back to
tocopherol by ascorbate, which can be reduced by GSH, forming GSSG. GSH is then
regenerated at the expense ofNADPH from the hexose monophosphate shunt.
9
Table 1.1. Reactive species found in normal pulmonary tissue and the antioxidants
that keep them under control.


































Glutathione (GSH), a tri-peptide (L-y-glutamyl-L-cysteinylglycine), is present at high
levels in lung lining fluid (Cantin et al., 1987). GSH is synthesised from glutamine,
cysteine and glycine, by y-glutamyl cysteine synthetase and GSH synthetase, where y-
glutamyl cysteine synthetase is the rate-limiting step enzyme in this reaction (Figure
1.3). The availability of cysteine also determines the rate of de novo GSH synthesis
(van Klaveren et al., 1997).
GSH maintains the redox balance in the lung by reacting with oxidising compounds to
form glutathione disulphide (GSSG). This reaction may occur spontaneously both
intracellularly and extracellularly, however it can also be enzymatically catalysed.
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Glutathione peroxidase catalyses the conversion of hydroperoxides or lipid peroxides
(ROOH) to less toxic, H2O or lipid hydroxyl compounds (Eq. 1), with conversion of
GSH to GSSG (Meister and Anderson, 1983). GSSG formed intracellularly is reduced
by glutathione reductase, at the expense of NADPH (Eq. 2).
Eq. 1) 2GSH + ROOH -+ GSSG + ROH +H20
Eq. 2) GSSG + NADPH + H+ -»• 2GSH + NADP+
GSSG can then exchange with protein sulphydryls to form mixed disulphides (protein-
SSG), catalysed by protein disulphide isomerase (Eq. 3) (Dickinson and Forman, 2002).
Formation of a protein-glutathione mixed disulphide with the active site thiol of an
enzyme would presumably result in its inactivation (Dickinson and Forman, 2002).
Eq. 3) GSSG + Protein-SH Protein-SSG + GSH
Furthermore, GSH can protect the lung from xenobiotic compounds by direct
conjugation (Figure 1.3), also resulting in the formation of mixed disulphides.
Compounds with an electrophilic center readily conjugate with GSH, this reaction may
be spontaneous, or catalysed by glutathione-S-transferases (GSTs). These conjugates
are typically converted to mercapturic acids before being safely excreted (Meister and
Anderson, 1983). Restoration of GSH levels after depletion by conjugation formation
requires de novo synthesis (Dickinson and Forman, 2002).
In order to maintain a high intracellular GSH to GSSG ratio, GSSG may be reduced
enzymatically by glutathione reductase (Dickinson and Forman, 2002). Alternatively,
GSSG and low molecular weight protein-SSG may be exported from the cell. Resulting
in depletion of intracellular cysteine, the availability of which is limiting in de novo
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GSH synthesis (stated earlier). To replenish cysteine levels, y-glutamyltransferase
located on the outer surface of the membrane transfers the y-glutamyl reside from
extracellular GSH, GSSG and protein-SSG to other amino acids (Figure 1.3, y-glutamyl
pathway). Cysteinyl-glycine is then degraded to cysteine and glycine by an
extracellular dipeptidase. y-Glutamyl-amino acid, cysteine and glycine are taken up
into the cell via an amino acid transporter (Dickinson and Forman, 2002), where GSH is
resynthesised.
In the lung, GSH is synthesised in the type II cell and exported to the lung lining fluid
(van Klaveren et al., 1987), where it is present at high levels (Cantin et al., 1987). It
appears that these high levels are maintained by the limited availability of y-glutamyl
transpeptidase at the type II cell surface (Cantin et al., 1987); the only enzyme capable
Of breaking the y-glutamyl bond (Meister and Anderson, 1983). The limited availability
of this enzyme likely contributes to decreased GSH catabolism and high extracellular
levels. Almost all of the GSH in the lung lining fluid is in the reduced state, which is
thought to be due to export of reduced GSH at a rate exceeding that of formation of
GSSG (Cantin et al., 1987). It has been shown that a high extracellular thiol
concentration stimulates GSH release from cells, whereas a high concentration of











































5-oxyprolinase ADP + Pi
AA 5-Oxyproline
ATP
Figure 1.3. Summary of glutathione metabolism.
(Taken from, Meister and Anderson, 1983)
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1.2. Chronic Obstructive Pulmonary Disease (COPD)
1.2.1. Overview
Chronic Obstructive Pulmonary Disease (COPD) is a collection of diseases, including
chronic bronchitis, and emphysema; defined by "airflow limitation that is not fully
reversible, usually both progressive and associated with an abnormal inflammatory
response" (Global Initiative for Chronic Obstructive Lung Disease (GOLD), Pauwels et
al., 2001). Cigarette smoking is the major aeitiological factor in the development of
COPD with 90% of COPD patients being current, or former smokers, however only 15-
20% of smokers develop COPD (Turato et al., 2001). The increasing prevalence of
COPD means that it will be the third most common cause of death worldwide by the
year 2020 (Murray and Lopez, 1996).
1.2.1.1. Chronic Bronchitis
Chronic Bronchitis is defined by "the presence of a chronic productive cough for three
months in each of two successive years in whom other causes of chronic cough have
been excluded" (Ciba Foundation Guest Symposium, 1959; ATS, 1962). Chronic
bronchitis is a disease of the central airways and the symptoms arise as a result of
hypersecretion of mucus in the respiratory tract; a consequence of an increase in the
volume of submucosal glands and an increase in the number and distribution of goblet
cells in the surface epithelium. Squamous metaplasia of bronchial epithelium with loss
of cilia occurs (Jeffrey, 2000), predisposing the tissue to cancer, but also impairing the
process of mucociliary clearance. In addition, chronic bronchitis is associated with
inflammation of the airway wall and mucus secreting apparatus (Mullen et al., 1985).
14
The production of sputum by COPD patients was originally considered to be irrelevant
to the development of airflow limitation and future prognosis (Peto et al., 1983)
however, more recent studies by Lange et al. (1990) and Vestebo et al. (1996) have
demonstrated that increased sputum production is associated with a more rapid decline
in FEV1 and increased risk of hospitalisation.
1.2.1.2. Emphysema
Emphysema was first described by Rene Laennec in 1834 after observation of the cut
surface of postmortem human lungs that had been dried in inflation (Laennec, 1834).
He proposed that the observed emphysematous lesions were due to over-inflation of the
lung, which compressed capillaries leading to atrophy of lung tissue. The definition of
emphysema has been revised a number of times since, by the Ciba Foundation Guest
Symposium (1959), the World Health Organisation (1961) and, most recently, by the
American Thoracic Society (ATS, 1962). The current definition is of "abnormal,
permanent enlargement of the airspaces distal to the terminal bronchioles accompanied
by destruction of their walls and without obvious fibrosis" (Snider et al., 1985).
Two distinct types of emphysema, centriacinar and panacinar, have been identified
based on the portions of the acinus involved in the disease. Centriacinar emphysema is
characterised by enlarged airspaces found in association with respiratory bronchioles
with preservation of the more distal ducts and alveoli, this form of emphysema is most
commonly associated with cigarette smoking. Panacinar emphysema, usually
associated with a i-antitrypsin deficiency, refers to abnormally large airspaces across
acinar units, and tends to involve all components of the acinus uniformly (Turato et al.,
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2001). The enlargement of alveolar spaces observed in emphysema (Figure 1.4) results
in impaired gas exchange due to decreased surface area. Moreover, collapse of the
airways occurs, which is thought to be the result of a loss of alveolar attachments
(section 1.1), and loss of elastic recoil due to loss of elastin (section 1.2.4.1.).
1.2.1.3. Systemic effects
COPD is not purely a disease of the airways, a loss of skeletal muscle mass is also
observed during the course of the disease. Indeed, exercise limitation is a frequent
complaint of COPD sufferers. Elegant studies by Killian et al. (1992) demonstrated that
COPD patients often stop exercise, not as a result of breathlessness, but because of leg
fatigue. The exact mechanism for the loss of muscle mass is not yet clear, however
systemic inflammation, increased resting metabolic rate, abnormal skeletal muscle
regeneration, and skeletal muscle apoptosis have been proposed to contribute to skeletal
muscle atrophy in COPD (Agusti, 2001).
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Figure 1.4. Electron micrograph of a normal lung (A) and a lung with emphysema
(B). Magnification x 100. Taken from Van Wynsberghe et al., 1990
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1.2.2. Inflammation in COPD
Inflammation is the general term for the local accumulation of fluid, plasma proteins,
and white blood cells that is initiated by physical injury, infection, or a local immune
response (Janeway and Travers, 1997). Inflammation is present in the airways of
asymptomatic smokers and is further increased in patients with COPD (Saetta et al.,
2001). A connection between these inflammatory changes and the pathophysiology of
COPD has been extensively studied; however, it is difficult to find a consensus
regarding the types of inflammatory cells and markers in the lung, and the importance
of each of these factors in the development of COPD. In many cases this is due to the
technique used to gain the information, different techniques sample different portions of
the lung, and thus a complete picture is difficult to obtain. Moreover, COPD is a term
encompassing a number of diseases, imprecise and variable definitions of the degree of
disease mean that categorising patients is complicated, and as a result each set of
researchers may study a slightly different sub-group of COPD patients. However, there
is a general consensus on the importance of inflammation in COPD and so its
characteristics will be described.
1.2.2.1. Inflammatory Cells
Central Airways
In the central airways of smokers with no airflow obstruction, T-lymphocytes and
macrophages are predominant in the airway wall, and neutrophils, while present in low
numbers in the airway wall, are most prevalent in the airway lumen. In smokers with
COPD, airflow limitation is associated with a further increase in T-cells and
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macrophages in the airway wall and neutrophils in the lumen. In addition, neutrophilia
is more apparent in the epithelium of these individuals (Saetta et al., 1997). A
comparison of chronic bronchitic subjects with asymptomatic smokers that have normal
lung function, revealed an increase in neutrophil and macrophage numbers and a
decreased T-cell CD4+/CD8+ ratio in the bronchial glands (Saetta et al., 1997). This is
in accordance with Lams et al., (2000) who observed increased CD8+ cells in bronchial
biopsies from smokers with COPD compared with asymptomatic smokers; however in
their study no significant difference in neutrophils was evident. The contrasting views
on the occurrence of neutrophilia in the airway wall is possibly due to the ability of
neutrophils to migrate rapidly across tissues, thus it is easier to detect neutrophils in the
airway lumen than the tissue. The presence of neutrophils in the bronchial glands,
lumen and wall may be directly responsible for increased sputum seen in these patients
as neutrophil elastase is a potent secretagogue for cultured airway submucosal glands
(Nadel, 1991). In severe COPD the numbers of neutrophils in the airway wall increase
and this is correlated with increased airflow limitation (Di Stefano et al., 1998).
Peripheral airways
In the seminal study by Hogg et al (1968), the peripheral airways were established as a
major site of increased airway resistance in smokers, and this has stimulated further
study into the pathogenesis of COPD focused on the peripheral airways. Evidence of
inflammation has been detected in the peripheral airways of young smokers who do not
show any signs of airflow limitation (Niewohener et al., 1974). Although no tissue
destruction or fibrosis was evident, mononuclear cells were detected in the airway wall
and clusters of macrophages in the respiratory bronchioles. More recent studies have
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detected increased numbers of inflammatory cells, such as neutrophils, macrophages
and CD8+ T-cells, in the peripheral airway epithelium of smokers as compared with
non-smokers (Saetta et al., 2000). In addition, increased numbers of goblet cells have
been seen in smokers with chronic bronchitis and airway obstruction when compared
with non-smokers; this may also be the cause of increased sputum production in COPD
(Saetta et al., 2000). When smokers with and without airflow obstruction are compared,
increased lung inflammation, demonstrated by increased total leukocytes (Figure 1.5),
occurs in both peripheral airway wall and the airway lumen of smokers with airflow
obstruction (Turato et al., 2002). These authors found increased numbers of CD4+ and
CD8+ T-cells in the airway wall and increased numbers of macrophages in the airway
lumen; however no difference in neutrophils was evident between smoking groups.
Comparison of smokers and non-smokers, regardless of the presence of airflow
obstruction, has demonstrated a decrease in the CD4+/CD8+ ratio in the submucosa,
however in one study an increased number of neutrophils was only observed in smokers
when ex-smokers were excluded from the non-smoking group and only life long non-
smokers were taken into account (Lams et al., 1998). When the data was reanalysed
comparing obstructed (FEVi 63 ± 1.6% predicted) with non-obstructed (FEVi 93 ± 2%
predicted) no difference in the presence of inflammatory cells was seen.
Parenchyma
In the parenchyma of the lung, little evidence of tissue destruction or fibrosis is present
in healthy smokers (Saetta et al., 2001). However, contrary to definition there is
evidence of some alveolar wall fibrosis in otherwise emphysematous lungs (Jeffrey,
2000). The predominant cell type in the parenchyma of COPD patients are CD8+ T-
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cells and their presence is correlated with increased airflow limitation (Saetta et al.,
1999). It has been shown that CD8+ T-lymphocytes can directly induce alveolar
destruction in a transgenic mouse expressing a target antigen on alveolar type II cells
(Enelow et al., 1998). This suggests the presence of T-lymphocytes in the alveolar
region of COPD patients may contribute to emphysematous lesions in these patients;
and also presents the possibility that COPD may indeed be an autoimmune disease.
Table 1.2 Inflammatory cells in the airways of smokers and patients with COPD.
Smokers COPD
PMN MO CD4+ CD8+ PMN MO CD4+ CD8+
Central wall - + + + + ++ ++ +++
Airways lumen + - - - + -
Peripheral wall + + + ++ + ++ ++ +++
Airways lumen + + + + + ++ + ++
Parenchyma
/Alveoli
+ + + + ++ ++ + +++
PMN- neutrophil, MO - macrophage, CD4+ - CD4 T-cell, CD8+ - CD8 T-cell
Systemic circulation
In addition to increased infiltration of inflammatory cells into the lung, increased cell
numbers are also detected in the peripheral blood of smokers and COPD patients. Total
blood leukocytes are increased in smokers (Bergmann et al., 1998), and COPD patients
(Sin and Man, 2003). Moreover, reminiscent of the airways, there is a decreased ratio
of CD4+/CD8+ T-cells in peripheral blood of COPD patients (Hodge et al., 2003).
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Figure 1.5. Leucocyte infiltration in the small airways. Infiltration of leucocytes
stained with anti-CD45 (red) in (A) a smoker with mild COPD and (B) a smoker with




Many inflammatory mediators including cytokines, chemokines, and cell adhesion
molecules, are upregulated in COPD. Although, no consensus on the cytokine profile
of COPD patients has been reached, it is generally accepted that COPD patients have
increased levels of the pro-inflammatory cytokines, interleukin (IL)-6, IL-8 and tumour
necrosis factor-a (TNF-a) in sputum and bronchioalveolar lavage (BAL) fluid, with
further increases occurring during exacerbations (Aaron et al., 2001; Bhowmik et al.,
2000; Keatings et al., 1996; Pesci et al., 1998; Tanino et al., 2002; Yamamoto et al.,
1997). Increased macrophage chemoattractant protein-1 (MCP-1) is also observed in
the lungs of COPD patients (de Boer et al., 2000). In addition, systemic inflammation is
observed, with increases in plasma IL-6, IL-8 and TNF-a (Eid et al., 2001; Hageman et
al., 2003; Yasuda et al., 1998). Moreover IL-10, an anti-inflammatory cytokine was
found to be decreased in COPD patients (Takanashi et al., 1999), which may contribute
further to inflammation.
Production of many of these cytokines can be induced by exposure to cigarette smoke.
Treatment of bronchial epithelial cells, endothelial cells and macrophages in vitro with
cigarette smoke results in the production of IL-8 and TNF-a (Churg et al., 2003a;
Hellermann et al., 2002; Mio et al., 1997; Wang, Ye et al., 2000) and increased levels
of cytokines have been detected in the BAL fluid of animals exposed to cigarette smoke
(Miller et al., 2002). Moreover, a systemic effect was found with increased plasma
TNF-a in mice and guinea pigs after cigarette smoke exposure (Churg et al., 2003b;
Wright et al., 2002).
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Increased TNF-a levels are thought to be central to the inflammation observed in
COPD, which is supported by the observation that mice deficient in the TNF-a receptor
are resistant to smoke-induced inflammation and connective tissue breakdown (Churg et
al., 2002a). Moreover, emphysematous changes induced by elastase are reduced in
TNF-a receptor deficient mice (Lucey et al., 2002). IL-10 inhibits the secretion of
TNF-a, thus decreased levels of this protein in COPD patients may intensify TNF-a
expression.
Inflammatory cells and resident lung cells secrete cytokines and other inflammatory
mediators. IL-8 is expressed by macrophages, neutrophils, endothelium and airway
epithelium; macrophages and epithelial cells express TNF-a. MCP-1 is expressed by
monocytes, endothelium, and epithelium. These mediators work in a paracrine and
autocrine manner activating cells or bringing in additional inflammatory cells. TNF-a
activates macrophages, inducing nuclear factor-KB (NF-icB)-dependent transcription of
IL-8, which is a strong chemoattractant for neutrophils. As indicated by the name,
MCP-1 is a chemoattractant for monocytes. Thus the production of these cytokines in
COPD may be responsible for the high numbers of inflammatory cells. Moreover,
TNF-a induces expression of intercellular adhesion molecule-1 (ICAM-1) and
endothelial-leucocyte adhesion molecule-1 (E-selectin/ELAM-1) on the endothelial cell
surface (Pober et al., 1986). Leukocytes pass through the pulmonary circulation,
propelled by local blood flow. Cell adhesion molecules, expressed on the endothelium,
serve to tether leukocytes, enabling extravasion into the tissues in response to
chemoattractants. The lung endothelium in COPD patients displays an increased
surface expression of E-selectin, and ICAM-1 (DiStefano et al., 1994; Riise et al.,
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1994), which may facilitate inflammatory cell influx. This upregulation may be due to
the action of cytokines however, a number of in vitro studies have demonstrated that
cigarette smoke itself induces expression of cell adhesion molecules on endothelial
cells. Increased expression of E-selectin (Stone et al, 2002) and ICAM-1 (Kalra et al.,
1994; Shen et al., 1996) was observed after exposure to cigarette smoke condensate,
which was associated with increased neutrophil and monocyte adhesion.
Thus in response to cigarette smoke, resident lung cells secrete chemotactic cytokines
while cell adhesion molecules are displayed on the endothelial surface, resulting in
inflammatory cell recruitment. In response to these cytokines, and also the presence of
cigarette smoke in the airways, the infiltrating inflammatory cells release further
cytokines, inducing additional cell adhesion molecule expression and inflammatory cell
influx. Thus in COPD patients, the presence of increased levels of inflammatory
mediators may not be responsible for disease pathogenesis, but merely a consequence of
increased inflammation.
1.2.4. Hypotheses for the pathogenesis of emphysema
The main theories for the development of emphysema involve loss of extracellular
matrix (ECM) components and degradation of elastin. The ECM, as in all tissues,
constitutes the structural framework of the lung architecture; it provides attachment for
epithelial cells and also affords outward traction for the small airways and alveoli by
enabling tissue attachment (section 1.1). Elastin is vital for the elastic recoil of the lung
and resistance of the small airways (Takashima and Mead, 1972; Mead, 1971). Thus,
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loss of ECM components and/or elastin is detrimental to the compliance of the lung as it
results in airway collapse and detachment of alveolar cells.
1.2.4.1. Protease-antiprotease
The hypothesis that emphysema results from an imbalance between the release of
proteases from infiltrating inflammatory cells and the antiprotease defence of the lung
was first advanced over 40 years ago. Two independent observations laid the
foundations for this hypothesis. Firstly, decreased plasma levels of the protease
inhibitor, ai-antitrypsin were observed in individuals who developed premature
emphysema (Laurell and Eriksson, 1963). Secondly, emphysematous lesions were
observed in rats and hamsters after intra-tracheal administration of the protease papain
(Gross et al., 1965). Since then a number of other proteases have been found to induce
experimental "emphysema", including the neutrophil serine proteases, elastase and
proteinase 3 (Damiano et al., 1986; Kao et al., 1988; Lucey et al., 1985; Senior et al.,
1977). A wide variety of proteases, which degrade elastin and collagen, the major
components of the ECM, are released by both neutrophils and macrophages (Stockley,
2002; Tetley, 2002). The breakdown products of elastin and collagen, desmosine and
hydroxyproline respectively, were increased in BAL fluid after exposure of mice to
cigarette smoke (Churg et al., 2002b). In addition to proteolytic destruction of invading
pathogens, the function of cellular proteases is to degrade matrix proteins to facilitate
migration of the cell through tissue to the site of injury/inflammation (Stockley, 2001).
As discussed earlier (section 1.2.2.1.), increases in airway inflammatory cell numbers
occurs in cigarette smokers, and neutrophil influx has been observed in mice exposed to
cigarette smoke (Churg et al., 2002b). Thus, it is proposed that tissue damage may
26
result directly from the increased influx of inflammatory cells in cigarette smokers. In
addition, proteases and oxidants (discussed later) may be released by these cells into the
lung lining fluid, resulting in destruction of matrix proteins. Indeed, increased elastin
peptide concentrations are observed in COPD patients (Betsuyaku et al., 1996; Schriver
et al., 1992), thus strengthening the hypothesis that emphysema results from lung matrix
breakdown. Furthermore, degradation products of elastin and collagen are
chemoattractants for monocytes and neutrophils (Hunninghake et al., 1981;
Postlethwaite and Kang, 1976; Riley et al., 1988; Senior et al., 1980). Thus matrix
breakdown may directly result in recruitment of additional inflammatory cells further
exacerbating tissue damage.
Proteases have also been implicated in many of the other pathological features of
COPD. Distortion and narrowing of the small airways may be due to, loss of
bronchiolar attachments as a result of ECM destruction, and also proteolytic destruction
of elastic fibres in respiratory bronchioles (Shapiro, 2002). Instillation of neutrophil
elastase resulted in damage to bronchial epithelium, and subsequent airway remodelling
(Lucey et al., 1985). Squamous metaplasia of epithelium with loss of cilia was
observed, consistent with epithelial changes detected in the bronchi of patients with
COPD.
Serine proteases
The serine proteases associated with COPD are, neutrophil elastase, proteinase 3 and
cathepsin G. These enzymes are stored as fully mature enzymes in cellular granules,
and are mainly limited to neutrophils, mast cells, and a subset of peripheral blood
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monocytes, but not tissue macrophages (Shapiro, 2002). Traditionally the serine
protease, neutrophil elastase, is viewed as the crucial protease for alveolar matrix
destruction and emphysema. As discussed earlier, instillation of elastase results in the
development of emphysematous lesions, and increased levels of elastase have also been
detected in human subjects with COPD. Elastase-substrate complexes have been
detected at sites of lung damage in human emphysema patients (Damiano et al., 1986),
and increased neutrophil elastase-ai-antitrypsin complexes have been detected in
individuals with sub-clinical emphysema (Betsuyaku et al., 1999, 2000). In animal
models, increases in matrix breakdown products and airspace enlargement induced by
cigarette smoke exposure, can be decreased by the administration of exogenous aj-
antitrypsin (Churg et al., 2003b; Dhami et al., 2000), thus further implicating neutrophil
elastase in the development of cigarette smoke-induced emphysema.
a1-antitrypsin deficiency
a i-antitrypsin is a member of the serine protease inhibitor (serpin) superfamily, it is
mainly synthesised in the liver and released into the circulation. Its primary function is
to protect the lung against neutrophil elastase, although it has been shown that ai-
antitrypsin protects against almost all proteases detected in the lung (Gadek et al.,
1981). The majority of the enzyme reaches the lung by diffusion from the plasma, but it
is also produced locally by macrophages and bronchial epithelial cells (Parfrey et al.,
2003). Approximately 70 variants of ai-antitrypsin have been identified, classified
according to their migration by isoelectric focusing (Pi) (Lomas and Mahadeva, 2002).
The two most common deficiency variants, are S (Glu264Val) and Z (Glu342Lys),
which result from point mutations within the protein. Individuals who are homozygous
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for the more severe Z mutation (ZZ) are rare, and have only 10-15% of the plasma ai-
antitrypsin of normal (MM) individuals. Heterozygotes for S ai-antitrypsin (MS)
results in plasma a\-antitrypsin levels that are approximately 60% of normal
individuals, and is not associated with any clinical symptoms. Individuals with
homozygous Z ai-antitrypsin (MZ) have 40% less plasma ai-antitrypsin than normal
individuals (Sandford and Pare, 2000). Decreased plasma ai-antitrypsin levels in
sufferers result from the formation of periodic acid Schiff-positive (PAS-positive)
inclusions, which are retained in the endoplasmic reticulum of hepatocytes (Sharp et al.,
1969), reducing ai-antitrypsin levels in plasma and preventing the usual increase in
plasma levels in acute-phase reactions. As a result these individuals develop junior
hepatitis, cirrhosis and hepatocellular carcinoma (Eriksson et al., 1986; Sveger, 1976).
It is thought that the point mutation in Z aj-antitrypsin causes the protein to form long
chain polymers, which become trapped in the endoplasmic reticulum (Lomas and
Mahadeva, 2002). Sufferers also develop early onset panacinar emphysema and chronic
bronchitis, which is accelerated further by cigarette smoking (Larsson, 1978). This is a
direct consequence of the lowered ai-antitrypsin levels in sufferers, however in the Z-
defrciency the enzyme is also less effective at inhibiting neutrophil elastase (Ogushi et
al., 1987). Polymer formation not only prevents secretion but also inactivates the
enzyme (Elliot et al., 1996), there is evidence of polymer formation in lung lining fluid
(Elliot et al., 1998), which may be induced by the presence of inflammatory mediators




Matrix metalloproteases (MMPs) are a large family of Zn2+ and Ca2+-dependent
proteases, which can degrade the extracellular matrix proteins collagen and elastin
(O'Connor and FitzGerald, 1994). Macrophages are the major source of MMPs,
although they can be expressed by epithelial cells and fibroblasts. Neutrophils contain
MMP8 and MMP9 in secondary and tertiary granules, which are released upon
activation (Tetley, 2002). MMPs are secreted as inactive proenzymes and/or are bound
to endogenous inhibitors, the tissue inhibitors of metalloproteases (TIMPs). MMPs can
be activated directly by proteolysis (Nagase, 1997); also degradation of associated
proteins by other proteases can also influence MMP activation, for example neutrophil
elastase can degrade TIMPs (Tetley, 2002). Once activated MMPs degrade extracellular
matrix proteins and can also cleave a variety of non-matrix proteins. MMPs also
inactivate inhibitors of other proteases, such as ai-antitrypsin (Gronski et al., 1997;
Sires et al., 1994; Tetley, 2002), thus amplifying the proteolytic burden on the lung. In
addition MMPs act upon inflammatory mediators, thereby regulating inflammation.
They proteolytically activate transforming growth factor-P (TGF-p) and TNF-a,
whereas they inactivate interleukin-ip by degradation (Tetley, 2002).
An association has also been observed between the development of COPD and presence
of MMPs. Increased MMP2, MMP8 and MMP9 have been detected in the BAL fluid of
COPD patients (Betsuyaku et al., 1999; Segura-Valdez et al., 2000). In addition,
macrophages from patients with COPD release more MMP-9 compared with non-
smokers and healthy smokers (Lim et al., 2000; Russell et al., 2002a,b). Increased
MMP1 expression by the alveolar epithelium has also been detected in patients with
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emphysema (Imai et al., 2001). Investigation of the role of MMPs in emphysema has
been aided by the use of transgenic technology. Increased expression of MMP1 in the
lungs of mice results in the development of emphysematous lesions (D'Armiento et al.,
1992; Foronjy et al., 2003; Shiomi et al., 2003). Moreover, MMP12 expression appears
to be critical to the development of emphysema in mice; exposure of MMP12 deficient
(MMP12-/-) mice to cigarette smoke resulted in decreased neutrophil and monocyte
recruitment and decreased matrix breakdown products (Churg et al., 2002b). Moreover,
MMP12-/- mice were resistant to cigarette smoke-induced emphysema (Hautamaki et
al., 1997).
1.2.4.2. Oxidant-antioxidant hypothesis
It has been suggested that an oxidant-antioxidant imbalance is an important feature in
the pathogenesis of COPD. In addition to antiproteases, the lung lining fluid contains a
multitude of antioxidants (MacNee, 2000). In smokers, the lung is exposed to oxidants,
both directly from cigarette smoke and released from infiltrating inflammatory cells.
The presence of free iron in the lung lining fluid enables the production of additional
ROS by Fenton chemistry (section 1.3.3.1 and appendix 1). Oxidative stress results
when an increased oxidative burden in the lungs of smokers and/or depletion of
antioxidant defences shifts the balance in favour of oxidants. Oxidative stress has many
effects; it can directly degrade the components of the lung matrix and induce epithelial
injury, inactivate antiprotease defences, induce sequestration of neutrophils in the
microvascular circulation and induce the expression of proinflammatory mediators.
Evidence of lung oxidative stress has been reported in COPD patients and smokers;
local oxidative stress can be detected as increases in exhaled nitric oxide (Ansarin et al.,
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2001; Montuschi et al., 2001; Silkoff et al., 2001), hydrogen peroxide (Dekhuijzen et
al., 1996) and the lipid peroxidation markers 8-isoprostane (Montushi et al., 2000) and
ethane (Paredi et al., 2000). Moreover, increases in plasma and urinary F2-isoprostane
(Morrow et al., 1995; Pratico et al., 1998) indicate that systemic oxidative stress also
occurs.
Effects on antioxidant defences
The lung epithelial lining fluid contains a well-developed antioxidant system, which
includes the enzymes superoxide dismutase, catalase, glutathione peroxidase and the
antioxidants, ascorbate, urate, vitamin E and glutathione. This system serves to protect
the components of the lining fluid and the underlying airway cells from oxidative injury
(MacNee, 2000; Van der Vliet et al., 1999). However, inhaled oxidants, and those
released by infiltrating inflammatory cells may deplete lung antioxidants resulting in
oxidative stress. Although GSH, the major antioxidant present in lung lining fluid, is
increased in the BAL fluid of chronic smokers (Morrison et al., 1999), it is depleted
during acute cigarette smoking. A dose- and time- dependent decrease in GSH levels
was observed after instillation of CSC into rat lungs in vivo, and after CSC treatment of
epithelial cells in vitro, which returned to above control levels within 12-24 hours
(Rahman et al., 1995). As outlined previously (section 1.1.2), GSH is oxidised to
GSSG to maintain a redox balance, and often inactivates electrophilic compounds by
the formation of GSH conjugates. GSH-protein conjugates have been recovered from
the lungs of rats exposed to cigarette smoke, and after in vitro exposure of lung
epithelial cells (Rahman et al., 1995). Thus, cigarette smoking may deplete GSH by the
formation of GSH conjugates, rather than direct oxidation of GSH to GSSG by free
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radicals. The increased GSH levels in chronic cigarette smokers may be attributed to
increased expression of y-glutamyl cysteine synthetase (section 1.1.2). In vitro
exposure of alveolar epithelial cells results in increased expression of mRNA transcripts
for this enzyme (Rahman et al., 1996). Thus increased GSH in the lungs of chronic
cigarette smokers may act as a protective mechanism, however the deleterious effects of
cigarette smoking may occur during and immediately after cigarette smoking when
these defences are depleted.
Decreased levels of vitamin-E are observed in the lungs of smokers compared to non-
smokers (Pacht et al., 1986), which was attributed to increased oxidative metabolism of
vitamin-E to the quinone product. Vitamin-E is a naturally occurring lipophilic
compound that preferentially inserts into cell membranes. Moreover it is a chain
breaking antioxidant that scavenges peroxyl radicals and thus protects against lipid
peroxidation (Ricciarelli et al., 2001; Wang and Quinn, 1999). Increased markers of
lipid peroxidation are seen in COPD patients when compared to unaffected individuals
(Corradi et al., 2003; Paredi et al., 2000; Pratico et al., 1998; Rahman et al., 2002), and
also in healthy smokers (Euler et al., 1996; Fahn et al., 1998; Hoshino et al., 1990;
Lepenna et al., 1995; Mezzetti et al., 1995; Morrow et al., 1995; Petruzzelli et al., 1998;
Steinberg and Chait, 1998). These effects can be prevented by vitamin-E
supplementation (Hoshino et al., 1990; Steinberg and Chait, 1998). Lipid peroxidation
may occur as a direct consequence of smoke exposure, exposure of rat tracheal




Cigarette smoking amplifies the protease-antiprotease imbalance by inactivating
endogenous antiproteases. Decreased ai-antitrypsin activity is detected in the lungs of
smokers when compared with non-smokers (Carp et al., 1982; Gadek et al„ 1979), and
in the lungs of rats exposed to cigarette smoke (Janoff et al., 1979). ai-antitrypsin has
an active site methionine, which is susceptible to oxidation. Oxidation of this residue
results in decreased inhibitory activity (Johnson and Travis, 1979). It has been shown
that cigarette smoke is capable of oxidising this enzyme in vitro (Evans and Pryor,
1992), and ai-antitrypsin recovered from the lungs of smokers was oxidised (Carp et al.,
1982). Thus, it is thought that cigarette smoking contributes to the pathogenesis of
COPD by causing a "functional ai-antitrypsin deficiency". However, numerous other
proteases and antiproteases are present in the lung; therefore the perception that
inactivation of one single antiprotease results in emphysema may be an
oversimplification.
Degradation of lung matrix/epithelial injury
Cigarette smoking results in damage to the airway epithelium, demonstrated by an
increase in airway permeability after acute cigarette smoking (Morrison et al., 1994).
This may be a consequence of epithelial cell detachment, which has been observed in
vitro in response to cigarette smoke (Lannan et al., 1994). Although GSH prevented
these effects, implying an oxidant-mediated process, detachment may be due to
proteolytic degradation of lung matrix as a result of cigarette smoke-induced oxidative
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inactivation of antiprotease defences. Acute cigarette smoking results in inflammatory
cell infiltration (Saetta et al., 2001), thus the recruited and activated cells may
exacerbate antiprotease inactivation. Moreover, oxidants are capable of directly
degrading matrix components, such as collagen (Riley and Kerr, 1985), and therefore
cigarette smoke-induced oxidative stress, may have a direct effect on matrix integrity.
Expression ofpro-inflammatory mediators
Many pro-inflammatory genes, upregulated in COPD patients, are under the control of
the redox-sensitive transcription factor NF-kB, including IL-6, IL-8, TNF-a and ICAM-
1. NF-kB is sequestered in the cytoplasm in an inactive form by inhibitory protein-icB a
(IkBcc,). Upon stimulation, by oxidants or cytokines, IkB kinase (IkK) phosphorylates
bcBa resulting in ubiquitination and degradation of IkBa and release of NF-kB. NF-
kB rapidly translocates to the nucleus, binds to its target motif in the promoter region of
key genes and activates transcription. After NF-kB dependent resynthesis, IkBoc enters
the nucleus and facilitates the removal of NF-kB from the DNA and back to the
cytoplasm (Janssen-Heininger et al., 2000).
Cigarette smoke has been shown to increase NF-kB activation and DNA binding in a
number of cell types (Anto et al., 2002; Shen et al., 1996). Also, acute in vivo exposure
of guinea pigs to cigarette smoke resulted in increased NF-kB nuclear translocation with
an increase in DNA binding potential in the lung (Nishikawa et al., 1999). Moreover,
lipopolysaccharide (LPS) stimulation of BAL cells from smokers resulted in more rapid
activation ofNF-kB than cells from non-smokers (Mochida-Nishimura et al., 2001).
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It has been shown that cigarette smoking can affect gene expression via modulation of
chromatin, the complex of DNA and histone proteins, which in an inactive state is
tightly wound. To enable transcription, chromatin is unwound, opening up the DNA
structure, enabling increased accessibility for transcription factors. DNA unwinding can
be promoted by acetylation of histone proteins (Gregory et al., 2001), which may be
induced by oxidative stress and is modulated by histone acetyltansferases (HATs) and
histone deacetylases (HDACs). HATs induce acetylation of histones, whereas HDACs
promote deacetylation (Figure 1.6). Repression of HDAC with the inhibitor
Trichostatin A leads to increased histone acetylation and increased inflammatory
cytokine gene expression (Ito et al., 2001). Decreased HDAC expression was observed
in macrophages after cigarette smoke exposure in vitro (Ito et al., 2001), which was
correlated with increased cytokine expression. As these results could be mimicked with
H2C>2 exposure the authors proposed that modulation of chromatin by acetylation could
be induced directly by oxidative stress. Thus cigarette smoke, via imposing oxidative
stress, may increase the expression of proinflammatory cytokines, by increased histone
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1.2.4.3. Apoptotic destruction ofalveoli
It has long been recognised that loss of alveolar epithelial cells occurs in emphysema,
however this was thought to be the consequence of detachment as a result of matrix
degradation. Recently apoptosis has been suggested as a mechanism for the loss of
alveolar cells in emphysema. Indeed, instillation of active caspase-3 into mouse lungs,
in combination with a protein transfection reagent, results in alveolar wall destruction
and airspace enlargement, as early as 2 hours after instillation (Aoshiba et al., 2003).
Increased numbers of apoptotic epithelial and endothelial cells have been detected in the
lungs of emphysema patients (Kasahara et al., 2001; Segura-Valdez et al., 2000),
associated with decreases in the expression of vascular endothelial growth factor
(VEGF) and VEGF-receptor (VEGF-R) (Kasahara et al., 2001). Moreover, instillation
of a VEGF receptor inhibitor induces lung cell apoptosis and the development of
emphysematous lesions (Kasahara et al., 2000). Also, high levels of VEGF were
measured in BAL fluid from non-smokers but were undetectable in healthy smokers
(Koyama et al., 2002), thereby implicating cigarette smoking in the downregulation of
VEGF and VEGF-R. VEGF is a growth factor required for the survival of endothelial
cells (Neufeld et al., 1999), and withdrawal of this factor results in apoptosis in vitro
(Gerber et al., 1998a, b) and in vivo (Alon et al., 1995). Thus decreased expression of
VEGF and its receptor by cigarette smoking, resulting in lung cell apoptosis, may be
responsible for the development of emphysematous lesions.
Exposure to cigarette smoke in vitro has been reported to induce apoptosis in many cell
types (Aoshiba et al., 2001; Hoshino et al., 2001; Ishii et al., 2001; Vayssier et al.,
1998; Wang 2001). Moreover, exposure of rats to cigarette smoke results in apoptosis
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in sites away from the lung, such as the gastric mucosa (D'Agostini et al., 2001; Ma et
al., 1999; Wang, Ma et al., 2000), the skin (D'Agostini et al., 2000), and the testis
(Rajpurkar et al., 2002). Although decreases in VEGF levels have been implicated in
cigarette smoke-induced apoptosis, the factors that mediate cigarette smoke-induced cell
death are yet to be elucidated. As discussed earlier, increased oxidative stress occurs in
cigarette smokers, and increased products of lipid peroxidation, such as 4-
hydroxynonenal (4-HNE) (Rahman et al., 2002), have been detected in COPD patients.
Increased apoptosis is evident after stimulation of cells with 4-HNE (Bruckner and
Estus, 2002; Herbst et al., 1999; Ji et al., 2001; Kalinich et al., 2000; Liu, Kato et al.,
2000; Reuf et al., 2001; Zhang et al., 2001), and oxidative stress has been demonstrated
to induce apoptosis in many cell types (reviewed in Chandra et al., 2000). Thus many
factors could be responsible for cigarette smoke-induced apoptosis, requiring further
investigation within this area.
1.2.5. Prevention of repair
The lung has a substantial capacity to mediate repair responses (Rennard, 2001).
Fibroblasts play an important role in tissue repair; they proliferate at sites of injury,
produce matrix proteins and remodel the matrix via contraction. However in the
presence of cigarette smoke, both the migration and proliferation of fibroblasts is
inhibited (Nakamura et al., 1995). Also, cigarette smoke impairs fibroblast-mediated
wound contraction in an in vitro system, via inhibition of fibronectin release from
fibroblasts (Carnevali et al., 1998). The effects of cigarette smoke condensate (CSC) on
collagen gel contraction and fibronectin production was attenuated by the addition ofN-
acetyl-L-cysteine (NAC), a precursor of GSH, and amplified by the addition of
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butathione sulfoxamine (BSO), an inhibitor of y-glutamyl cysteine synthetase (Kim et
al., 2002). These data demonstrate the effects of cigarette smoke on wound repair could
be prevented by GSH, thus oxidative stress may be responsible for the inhibition of
repair mechanisms by cigarette smoke.
Cigarette smoke has also been shown to significantly decrease elastin resynthesis both
in vitro and in vivo. Cigarette smoke exposure resulted in approximately 85% inhibition
of elastin resynthesis, assessed by the formation of desmosine, the final step in the
synthesis of mature elastin (Laurent et al., 1983). Osman et al (1985) instilled elastase
into the lungs of hamsters and monitored subsequent elastin resynthesis by
incorporation of 14C into desmosine. Animals exposed to cigarette smoke for 1 week
after elastase exposure showed 40% reduction in cross-link formation when compared
with animals left to recover in room air for an equivalent time period. Thus, in addition
to inducing lung damage, cigarette smoke appears to exacerbate this damage by
preventing regenerative processes.
1.2.6. The effector cells of COPD
As discussed earlier, both neutrophils and macrophages are present in the lung of
smokers and COPD patients, so it is unlikely that there is a single effector cell that is
responsible for the development of COPD. The cells of the immune system work in
concert with each other; each cell type releasing mediators that modify the behaviour of
others. For instance, the proteases released by inflammatory cells can affect the
proteases of another, as in the case of MMPs, which can inactivate ai-antitrypsin
(Gronski et al., 1997; Sires et al., 1994; Tetley, 2002) making the lung more susceptible
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to neutrophil elastase-mediated attack. In addition neutrophil elastase can activate
MMPs by proteolysis (Gronski et al., 1997; Sires et al., 1994), increasing the
macrophage-mediated protease burden in the lung. Mice deficient in the macrophage
metalloelastase, MMP12, did not develop emphysema (Hautamaki et al., 1997) so
implicating the macrophage in emphysematous tissue destruction. However the
presence of normal levels of MMP12 was not sufficient to develop emphysema,
elevated lung neutrophil numbers were also required (Churg et al., 2002b).
Administration of an anti-neutrophil antibody to smoke exposed mice prevented
neutrophil influx, but not macrophage numbers, and attenuated smoke-mediated
increases in the matrix breakdown products, desmosine and hydroxyproline (Dhami et
al., 2000). Thus the development of COPD is therefore most likely due to combined
effects of a number inflammatory cell types.
1.2.7. Susceptibility
Only a small proportion, approximately 10-20%, of smokers develop COPD, suggesting
an interaction between genetic and environmental factors. Many studies have
investigated specific "susceptibility factors" for COPD, but with little success so far.
Increased reactivity of inflammatory cells, gene polymorphisms, and adenoviral
infection, have all been implicated in the susceptibility to COPD.
The process of neutrophil migration results in damage to the extracellular matrix thus,
smoke-induced neutrophil migration in susceptible individuals may be higher than in
non-susceptible individuals. A study by McCrea et al (1994) studying IL-8 levels
observed no overall difference between non-smokers and healthy smokers, however a
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small subset of smokers had levels above that of healthy controls, and the BAL fluid
had a greater chemotactic potential for neutrophils. Thus these smokers may represent a
susceptible population. It has also been shown that neutrophils from patients with
emphysema are more sensitive to chemoattractants, and have an increased potential to
digest connective tissue (Burnett et al., 1987). Migration of neutrophils is facilitated by
expression of endothelial cell adhesion proteins, which bind to proteins on the surface
of the neutrophil, capturing them from the circulation and enabling extravasation into
the tissues. COPD patients have increased endothelial cell expression of E-selectin, and
ICAM-1 (DiStefano et al., 1994; Riise et al., 1994). These proteins capture circulating
neutrophils to enable extravasation into the tissues. Thus the enhanced inflammatory
response in these individuals may be due to the enhanced neutrophil numbers, or rate of
neutrophils recruited, compared with non-susceptible smokers.
Polymorphisms in the TNF-a promoter have been identified and implicated in the
pathogenesis of COPD but are associated with different ethnic populations. A guanine
to adenine substitution at position -308 (TNF-a308G/A) has been associated with
chronic bronchitis in Japanese (Sakao et al., 2001) and Taiwanese (Huang et al., 1997)
populations, but appears to have no association with the development of COPD in
Caucasian subjects (Higham et al., 2000). This polymorphism is thought to increase
TNF-a production (Thomas, 2001), and could be the mechanism for the increased TNF-
a levels observed in COPD patients.
Polymorphisms in enzymes that are involved in detoxification of xenobiotic agents
present in cigarette smoke (discussed in section 1.3.3.2) have also been linked to COPD
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pathogenesis. Glutathione-S-transferases (GSTs) catalyse the conjugation of GSH with
electrophilic compounds. Six isoenzymes of GST have been identified; alpha, mu, pi,
theta, sigma and kappa. GSTpi-1 (GSTP1) and GSTmu-1 (GSTM1) are expressed in
alveoli, alveolar macrophages and respiratory bronchioles (Sandford and Pare, 2000).
Homozygous deletion of the GSTM1 gene results in a complete absence of the protein
and is associated with emphysema in individuals with lung cancer (Harrison et al.,
1997) and chronic bronchitis in heavy smokers (Baranova et al., 1997). Polymorphisms
in GSTP1 have also been associated with COPD; substitution of valine for isoleucine at
position 105 (GSTPl-105Ile/Val) is increased in these individuals (Ishii et al., 1999),
which results in decreased activity of the enzyme (Johansson et al., 1998; Sundberg et
al., 1998). However, this appears to have no association with COPD in Korean (Yim et
al., 2002) populations. Microsomal epoxide hydrolase (mEH) is a xenobiotic-
metabolising enzyme that also aids detoxification of highly reactive intermediates in
cigarette smoke. Two polymorphisms have been detected in this gene, which encode
for fast or slow enzyme activity (Hassett et al., 1994). A higher occurrence of
homozygosity for slow activity mEH was detected in COPD patients than normal
individuals (Smith and Harrison, 1997). Individuals with any of these polymorphisms
may have a decreased ability to metabolise harmful compounds in cigarette smoke. A
number of other polymorphisms have also been associated with the pathogenesis of
COPD, such as in matrix metalloproteases (reviewed in Wallace and Sandford, 2002),
surfactant proteins (Guo et al., 2001), hemeoxygenase-1 (Yamada et al., 2000), and IL-
13 (van der Pouw Kraan et al., 2002).
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It has also been proposed that susceptibility to COPD may result from childhood
adenoviral infection. Hogg and colleagues have shown that adenoviral DNA persists in
the lungs after infection, and have shown that individuals with COPD possess more
adenoviral DNA, specifically the E1A gene, than control subjects (Matsuse et al.,
1992). Moreover, expression of ElA protein was detected in lung epithelial cells lining
the airways, alveoli, and submucosal glands (Elliott et al., 1995). A guinea pig model
of latent adenoviral infection displayed increased inflammatory cell influx when
exposed to cigarette smoke than uninfected animals (Vitalis et al., 1998), indicating that
adenoviral infection may exacerbate the local inflammatory response and subsequent
lung damage. This was reinforced by further studies that demonstrated that
emphysematous changes were increased in smoke-exposed ElA infected animals
compared to uninfected animals (Meshi et al., 2002). Moreover, E1A protein
expression increased with the severity of emphysema in human subjects, which was also
associated with increased inflammation (Retamales et al., 2001). Increased
inflammation by ElA infection may be related to increased production of chemotactic
agents. Transfection of lung epithelial cells with El A resulted in increased production
of IL-8 in response to LPS stimulation (Keicho et al., 1997).
As outlined above, individual susceptibility to COPD may be due to a variety of
reasons, which makes study of the disease difficult. Treatment of cells in culture, or
animal models, with cigarette smoke produces a range of effects, however these studies
with normal systems may not aid our understanding of susceptibilty. This is
emphasised by the fact that it is difficult to induce emphysema in animal models using
cigarette smoke as the stimulus, without using susceptible strains (Mahadeva and
44
Shapiro, 2002). Thus, elucidation of the susceptibility factor for COPD would greatly
aid our understanding of, and research into, this disease.
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1.3. Cigarette Smoking
1.3.1. History of tobacco use
Tobacco was brought to Europe from the Americas in the 15th century and nearly 100
years after its introduction, the smoking of tobacco in pipes was widespread. This gave
way to the consumption of tobacco as snuff, followed by smoking of cigars and
cigarettes. Cigarette smoking became the dominant form of tobacco consumption in the
developed world during the 20th century. Although initially hailed for its medicinal
properties, the detrimental effects of tobacco consumption were soon realised. In the
early 20th century many articles were published addressing the health effects of
smoking. In 1912 Dr I Adler made the first strong association between cigarette
smoking and lung cancer (Adler, 1912), however it wasn't until 1930 that a statistical
Correlation was made. A number of studies in the 1950's and 1960's demonstrated an
association between smoking and the symptoms of COPD; breathlessness, cough and
sputum production (reviewed in Bumey, 1964). The publication of the 1964 report of
the US Surgeon General highlighted the deleterious health effects of smoking to the
general public (Burney, 1964), resulting in a dramatic decline in the numbers of
smokers. This has continued to the present day, for example in 2002, 25% of the British
population were current smokers (Lader and Meltzer, 2003), compared with 41% in
1976 (Office ofNational Statistics, 1976).
1.3.2. Diseases caused by cigarette smoking
In addition to COPD over 40 different diseases have been associated with cigarette
smoking. In 2000 cigarette smoking resulted in 114,000 deaths in the United Kingdom,
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25% of which were the result of COPD (Peto et al., 1994). A number of cancers, not
just of the lung, are connected with smoking as well as correlations with other fatal
diseases, such as heart disease, stroke, pneumonia and the development of aortic
aneurysm. Moreover, many non-fatal diseases such as ulcers, cataracts and periodontal
disease have a positive correlation with smoking history. Smoking during pregnancy
also poses risks for the unborn child, such as low birth weight and limb defects (Wald
andHackshaw, 1996).
1.3.3. Constituents of cigarette smoke
1.3.3.1. Free Radicals
Cigarette smoke contains a number of reactive oxygen and nitrogen species with the
potential to generate additional radicals by a number of reactions, in total cigarette
smoke contains 1014-16 free radicals per puff. One of the most interesting, and highly
studied, radicals in smoke is the semiquinone. Semiquinones (QH*) exist in equilibrium
with quinones (Q) and hydroquinones (QH2) in the tar phase of cigarette smoke. Redox
cycling by these quinone radicals produces superoxide (O2'"), which can further
dismutate to form hydrogen peroxide (H2O2) (appendix 1A). During the process of
smoking the tar fraction of cigarette smoke is deposited in the lung where water-soluble
components dissolve into the pulmonary fluids. These water-soluble compounds
include components of the quinone system, thus 0{' and H2O2 can form within lung
lining fluid. Moreover, both cellular fluids and cigarette tar contain free iron, which can
catalyse the production of hydroxyl radicals (*OH) from hydrogen peroxide by Fenton
chemistry (Pryor and Stone, 1993) (appendix IB).
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Nitric oxide (NO) is present in cigarette smoke, at levels as high as 250ppm (Chow et
al., 1993), which can be oxidised to form reactive nitrogen dioxide (NO2) (Beckman
and Koppenol, 1996). Additional reactive molecules, peroxynitrate (OO-NO2) and
peroxynitrite (00-N=0), can be formed by reaction of O2'" with NO2, or NO
respectively (appendix 1C) (Augusto et al., 2002).
Free radicals can attack lipid membranes inducing lipid peroxidation (appendix ID),
which results in the production of peroxyl radicals (ROO) (Halliwell and Chirico,
1993). NO2, OH* or O2'", the initiator radicals (In*), can react with polyunsaturated fatty
acids (PUFA's; RH) to form carbon-centred radicals (R*), which react with oxygen to
form peroxyl radicals (Porter et al., 1995). Peroxyl radicals then attack an additional
PUFA molecule, which enables the process to continue in a chain reaction, attack other
membrane proteins, or two peroxyl radicals may combine resulting in termination of the
reaction (Halliwell and Chirico, 1993).
1.3.3.2. Chemical components
Cigarette smoke is a complex mixture of over 4000 chemicals, a number of which are
listed in appendix 2 (Heseltine, 1987). Many of these chemicals arise from combustion
of the tobacco leaf itself, however a number of chemicals are added during cigarette
manufacture (Action on Smoking and Health, 2001). Most of the additives serve an
unknown purpose, but many others appear to be added to enhance "flavour" or augment
the uptake of specific components, such as nicotine (Action on Smoking and Health,
2001). From the identified list of chemicals, 47 have been classified as carcinogens by
48
the International Agency for Research on Cancer (IARC, 2000), however this may be an
underestimation, as many have not yet been tested.
Many of the individual components of cigarette smoke have been implicated in the
pathogenesis of COPD. For example, in addition to its addictive properties encouraging
continuation of the smoking habit, nicotine is chemotactic for human neutrophils and
enhances responsiveness to chemotactic agents (Totti et al., 1983); therefore it may
contribute to the increased inflammatory response observed in COPD (Section 1.2.2).
Acrolein and acetaldehyde are the major a,(3-unsaturated aldehydes present in cigarette
smoke. As electrophilic components they conjugate with GSH (Section 1.1.2) and thus
may deplete lung antioxidants as observed in cigarette smokers (described in section
1.2.4.). In addition, acrolein is an initator of, as well as a product of, lipid peroxidation
(Esterbauer et al., 1991). Therefore, acrolein in cigarette smoke may propagate the lipid
peroxidation observed in response to cigarette smoke (section 1.2.4.). Moreover, these
compounds have pro-apoptotic properties; they induce apoptosis in a number of cell
types (Li, Hamilton et al., 1997; Menegola et al., 2001), and thus may be implicated in
the cell loss observed in the pathogenesis of emphysema. Acrolein and acetaldehyde in
cigarette smoke may also inhibit repair processes, discussed in section 1.2.5. The
inhibitory effects of cigarette smoke on fibronectin production and fibroblast migration
can by mimicked by the addition of either acrolein or acetaldehyde (Carnevali et al.,




Cell death has been recognised since the nineteenth century. Initially, cell death was
considered to be a degenerative phenomenon produced by injury and termed necrosis.
However, the occurrence of a physiological, naturally occurring cell death was
documented in Lecture XV of Virchows Cellular Pathology (1859) "death brought on
by (altered) life - a spontaneous wearing out of living parts", and was termed
necrobiosis. It has been suggested recently that Virchow may have documented the first
observations of apoptosis as he clearly states that necrobiosis was very different from
necrosis (Gerschenson and Geske, 2001). The development of staining methods in the
late 1800's, and more elaborate and powerful microscopes, enabled cell death to be
studied in more detail (Majno and Joris, 1995). In 1885 Walther Flemming documented
that the epithelial lining of regressing ovarian follicles was littered with cells, the nuclei
of which were "breaking up". His drawings show cells with pyknotic chromatin typical
of apoptosis and many free apoptotic bodies, he termed this death "chromatolysis"
(Flemming, 1885). Since then many striking examples of apoptosis have been
documented (for review see Majno and Joris, 1995).
However it wasn't until John Kerr joined forces with Andrew Wyllie and Sir Alastair
Currie that the term "apoptosis" was coined, Kerr had previously called the
phenomenon "shrinkage necrosis", describing a characteristic cell death with distinct
morphological features (Kerr et al., 1972). The name apoptosis was taken from the
Greek word used to describe the "dropping off' or "falling off' of petals from flowers,
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or leaves from trees. The cell death they described was characterised morphologically
by structural changes involving "nuclear and cytoplasmic condensation and breaking up
of the cell into a number of membrane-bound, ultrastructurally well-preserved
fragments" (Kerr et al., 1972). However, since then a number of biochemical and
morphological markers to enable identification of apoptotic cells have surfaced.
However the discovery that the DNA of apoptotic cells is fragmented into discrete
oligonucleosomal fragments, easily detected by gel electrophoresis was a significant
finding (Axends et al., 1990; Wyllie, 1980). The discovery of this marker has lead to an
enormous increase in the volume of published papers on apoptosis.
Development of Caenorhabditis elegans as a tool for genetic research revealed that
exactly 131 of 1090 somatic cells in the C. elegans embryo die during development
(Sulston and Horvitz, 1977; Sulston et al., 1983). More interestingly, individual cells of
developmental cell lineages die at specific, apparently pre-determined stages of
development. Further study revealed the existence of the Ced genes, which controlled
essentially all the somatic deaths in C.elegans (Horvitz et al., 1983). Thus it was
thought that cell death in other species may result from the activation of a specific death
program. Sequencing of Ced-3 revealed that it was related to a family of cysteine
proteases, called caspases due to their requirement to cleave after an aspartate residue
(Yuan et al., 1993). The name caspase denotes that they are cysteine-dependent
aspartate-specific proteases (Alnemri et al., 1996). In many cases, activation of
caspases is seen as an essential marker, alongside morphological changes, to identifiy
apoptosis; cell death that assumes any other form is labelled necrotic. However, the
caspases are not the only death effector pathway; a number of caspase-independent cell
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death mechanisms, many with characteristics of apoptosis, necrosis, or a mixture of the
two have been documented, making the field of cell death highly complex!
1.4.2. Apoptosis
1.4.2.1. The Caspases
The caspases are a family of cysteine proteases, which can be further divided into two
sub-families. One sub-family is an essential part of the cell death machinery; the other
plays a role in inflammation (Nicholson and Thornberry, 1997). Fourteen caspases have
been identified so far, including the murine caspases -11 and -12 which as yet have no
identified human homolog (Thornberry and Lazebnik, 1998). These proteases are
highly specific, recognising a four amino acid sequence, designated P1-P4. They
possess an absolute requirement for aspartate at the Pi position. The caspases can be
divided into three groups based on their substrate specificity: group one recognises the
consensus sequence WEHD (caspase-1, -4, and -5), the second group DEXD (caspase-
2, -3, and -7) and the third group (L/V)EXD (caspase-6, -8, and -9) (Tablel.3). The
pro-apoptotic C.Elegans caspase Ced-3, the most closely related to caspase-3,
recognises a DEXD consensus sequence (Table 1.3).
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Adapted from Nicolson and Thornberry, 1997
The division of caspases by their substrate specificity correlates with their function.
Group I caspases are predominantly involved in inflammatory processes. Group II
caspases recognise a sequence often found in non-caspase proteins cleaved during
.apoptosis. These caspases are designated "effector caspases" and they are responsible
for cell disassembly. The caspases belonging to group III are all "initiator caspases",
responsible for initiation of the caspase cascade. (Nicholson and Thornberry, 1997).
Activation ofthe caspases
The caspases exist in normal cells as inactive zymogens consisting of three domains: an
NH2 terminal domain, a large subunit and a small subunit (Thornberry and Lazebnik,
1998). Both subunits contain essential components of the catalytic machinery and
activation occurs via proteolytic cleavage within a short linker segment that connects
the large and the small subunits of the proenzyme (Salvesen and Dixit, 1999;
Thornberry and Lazebnik, 1998). This linker domain may play a role in preventing
spontaneous autoactivation of the proenzyme, as it is too short to enable heterodimer
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formation (Chang and Yang, 2000). Following cleavage, the large and small subunits
associate to form a heterodimer, after which, two heterodimers associate to form a
tetramer with two independent catalytic sites (Thornberry and Lazebnik, 1998).
Cleavage of the linker domain results in a partially active intermediate caspase, which
processes itself to yield the active caspase. This self-cleavage removes the short
inhibitory NH2 prodomain from the large subunit, which enhances the activity of the
caspase (Thornberry and Lazebnik, 1998). The NH2 domain plays a role in regulating
activation of the proenzyme, as recognition of at least four amino acids in this region is
a necessary requirement for efficient catalysis (Thornberry and Lazebnik, 1998).
Caspases are proteolytically activated by other caspases, either by an upstream caspase
or by "induced proximity". The effector caspases are activated by an upstream caspase,
however concentrating the zymogens results in activation of the initiator caspases.
Unprocessed enzymes have limited proteolytic capability, yet it is thought that bringing
them into close proximity enables activation of either themselves, or adjacent caspases
(Salvesen and Dixit, 1999; Donepudi and Grntter, 2002). Execution of apoptosis by
caspases occurs via two specific pathways, namely the extrinsic and intrinsic pathways.
1.4.2.2. Death-receptor mediated apoptosis: the extrinsic pathway
The "extrinsic" pathway of cell death is initiated by the binding of a death receptor to its
cognate ligand (Figure 1.7). A number of death receptor pathways exist, such as Fas
and TNF, however the basic mechanism of activation for all pathways is the same.
Binding of a ligand to a cell-surface death-receptor results in trimerisation and
recruitment of a death domain (DD)-containing adaptor molecule to the cytoplasmic DD
54
of the receptor. In the case of the Fas pathway the adaptor molecule is FADD (Fas-
associating protein with death domain). This complex is termed the death-inducing
signaling complex (DISC). The N-terminal of FADD contains a death effector domain
(DED), which binds to two DED domains present in caspase-8, bringing multiple
molecules together resulting in autoactivation as discussed above; from this point, death
receptor signalling diverges in different cells (Scaffidi et al., 1998). In type I cells1,
such as lymphoid cells, receptor ligation leads to a massive activation of caspase-8,
which then directly cleaves and activates procaspase-3 (Budihardjo et al., 1999).
However, in type II cells , caspase activation is generally insufficient to activate
procaspase-3. In this case caspase-8 cleaves the cytoplasmic protein Bid to form
truncated Bid (tBid), which activates the "intrinsic" mitochondrial pathway (Kaufmann
and Hengartner, 2001).
1,2 The nomenclature of type I and type II cells here refers to the ability of the extrinsic pathway to

















Figure 1.7. Basic schematic illustrating the extrinsic and intrinsic pathways of
caspase activation. The extrinsic pathway. Ligation of death receptors, results in
autoactivation of caspase-8 and subsequent activation of the effector caspase, caspase-
3. Cleavage of Bid by caspase-8 induces cytochrome-c release from the mitochondria,
which can also be induced by environmental or chemical induced stress. The intrinsic
pathway, cytochrome-c, dATP, APAF-1, and procaspase-9 associate to form the
apoptosome, resulting in autoactivation of caspase-9, which also activates caspase-3.
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1.4.2.3. The apoptosome
The "intrinsic" pathway is controlled by the mitochondria and is activated by
environmental stresses, such as growth factor withdrawal, or via the action of truncated
Bid from the extrinsic pathway (Figure 1.7). Originally mitochondria were not thought
to play a role in apoptosis, as few noticeable changes of this organelle were seen.
However, this changed after Xiadong Wang and colleagues identified three factors
essential for activation of the intrinsic pathway, cytochrome-c, dATP and a new protein
apoptotic protease-activating factor-i (Apaf-1) (Liu et al., 1996; Yang et al., 1997; Zou
et al., 1997). During apoptosis cytochrome-c is released from the mitochondria (Kluck
et al., 1997; Scaffidi et al., 1998; Yang et al., 1997) and forms a complex with APAF-1
and dATP, which is termed the apoptosome. The apoptosome complex is formed by a
mechanism that is not clearly understood, however it has been proposed that dATP
binds to the consensus nucleotide-binding domain of APAF-1 and is hydrolysed to
dADP inducing a transient conformational change in APAF-1. This conformational
change is stabilised by the recruitment of cytochrome-c, which promotes
multimerisation of the APAF-1-cytochrome-c complex enabling recruitment of
procaspase-9 via the caspase recruitment domains (CARDs) of the molecules (Figure
1.7). Activation of procaspase-9 occurs via autocatalysis as a result of zymogen
clustering, after which the active enzyme activates downstream caspases (Li, Nijhawan
et al., 1997; Zou et al., 1999). It was initially believed that APAF-1 was only required
transiently for caspase-9 activation after which active enzyme was released, however it
is now thought that the complex represents the true, active form of caspase-9
(Rodriguez and Lazebnik, 1999)
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1.4.2.4. How caspases result in the demise ofthe cell
The caspases play a key role in the self-degradation of complex cellular material to
enable safe and efficient removal of the cell "corpse". Once activated by initiator
caspases, the effector caspases cleave a distinct set of proteins enabling disassembly of
the cell (Nicholson and Thornberry, 1997). In most cases, proteolytic cleavage results
in loss of function of the target protein; however gain of function can be obtained, either
by removal of a negative regulatory domain, or by inactivation of a regulatory subunit
(Hengartner, 2000). There are over 100 identified substrates of the caspases, although
not all are cleaved during the process of apoptosis (Fischer et al., 2003). In most cases
the consequences of cleavage are poorly understood, however, in a few cases,
proteolysis of certain components can be linked to discrete morphological and
biochemical changes of cell death.
Caspases activate the nuclease that mediates oligonucleosomal DNA fragmentation,
caspase-activated DNase (CAD, Enari et al., 1998). In healthy cells CAD is complexed
with its inhibitor, inhibitor of CAD (ICAD) and is functionally inactive. In apoptotic
cells, caspases-3 and -7 cleave ICAD, releasing CAD and enabling DNA degradation
(Sakahira et al., 1998). DNA is an immunogenic molecule, it has been proposed that
break down of DNA into oligonucleosomal fragments not only aids removal of the
corpse, but also prevents inappropriate immune responses in vivo (Nagata et al., 2003).
Poly (ADP-ribose) polymerase (PARP) is inactivated by caspases during the process of
apoptosis (Kauffman et al., 1993; Lazebnik et al., 1994; Tewari et al., 1995). PARP is
a nuclear enzyme that catalyses the ADP-ribosylation of histones and other nuclear
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proteins in order to facilitate DNA repair. During apoptosis PARP is cleaved at a single
site by caspase-3, which separates the DNA-binding and catalytic domains, inactivating
the enzyme activity. It was originally thought that cleavage of PARP occurred to
prevent DNA repair during the breakdown of the nucleus. However, PARP-mediated
DNA repair is energetically expensive. During apoptosis DNA fragmentation by CAD
can cause significant activation of PARP and thus deplete cellular energy stores, energy
that is required to execute apoptosis. In some cases an inability to cleave PARP during
apoptosis results in depletion of the ATP pool and enhanced cell death, possibly by
necrosis (Herceg and Wang, 1999) (see section 1.4.4). However, it has been
documented that, in some cases, PARP cleavage is not essential for apoptotic cell death
(Leist et al., 1997; Wang et al., 1997).
Pyknosis and fragmentation of the nuclei, along with shrinkage of the cell, is one of the
most profound and striking morphological changes observed during apoptosis. Major
cytoskeletal changes occur during this process, many of which are caspase-mediated.
Lamins are nuclear envelope proteins that are cleaved by caspases (Takehashi et al.,
1996) resulting in nuclear fragmentation during the final stages of apoptosis execution
(Lazebnik et al., 1995). That this process was caspase-mediated was demonstrated by
the use of lamins with mutated caspase cleavage sites. The presence of these mutants
delayed the onset of apoptosis and prevented classical nuclear condensation; instead the
nuclear envelope collapsed while the nuclear lamina remained intact (Rao et al., 1996).
Thereby implicating caspase-dependent lamin cleavage as an important stage in nuclear
pyknosis. Disassembly of the cell requires breakdown of actin filaments. Neutrophils
deficient in gelsolin display delayed membrane blebbing, indicating that actin
reorganisation is an important factor for this hallmark of apoptosis (Kothakota, 1997).
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Gelsolin is cleaved by caspases during apoptosis to produce a constitutively active
fragment, which induces F-actin depolymerisation (Kothakota, 1997).
1.4.2.5. Regulation ofcell death
Given the irreversible nature of proteolytic degradation of cellular proteins, caspase
activation and activity have to be tightly regulated. The conversion of zymogens to
their active forms comprises the initial level of caspase regulation (see section 1.4.2.1).
However, additional levels of regulation exist in the form of endogenous caspase
inhibitors that act either at the level of cytochrome-c release or by specific inhibition of
active caspases.
The Bcl-2 Family
One of the most prominent families of apoptosis regulators is the Bcl-2 family, which
consists of approximately 16 proteins in humans. Bcl-2, an apoptosis-suppressor, was
originally discovered in B-cell lymphoma as a proto-oncogene located at the
breakpoints of t(14; 18) (q32;q31) chromosomal translocations (Bakhshi et al., 1985).
In these translocations the Bcl-2 gene is moved into juxtaposition with powerful
enhancer elements of the immunoglobulin heavy chain (IgH) locus resulting in the
overexpression of Bcl-2. It was shown in early experiments that exogenous
overexpression of this gene conferred increased cell survival of pre-B-cells after
withdrawal of essential growth factors (Vaux et al., 1988). In addition, the use of anti-
sense technology has shown that reduction of the levels of Bcl-2 results in accelerated
cell death after growth factor withdrawal (Reed et al., 1990a,b). Thus Bcl-2 emerged as
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the first example of an intracellular apoptosis suppressor and also the first identified
proto-oncogene that affected tumour development via cell death regulation rather than
cell division. The Bcl-2 family of proteins seem to act upon the mitochondria to either
facilitate, or prevent, cytochrome-c release (Adams and Cory, 1998), and therefore they
mostly confer protection upon cells undergoing apoptosis via the "intrinsic" pathway.
However, they may protect cells acting via the death-receptor induced "extrinsic"
pathway depending on whether the cells require a mitochondrial amplification step to
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Figure 1.8. The Bcl-2 family. Three sub-families exist in the Bcl-2 family, the Bcl-2
cohort promote cell survival whereas the Bax and BH3-only subfamilies facilitate
apoptosis. All contain between at least one Bcl-2 homology (BH) regions, many
contain hydrophobic transmembrane (TM) domains.
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The Bcl-2 family of proteins contain at least one of four Bcl-2 homology (BH) domains,
termed BH1-4. The family can be sub-divided into three sub-families, Bcl-2, Bax and
BH3-only (Figure 1.8). The pro-survival family members (Bcl-2, Bc1-xl, Bcl-w, Mcl-1,
Al, NR-13, BHRF1 and LMW5-HL) contain at least three domains, BH1, BH2 and
BH4 (Zha et al., 1996), however those most similar to Bcl-2 (Bcl-w and Bcl-xL) contain
all four regions. The members of the Bax sub-family (Bax, Bak and Bok), are also very
similar to Bcl-2 in that they contain the domains BH1-3. The third sub-family contains
only the BH-3 domain and thus bears little resemblance to any other family members,
and is named the BH3-only sub-family (Bik, Blk, Hrk, BNIP3, BimL, Bad, Bid and
EGL-1). Most anti-apoptotic Bcl-2 family members also contain a hydrophobic stretch
of amino acids at the C-terminus that anchors them in membranes (Figure 1.8), most
commonly the outer mitochondrial membrane, the endoplasmic reticulum and the
nuclear envelope, whereas the pro-apoptotic members are mainly located in the cytosol
or associated with the cytoskeleton (Hsu et al., 1997; Krajweski et al., 1993;
Puthalakath et al., 1999; Wolter et al., 1997). However, the localisation of Bcl-2 family
members to the mitochondrial membrane is important in their pro-/anti-apoptotic action
(Zamzami et al., 1996). The regulation of apoptosis by the Bcl-2 family remains poorly
defined. These proteins are multifunctional and at least three general functions have
been defined, a) dimerisation with other family members, b) binding to non¬
homologous proteins, and c) formation of ion channels.
The formation of dimers is thought to play a key role in maintaining a balance between
the pro- and anti-apoptotic members of the family, dictating the relative sensitivity or
resistance to apoptotic stimuli. It has been shown that Bcl-2 is able to form both
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homodimers with itself and also form heterodimers with Bax (Yin et al., 1994).
Similarly Bcl-xL can form homodimers, and heterodimerises with Bax and Bak, (Diaz et
al., 1997). The mechanism of dimerisation was elucidated after analysis of the crystal
structure of Bc1-xl, which contains two central hydrophobic a-helices surrounded by
five amphipathic helices (Muchmore et al., 1996). The a-helices representative of the
BH1, BH2 and BH3 domains form the borders of an elongated hydrophobic cleft, to
which the hydrophobic face of a BH3 amphipathic a-helix can bind (Muchmore et al.,
1996; Sattler et al., 1997). A model has been proposed that some Bcl-2 family
members may exist in two conformations: one in which the BH domains form a pocket,
and the other in which the amphipathic a-helix of BH3 rotates to expose its hydrophobic
surface so that it can bind to the receptor-like crevice on its dimerisation partner (Sattler
et al., 1997). Expression of a synthetic peptide representing the BH3 domain of Bax
prevented dimer formation between endogenous Bax and Bc1-xl, indicating the
importance of this domain in dimer formation (Jurgensmeier et al., 1998). Thus,
heterodimers are formed when there is an equal balance of pro- and anti- apoptotic
family members, however when either are in excess, homodimers form between either
two anti-apoptotic members, or two pro-apoptotic members, and cells are either
protected from, or susceptible to, apoptosis respectively (Oltvai et al., 1993; Oltvai and
Korsmeyer, 1994). It is thought that the BH3-only tribe, with the exception of Bid,
induce apoptosis solely by binding and inactivating their pro-survival cousins (Cory and
Adams, 2002).
Binding of Bcl-2 family members to non-homologous proteins may explain activities
previously associated with Bcl-2 members. For example, Bcl-2 can bind with Raf-1 via
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the BH4 domain, pulling the kinase from the cytosol to the mitochondrial membrane
where it induces phosphorylation of Bad (Wang et ah, 1996), a pro-apoptotic family
protein that antagonises both Bcl-2 and Bc1-xl by heterodimer formation (Yang et al.,
1995). However, phosphorylation of Bad interferes with its ability to bind Bcl-2/Bcl-xL
(Zha et ah, 1996) and as Bad contains no membrane-anchoring domain, it moves into
the cytosol and forms a complex with 14-3-3 scaffold proteins (Zha et ah, 1996).
Liberation of Bc1-2/Bc1-xl from Bad results in increased cell survival as these proteins
are able to perform their anti-apoptotic function (Wang et ah, 1996).
The translocation of cytochrome-c from the mitochondrial intermembrane space to the
cytoplasm plays a crucial role in apoptosis, and it is thought that the Bcl-2 proteins act
by either facilitating or preventing this release. Currently two models have been
proposed as possible mechanisms for cytochrome-c release, each supported by
substantial evidence. Elucidation of the structure of Bc1-xl indicated that the Bcl-2
family members may act by forming pores in membranes; Bc1-xl, in particular the a5
and a6 helices, shares striking similarity to the pore-forming domains of some bacterial
toxins, such as diptheria toxin (Muchmore et ah, 1996). As predicted, Bcl-2, Bcl-xL,
and Bax form ion channels when added to synthetic membranes (Antonsson et ah,
1997; Minn et ah, 1997; Schendel et ah, 1997; Schlesinger et ah, 1997) and can lyse a
suspension of erthrocytes when added extracellularly (Antonsson et ah, 1997).
Moreover, deletion of the a5 and a6 helices abolishes channel formation by Bcl-2 and
Bax (Schendel et ah, 1997). The pro-apoptotic protein Bax provides the most
convincing argument for pore formation by Bcl-2 proteins. Bax is located in the cytosol
of healthy cells, however upon apoptotic stimulation it dimerises and translocates to the
mitochondria, inserting into the outer membrane (Gross et ah, 1998). It is thought that
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this may create a channel in the outer mitochondrial membrane and facilitate release of
cytochrome-c (Jiirgensmeier et al., 1998). Whether the pore formed by Bax is of a
sufficient size to enable release of cytochrome-c and other intermembrane proteins from
the mitochondria is unclear; however it may be that larger channels are formed by
oligomerisation of identical family members, although evidence is not forthcoming
(Newmeyer and Ferguson-Miller, 2003). Antagonism by heterodimer formation may
play a direct role in regulating the formation of pores; Bcl-2 can prevent dimerisation
and channel formation by Bax (Antonsson et al., 1997; Gross et al., 1998).
Alternatively, release of cytochrome-c from the intermembrane space may result from
rupture of the outer mitochondrial membrane. In some apoptosis scenarios, loss of
inner mitochondrial membrane potential occurs, indicating the opening of a large
conductance channel known as the mitochondrial permeability transition (PT) pore
(Zamzami et al., 1996). Although the actual architecture of the PT pore is not yet
known, it is thought to be formed from a combination of proteins normally located in
the inner and outer mitochondrial membranes, such as the voltage-dependent anion
channel (VDAC), Cyclophilin-D, and the adenine nucleotide translocator (ANT), which
operate in concert to form a pore with a diameter of approximately 1.5kDa (Crompton,
1999). The PT pore is thought to form at contact sites between the outer and inner
membranes (Zoratti et al., 1994). Formation of the pore results in equilibration of ions
within the intermembrane space and the matrix resulting in disruption of the inner
mitochondrial membrane potential (Aym), uncoupling of oxidative phosphorylation and
matrix swelling. As the inner mitochondrial membrane has a larger surface area than
the outer membrane, matrix swelling can eventually lead to outer membrane rupture and
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release of proteins from the intermembrane space (Green and Reed, 1998). Bcl-2
family proteins have been reported to associate with the PT pore and regulate its
function (Zamzami et al., 1996). Overexpression of Bcl-2, or Bcl-xL, inhibits
mitochondrial permeability transition (Shimizu et al., 1996c; Single et al„ 2001;
Zamzami et al., 1996), whereas Bax overexpression induces it (Xiang et al., 1996).
However the importance of the PT pore in apoptosis has not yet been fully established;
it is still unclear as to whether PT pore formation occurs prior to caspase activation, as
some studies have shown that cytochrome-c release and caspase activation can occur
prior to any detectable loss of A\\im (Yang et al., 1997).
In contrast to the hypopolarisation associated with PT pore opening, hyperpolarisation
of the inner membrane has been observed prior to cytochrome-c release (Vander Heiden
et al., 1997, 1999). This is thought to result from the continued creation of the H+ ion
gradient despite loss of the ability to exchange mitochondrial ATP for cytosolic ADP,
reflecting dysfunction of the VDAC, ANT or both. Ion channel formation by Bcl-xL
prevents hyperpolarisation of the inner mitochondrial membrane, subsequent matrix
swelling and outer membrane rupture (Vander Heiden et al., 1997), by preventing
VDAC closure (Vander Heiden et al., 2001) and maintaining ATP/ADP exchange
(Vander Heiden et al., 1999).
Inhibitor ofapoptosis proteins (IAPS)
While the Bcl-2 proteins act to prevent caspase activation, an additional level of
regulation acts to prevent integration of the caspase signal, once activated. Inhibitor of
apoptosis proteins (IAPs) are a family of proteins that contain at least one baculovims
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IAP repeat (BIR) domain. The BIR domain is a ~70kDa-residue zinc-binding domain,
of which, between one to three copies are found in the IAP proteins. Seven family
members have been identified in humans, NIAP, c-IAP-l/HIAP-2/MIHB, c-IAP-
2/HIAP- 1/MIHC, XIAP/hlLP/MIHA, ML-IAP/Livin/KIAP, Survivin/TIAP and
Apollon/BRUCE (Deveraux and Reed, 1999). These IAPs have also been found in
organisms such as yeast, which neither contain caspases nor undergo apoptosis (Uren et
al., 1998); indicating that the IAPs have functions in addition to caspase inhibition.
More recently it has arisen that the IAPs are also involved in a number of diverse
cellular processes including, cell cycling, ubiquitination and receptor-mediated
signalling (Holcik, 2002). Nevertheless, they regulate caspase activity by binding to,
and inhibiting, active caspase-3, -7 and -9 (Datta et al., 2000; Deveraux et al., 1998;
Roy et al., 1997). The BIR domains are responsible for inhibiting specific caspases; in
particular BIR2 specifically targets caspases-3 and -7 whereas BIR3 targets caspase-9.
The IAPs act upon active caspases and processing of the proenzyme is essential for their
action. This is demonstrated by overexpression of X-linked IAP (XIAP) in U937 cells,
which did not inhibit caspase-9 processing, yet inhibition of the mature enzyme was
observed (Datta et al., 2000). Moreover, XIAP does not associate with or inhibit a
catalytically active unprocessed form of caspase-9, XIAP associates, via the BIR3
domain, with a segment of the small subunit which becomes exposed after proteolytic
processing (Srinivasula et al., 2001). The N-terminus of the pl2 subunit of caspase-9
fits in a conserved groove on the BIR3 domain of XIAP. The close proximity of the N-
terminus to the catalytic active site suggests that XIAP may hinder the entry of the
substrate to the active site (Srinivasula et al., 2001). However, more recent studies have
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shown that binding of XIAP traps caspase-9 in a monomeric state and thus prevents
formation of the catalytically active dimer (Shiozaki et ah, 2003).
The BIR region is less critical during IAP inhibition of caspase-3 and -7. The linker
sequence between BIR1 and 2 possesses higher affinity for the caspase than the BIR
domain (Huang et al., 2001). This linker occupies the active site of the caspase
preventing entry of the substrate (Chai et al., 2001; Huang et ah, 2001; Riedl et ah,
2001; Sun et ah, 1999). Interestingly, the linker sequence occupies the active site in a
reverse orientation to the substrate (Chai et ah, 2001; Huang et ah, 2001; Riedl et ah,
2001). The BIR2 region, with its weaker affinity for the caspase, subsequently latches
onto the caspase to stabilise the interaction (Huang et ah, 2001). Although the linker
sequence is the essential component for caspase inhibition it cannot bind, or inhibit,
either caspase on its own (Chai et ah, 2001; Sun et ah, 1999). However the BIR2
domain can be replaced with either glutathione-S-transferase (GST) or BIR1 without
significant loss of caspase inhibition (Chai et ah, 2001; Huang et ah, 2001; Sun et ah,
1999). It has been proposed that the presence of BIR2, or BIR/GST, may prevent the
linker sequence forming a "non-productive conformation" due to an intramolecular
interaction or possibly by preventing aggregate formation due to the hydrophobicity of
the linker sequence (Chai et ah, 2001; Huang et ah, 2001).
In much the same way as the Bcl-2 family have anti-apoptotic factors to keep the pro-
apoptotic factors in check, endogenous antagonists of the IAP family exist. The first
identified inhibitor of the IAPs was discovered simultaneously in humans and in mice
and was named Smac/DIABLO (second mitochondrial activator of caspases (hu)/ direct
IAP binding with low pi (ms)) (Du et ah, 2000; Verhagen et ah, 2000). This protein
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resides in the mitochondrial intermembrane space (Du et al., 2000; Verhagen et al.,
2000), and is released alongside cytochrome-c upon induction of apoptosis (MacFarlane
et al., 2002). Once released, Smac/DIABLO eliminates the caspase inhibitory effect of
many IAPs (Chai et al., 2000; Du et al., 2000; Verhagen et al., 2000) by binding to
either the BIR2 or BIR3 domain, liberating the bound caspase (Chai et al., 2000, 2001;
Huang et al., 2001; Liu et al., 2000; Srinivasula et al., 2001). More recently another
LAP antagonist has been identified, XIAP-associated factor 1(XAF1) (Liston et al.,
2001). XAF1 neutralises the IAPs in a different manner to Smac/DIABLO, XAF1
interacts directly with XLAP resulting in its sequestration in the nucleus where it is
unable to interact with caspases in the cytosol (Liston et al., 2001). In addition to
quenching IAP proteins by direct binding, it has been demonstrated that the IAP
antagonists can affect IAP protein levels by suppressing global protein translation,
resulting in depleted intracellular levels (Holley et al., 2002; Yoo et al., 2002).
Differential expression of the IAP proteins is detected in vivo, which may provide a
mechanism for controlling the presence or absence of IAPs in response to particular
stimuli. However, regulation of the IAPs also occurs as a result of post-translational
modification. Decreased levels of LAPs have been detected after the induction of
apoptosis, which can be prevented by the addition of proteosome inhibitors (Yang et al.,
2000). In addition to the BIR domains, the IAPs possess a RING domain that is
responsible for self-ubiquitination and degradation (Yang et al., 2000). Moreover it has
been demonstrated that the IAPs also ubiquitinate associated proteins such as
Smac/DIABLO (MacFarlane et al., 2002), and caspases (Huang et al., 2000; Suzuki et
al., 2001) resulting in their degradation. The degradation of caspases may serve to
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prevent release of active enzyme from the XIAP:caspase complex by Smac/DIABLO.
Thus in addition to direct degradation of Smac/DIABLO this may provide an additional
mechanism by which IAP counteracts its antagonists. However, it has been elegantly
demonstrated that the antagonists can also provide a pro-apoptotic counterbalance to the
anti-apoptotic effects of ubiquitination of proteins by IAPs, by promoting the self-
ubiquitination and degradation of the IAPs themselves (Holley et al., 2002; Yoo et al.,
2002). Thus, depending on the target, ubiquitination by the IAPs serves to both
promote and prevent apoptosis.
Thus, the IAPs and their antagonists act as an apoptotic rheostat, working against one
another to either lower or increase the threshold of activation for the execution of the
apoptotic pathway by caspases.
Heat-shockproteins (HSPs)
Heat shock proteins (HSPs) are a family of highly conserved proteins that are induced
in response to an array of physiological and environmental stresses (For review see
Beere, 2001). HSPs are classified according to their molecular weights, HSP-25, HSP-
47, HSP-60, HSP-70/72, HSP-90, HSP-110. These proteins fulfil a variety of roles; in
unstressed cells they function as molecular chaperones to facilitate the correct folding of
polypeptide chains. However HSPs-27, -70 and -90, also interfere with both death-
receptor mediated and mitochondria-mediated apoptosis.
Each of these proteins have been shown to prevent formation of a functional
apoptosome. HSP-70 and -90 act by binding APAF-1, HSP-70 prevents recruitment of
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procaspase-9 (Saleh et al., 2000), HSP-90 prevents the oligomerisation of APAF-1
(Pandey et al., 2000). HSP-27 binds and sequesters cytochrome-c after its release from
the mitochondria (Bruey et al., 2000). Therefore expression of these proteins can confer
protection against apoptotic cell death.
Other mechanisms ofcaspase regulation
Post-translational modification by either phosphorylation or nitrosylation, in addition to
ubiquitination described above, is a mechanism employed to regulate the caspases.
Caspases contain an essential cysteine thiol group, which is susceptible to S-
nitrosylation resulting in its inactivation (Dimmeler et al., 1997; Li, Billiar et al., 1997;
Mannick et al., 1999; Melino et al., 1997; Rossig et al., 1999; Tenneti et al., 1997;
Torok et al., 2002; Zeigler et al., 2003). Substitution of the active site cysteine for
alanine renders the caspase resistant to S-nitrosylation (Dimmeler et al., 1997; Mannick
et al., 1999; Rossig et al., 1999). Inhibition of caspase activity by .S-nitrosylation has
been shown to prevent apoptotic cell death (Li et al., 1999; Melino et al., 1997; Rossig
et al., 1999; Tenneti et al., 1997; Torok et al., 2002; Zeigler et al., 2003). In addition to
inhibiting the activity of caspases, nitric oxide a potent nitrosylating agent, prevents
their activation (Li et al., 1999; Torok et al., 2002; Zech et al., 2003). It has been
demonstrated that nitric oxide prevents functional oligomerisation of APAF-1, and
recruitment of caspase-9 (Zech et al., 2003). Nitric oxide prevented apoptosome
formation only in the presence of additional cytosolic factors, indicating there may be
another, yet unknown, target for caspase regulation by nitrosylation. Caspase
nitrosylation has been shown to have a role in physiological regulation of the apoptotic
pathway. In healthy cells caspase-3 can be detected in a nitrosylated state, whereas
72
upon induction of apoptosis it becomes denitrosylated, freeing the active site thiol
(Mannick et al., 1999, 2001). More recently it has been shown that a higher percentage
of caspase-3 and -9 compartmentalised in the mitochondria is nitrosylated, compared to
that present in the cytosol (Mannick et al., 2001), implying that nitrosylation acts to
prevent activation of caspases in the mitochondrial intermembrane space where
zymogens are kept in close proximity.
Activation of either the phosphatidylinositol 3-kinase (PI3-K) pathway (Cardone et al.,
1998), or the extracellular signal regulated kinase (ERK) pathway (Allan et al., 2003),
can induce phosphorylation of procaspase-9 preventing its activation by the
apoptosome. Moreover, the activity of active caspase-9 can be affected by
phosphorylation (Cardone et al., 1998). Caspase-9 does not need to be processed to be
enzymatically active (Stennicke et al., 1999). Phosphorylation of either form may act
as a regulator of enzymatic activity, preventing both autoactivation of pro-caspase-9 as
a result of induced proximity, and activation of downstream caspases by processed
caspase-9. Alternatively, it has been demonstrated that the activity of processed
caspase-9 is low in the absence of cytochrome-c and dATP, addition of these factors
induced a 2000-fold increase in caspase activity (Stennicke et al., 1999). As discussed
earlier, binding to a cytosolic factor, Apaf-1, is not only essential for the activation of
procaspase-9 but also appears to represent the active form of caspase-9 (Rodriguez and
Lazebnik, 1999). Therefore, like nitrosylation, phosphorylation of caspase-9 may
prevent assembly of the apoptosome resulting in an inability to activate itself, or prevent
activated caspase-9 from processing downstream caspases. Thus, phosphorylation and
nitrosylation may act as cellular survival signals; to prevent induction of the apoptotic
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pathway by spontaneously activated caspases, possibly via a requirement for the
activation of a denitrosylation/dephosphorylation pathway as part of the death-inducing
signal.
1.4.3. Caspase-independent cell death
Recently, cell death that displays many of the morphological and biochemical markers
of apoptosis, but without the activation of caspases, has been identified (Belmokhtar et
al., 2001; Brown et al., 2000; Carmody and Cotter, 2000; Clarke et al., 2003; Larmonier
et al., 2002; Mathiasen et al., 2002; Quignon et al., 1998; Sperandio, et al., 2000; Susin
et al., 2000; Wolf et al., 1999). Moreover, inhibition of caspases does not necessarily
result in survival but rather changes the form of cell death (Chautan et al., 1999; Liu et
al., 2003; Lemaire et al., 1998; McCarthy et al., 1997; Oppenheim et al., 2001; Sane
and Bertrand, 1999; Uzzo et al., 2001; Volbracht et al., 2001; Xue et al., 2001). As
discussed earlier, caspases are directly responsible for the hallmarks of apoptosis. Thus
additional pathways that enable disassembly of the cell, possibly by cleaving the same
substrates, must exist. A number of alternative death pathways have been described,
many mediated by proteases. Cathepsins, calpains, and granzyme B have the ability to
cleave caspase substrates and are activated in many of the alternative death pathways
(reviewed in Leist and Jaattela, 2001). Cell disassembly in many of these alternative
cell deaths, although appearing to mimic classical apoptosis, contain subtle differences,
e.g. often chromatin condensation is less compact. These types of cell death may also
only possess some apoptotic markers and not others, or may display some necrotic-like
markers. The propensity of some authors to label cell death as apoptotic after detection
of only one or two morphological or biochemical markers makes determination of the
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frequency of alternative cell deaths in the literature problematic. However, the
increasing recognition of alternative death pathways may enable more detailed analysis
in the future.
One, well characterised caspase-independent cell death pathway is that of apoptosis
inducing factor (AIF). Like many classical apoptotic components, AIF is normally
contained in the mitochondrial intermembrane space (Daugas et al., 2000a; Susin et al.,
1999), however after a death stimulus AIF is liberated through the permeabilised outer
membrane. Once released AIF translocates to the nucleus (Cande et al., 2002; Daugas
et al., 2000a,b) where it induces peripheral chromatin condensation and high molecular
weight DNA fragmentation, where the DNA is fragmented into 50kbp fragments (Wang
et al., 2002). Cell death induced by AIF can be both caspase-dependent and caspase-
independent, according to a number of pieces of evidence. Translocation of AIF to the
nucleus occurs in response to certain stimuli, in the presence of chemical caspase
inhibitors (Ferri et al., 2000; Susin et al., 1999). Moreover, translocation of AIF has
also been documented in cells in which there is no caspase activation owing to knockout
ofApaf-1, caspase-3 or caspase-9 (Susin et al., 2000). Microinjection of knockout cells
with exogenous AIF also induces cell death without caspase activation but with an
apoptotic morphology (Susin et al., 2000). Interaction between AIF and the caspase
pathway also occurs, with AIF triggering release of cytochrome-c from the
mitochondria and thus inducing activation of the caspase cascade (Daugas et al., 2000b;
Susin et al., 1999; Yu et al., 2002). However, it has been demonstrated that release of
AIF can occur after caspase activation (Arnoult et al., 2002; Lassus et al., 2002;
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Robertson et al., 2002; Susin et al., 1997), indicating involvement in caspase-dependent
pathways.
1.4.4. Necrosis
Necrotic cell death is characterised by osmotic swelling of the cell and organelles,
cytoplasmic vacuolisation and eventually cell lysis (Wyllie et al., 1980). Traditionally
this form of cell death has been though of as a passive "accidental" cell death, however
inhibition of caspases, or induction of apoptosis in a caspase-defective cell type, can
result in a caspase-independent cell death with a necrotic phenotype (Chautan et al.,
1999; Hirsch et al., 1997; Matsumura et al., 2000). In many cases necrotic cell death
can be prevented by inhibition of a pathway or overexpression of a protein. Thus
necrotic cell death may represent an active cell death additional to the traditional
caspase-dependent pathway.
If the energy status of the cell is compromised, apoptotic stimulation results in necrosis
(Formigli et al., 2000). The main ATP-dependent steps in the apoptotic pathway are,
active nuclear transport to enable nuclear apoptosis (Yasahura et al., 1997), and
formation of the apoptosome (Eguchi et al., 1999). Thus, it is not surprising that ATP
depletion prevents execution of the apoptotic pathway. However prevention of
apoptosis in this situation does not promote cell survival, instead the cell dies by
necrosis (Eguchi et al., 1999; Lee and Shacter, 1999; Leist et al., 1997; Samali et al.,
1999; Single et al., 2001). Artificial maintenance of the cellular ATP level prevents
necrosis and enables apoptosis to occur (Leist et al., 1997; Samali et al., 1999). In
situations of DNA damage, the DNA repair enzyme PARP is activated, which as
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discussed earlier (Section 1.4.2.4), results in rapid ATP depletion. This leads to
inhibition of apoptosis and induction of necrotic cell death, which can be prevented by
the use of PARP inhibitors (Lee and Shacter, 1999; Palomba et al., 1996). In some
cases opening of the mitochondrial PT pore, with associated loss of A\|/m, is responsible
for ATP depletion and necrosis (Qian et al., 1997; Single et al., 2001). Opening of the
PT pore prevents ATP synthesis for as long as the pore is open (Bernardi et al., 1999),
thus prolonged opening can lead to depletion of intracellular ATP stores. During
apoptosis, not all mitochondria in a cell undergo permeability transition at the same
time, enabling intact mitochondria to supply the energy required to execute the
apoptotic program (LeMasters, 1999). However, rapid and profound opening of the PT
pore is thought to occur during necrosis, resulting in energy depletion (Denecker et al.,
2001a). Cells can be protected from necrosis by overexpression of Bcl-2, or Bc1-xl,
(Denecker et al., 2001b; Fukuda and Yamamoto, 1999; Guenal et al., 1997; Shimizu et
al., 1996a,b,c; Subramanian et al., 1995), which has been associated with delaying, or
preventing, the of loss A\|/m (Guenal et al., 1997; Shimizu et al., 1997c; Single et al.,
2001) possibly by prevention of PT pore opening.
Autophagy, a mechanism for degradation and recycling of cytosolic proteins, is
employed during starvation, differentiation and aging to enable cell survival, however
autophagy is also involved in the cells demise. Autophagic (type II) cell death is
characterised by the formation of large cytoplasmic vacuoles, a morphology reminiscent
of necrosis. Autophagic vacuoles, formed with the aid of a distinct set of proteins,
engulf cytoplasmic organelles and fuse with lysosomes, degrading their contents
(Mizushima et al., 2002). During autophagic cell death mitochondria are engulfed and
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destroyed (Tolkovsky et al., 2002; Xue et al., 2001), a process initiated by
mitochondrial permeability transition (Elmore et al., 2001), and prevented by Bcl-2
(Tolkovsky et al., 2002). It has been proposed that death ensues as a result of ATP
depletion however, cells without mitochondria can produce ATP by glycolysis,
although temporarily (Tolkovsky et al., 2002). An inability to synthesise proteins has
been observed, possibly as a result of autophagic degeneration of ribosomes,
endoplasmic reticulum and Golgi (Bursch et al., 2000). Ultimately, autophagic cell
death results in fragmentation and phagocytosis of the cell corpse (Kitikana and
Kuchino, 1999). Autophagic cell death has been observed during development (Clarke,
1990), however it also occurs when apoptosis is induced via the mitochondria in the
presence of caspase inhibitors (Tolkovsky et al., 2002), thus it may be another form of
caspase-independent cell death.
1.4.5. Apoptosis vs. Necrosis
The original description of apoptosis by Kerr, Wyllie and Currie (1972) identified
apoptosis and necrosis as "two distinct patterns of morphological change", thus
separating them as mutually exclusive phenomenon. However, it has become clear that
apoptosis and necrosis more likely represent two extremes of a near continuum of cell
death, emphasised by the fact that inhibition of one form of cell death does not result in
survival but enables another form of cell death to predominate. In most situations it is
only possible to study these alternative cell deaths when caspases are inhibited,
indicating that in most cell types caspase-dependent cell death is dominant. However,
this does indeed demonstrate that other death pathways exist. Moreover, there appears
to be enormous overlap and shared signalling pathways among the different death
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programs. Depending on the conditions and/or cell type different steps are activated in
response to a death stimulus, resulting in different degrees and combinations of the
features of cell death. In order to study these alternative cells death adequately, the
propensity to label cell death as apoptotic on the basis of one or two positive markers
must be discouraged. Instead detailed analysis of the biochemical and morphological
changes occurring during cell death must be undertaken. Thus, it may be that we should
categorise cell death as either "active" or "passive", with the apoptotic-like and
necrotic-like characteristics being merely an observation not a classification. The
frustration felt by many researchers when classifying death as apoptotic or necrotic, is
summed up in an eloquent discussion by Robert Sloviter (2002). He proposes, "that the
direct description of entities is preferable to the confusing use of names that do not
accurately describe the entities they purport to represent", which he surmises in the
following statement "By analogy, the presence of teeth easily differentiates a dog from a
bottle of wine, but it does not define a dog. If it did, a cat would also be a dog".
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1.5. Aims
• Determine whether cigarette smoke condensate induces apoptosis of an alveolar
epithelial type II like cell line (A549) or primary human umbilical vein
endothelial cells (HUVECs).
• Investigate the molecular mechanisms involved in cigarette smoke-induced
apoptosis
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Chapter 2: Materials and Methods
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2.1. Cell lines
2.1.1. Human alveolar epithelial type II cells (A549)
The human alveolar type II-like epithelial cell line (A549) were obtained from the
European Collection of Animal Cell Cultures (ECACC, Porton Down, UK) and grown
in Dulbecco's Modified Eagles medium (DMEM, Sigma, Poole, UK) supplemented
with 10% heat-inactivated foetal calf serum (HI-FCS, LabTech International, Ringmer,
UK) lOOU/ml Penicillin, lpg/ml Streptomycin (P/S, Invitrogen Life Technologies,
Paisley, UK) and 2mM L-Glutamine (L-Glut, Invitrogen Life Technologies). A549 cells
were grown in 162cm tissue culture flasks (CoStar, Corning, NY) and subcultured 1 in
4 every two days. Cells were seeded into tissue culture plates at 3xl04 cells/cm2,
incubated overnight and treated at approximately 70% confluency in media containing
2% HI-FCS. For serum-free treatments cells were seeded at 2xl04 cells/cm2 and
incubated overnight. The media was removed, the cells washed with
calcium/magnesium-free phosphate-buffered saline (CMF-PBS) and serum-free media
was applied. Cells were further incubated overnight and treated at 70% confluency in
serum-free media.
2.1.2. Human leukaemic T cell line (Jurkat)
The human leukaemic T cell line (Jurkat) was obtained from the European Collection of
Animal Cell Cultures (ECACC) and grown in continuous culture in RPMI (Invitrogen
Life Technologies) supplemented with 10% HI-FCS, P/S and L-Glut. Jurkat cells were
grown in 75cm2 tissue culture flasks (CoStar) and subcultured 1 in 3 every two to three
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days. Cells were treated at a density of lxlO6 cells/ml in either full media or media
containing 1% HI-FCS
2.1.3. Human umbilical vein endothelial cells (HUVEC)
Primary Human Umbilical Vein Endothelial Cells (HUVEC's) were donated by Dr
Peter Henriksen of the Rayne Laboratory, University of Edinburgh. Cells were grown
in EBM-2 media (BioWhittaker, Verviers, Belgium) with supplements supplied by the
manufacturer. Cells were seeded into 24 well plates at a density of 0.05xl06 cells/well
or 96 well plates at 0.0lxl06 cells/well and cultured overnight prior to treatment. Cells
were treated in full media between passages 4 and 6.
2.2. Cigarette Smoking
2.2.1. Preparation of Cigarette smoke condensate (CSC)
Cigarette smoke condensate was prepared fresh at a concentration of 1 cigarette/ml
CMF-PBS. The smoke from a medium tar cigarette (Regal) was drawn up into a glass
syringe and passed into a tonometer agitating CMF-PBS (Figure 2.1). Each puff
consisted of approximately 35ml of cigarette smoke, with 20 puffs consisting one





Cytospins of Jurkat cells, or cells grown on coverslips were fixed for one minute in
methanol (BDH, Lutterworth, UK). Cytoplasm was stained for one minute in
DiffQuick solution 1 and nuclei were stained for one minute with DiffQuick solution 2.
2.3.2. Protein Assay
Protein concentration of samples was measured using the bicinchoninic acid method
(BCA, Pierce, Rockford, IL). This method utilises the reduction of Cu2+ to Cu+ by
protein and is detected by a unique reagent containing bicinchoninic acid. Two
molecules of bicinchoninic acid chelate one molecule of Ca+ forming a purple reaction
product. This product exhibits a strong absorbance at 562nm, which is nearly linear
with increasing protein concentration.
A standard curve was prepared of Bovine Serum Albumin (BSA, Sigma) ranging from
0.6 to 0.05mg/ml. 10pl of standards and samples were applied to wells of a 96-well
plate (Costar) and incubated at 37°C with 200pl of assay reagent for 30 minutes. The
absorbance was read at 570nm and the concentration of the samples was determined by
linear regression.
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2.3.3 Assay for total glutathione (GSH)
Intracellular GSH was measured by a method adapted from Tietze (1969) and
Vandeputte et al. (1994) Briefly, cells grown in 6-well plates were treated, washed
twice in CMF-PBS and harvested by adding 0.5ml trypsin-EDTA (Invitrogen Life
Technologies) and incubating at 37°C until cells had detached. The trypsin was
neutralised with 1ml of culture medium and the suspension was transferred into 1.5ml
eppendorfs. Cells were then pelleted by centrifugation at 2000rpm (Heraeus Biofuge
Pico) for 4 minutes. The supernatant was removed and the cells were washed in 1ml
CMF-PBS prior to repelleting. The CMF-PBS was removed and the pellets were stored
at -70°C until required.
Pelleted cells were lysed in 1ml of ice-cold extraction buffer (see appendix 3) and
homogenised with a teflon pestle. The lysates were then sonicated in icy water for 2-3
minutes with regular vortexing. To ensure that the cells were properly lysed two
freeze/thaw cycles were performed at -70°C defrosting the samples on ice. The lysates
were centrifuged at 3000 rpm for 4 minutes at 4°C prior to transferring the supernatant
to pre-chilled eppendorfs. All samples and solutions were kept on ice for the assay.
GSH (Sigma) stock solution was prepared at lmg/ml in KPE (appendix 3) and a
standard curve was prepared ranging from 8pg/ml (23.85nmoles) to 0.125mg/ml
(0.37nmoles). 20pi of standard or samples were added to a 96-well plate (CoStar) in
singular, filling no more than 32 wells of the plate. 120pl of 0.66mg/ml DTNB and
13.3pl/ml glutathione reductase were added to each well with a multichannel pipette.
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Conversion of GSSG to GSH was allowed to occur for 30 seconds when 60pl of
0.66pg/ml p-NADPH was added to each well. The absorbance at 410nm was
determined immediately in a microplate reader and then every 30 seconds for 2 minutes.
This process was repeated twice more on the same plate to provide replicates. Linear
regression was used to determine the GSH content in nmoles/ml of each the samples
and was expressed as nmoles GSH/mg protein after determining protein concentration
as described earlier.
2.4. Assays to detect apoptosis
2.4.1. Flow cytometry analysis of phosphatidylserine exposure
Externalisation of phosphatidylserine (PS) is an early marker of apoptosis, which can be
detected by binding of annexin-V. Viable cells do not bind annexin-V or take up PI and
were detected in the bottom left hand corner of the FACS dot-plot (Figure 2.2, green),
cells in the early stages of apoptosis display PS on the outer membrane leaflet yet retain
cell membrane integrity thus they bind annexin-V but are not permeable to PI; these
cells were detected in the bottom right hand corner of the FACS dot-plot (Figure 2.2,
blue). Using this method it is not possible to differentiate late apoptotic cells
(secondary necrosis) from necrotic cells. Late apoptotic cells display PS on the outer
membrane leaflet and are permeable to PI, PS remains on the inner membrane leaflet in
necrotic cells yet as they have lost their cell membrane integrity annexin-V can enter the
cell along with PI and bind the intracellular PS. Therefore these cells fluoresce in both
FL-1 (annexin) and FL-2 (PI) and were detected in the top right hand corner of the
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FACS dot-plot (Figure 2.2, pink). In all experiments apoptotic and necrotic controls of
2pM staurosporine (SS) and lOmM H2O2 were included (Figure 2.2. B and C).
Treated cells were trypsinised and collected in eppendorf tubes. The cell pellets were
washed sequentially with CMF-PBS and annexin-V binding buffer (2mM CaCL in
Hanks Balanced Saline Solution HBSS, Sigma). Cells were stained in Annexin-V
(Molecular Probes, Leiden, Holland) diluted 1/600 and PI (Molecular Probes) at
0.3pg/ml in Annexin-V binding buffer, at a concentration of Ixl06/15pil. Cells were
analysed immediately on a Becton Dickinson FACSComp using CellQuest software.
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Annexin-V
Figure 2.2. Detection of PS externalisation by annexin-V binding in A549 cells.
A549 cells were incubated with either media alone (A), 2pM SS (B), or lOmM H202
(C). Cells were stained with Annexin-V and PI and analysed by flow cytometry to
determine the percentage of viable (Annexin -ve, PI -ve, green), apoptotic
(Annexin +ve, PI -ve, blue) and necrotic (Annexin +ve, PI +ve, pink) cells.
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2.4.2. Oligonucleosomal DNA fragmentation (DNA laddering)
2.4.2.1. Genomic DNA extraction protocol
Initially DNA fragments were isolated using a genomic DNA extraction kit (Promega).
Briefly, 600pl nuclei lysis buffer was added to the cell pellet, 5pi RNase A was added
and tubes were incubated at 37°C in a dri-block (Stuart Scientific, Tilling Drive Stone,
Staffs, UK) for 30 minutes. Samples were cooled to room temperature and 200pl
protein precipitation solution was added. Samples were vortexed, chilled on ice for 5
minutes and the precipitate was pelleted by centrifugation at 13000 rpm (Heraeus
Biofuge Pico) for 4 minutes. Supernatant was removed, placed in 1.5ml eppendorf, and
600pl of room temperature iso-propyl alcohol was added. Samples were mixed by
inversion until DNA was visible, which was pelleted by centrifugation at 13000 rpm
(Heraeus Biofuge Pico) for 1 minute. Supernatant was decanted and 600pl of room
temperature 70% ethanol was added. Samples were inverted gently to wash the DNA
and pelleted at 13000 rpm (Heraeus Biofuge Pico) for 1 minute, and supernatant was
gently aspirated. Pellets were air-dryed for 10-15 minutes prior to rehydration. 100pi
of DNA rehydration solution was added to the DNA and incubated at 65°C for 1 hour.
DNA was analysed by agarose gel electrophoresis on a 1% gel at 50V as in section
2.4.2.4.
2.4.2.2. "CURRENT PROTOCOLS IN IMMUNOLOGY"protocol
Adapted from Current Protocols in Immunology, Section 5, basic protocol 3. Floating
cells were harvested from the media by centrifugation. Adherent cells were washed and
250pl TTE solution (see appendix 3) was added per well (500pl total) and cells were
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scraped from the well with a Teflon scraper. Cell lysates was added to 1.5ml eppendorf
containing floating cells, labelled tube "B". Tubes were centrifuged at 13000 rpm for
10 minutes at 4°C (Heraeus Biofuge Fresco) and supernatant was placed into fresh
eppendorfs labelled "T". The pellet in tube "B" was resuspended in 0.5ml TTE solution
and 0.1ml ice-cold 5M NaCl (see appendix 3) added to the tubes labelled B and T.
Tubes were vortexed vigorously, 0.7ml ice-cold isopropanol was added to each tube and
vortexed once more. The DNA was precipitated and collected by placing the tubes at -
20°C for 30 minutes and centrifuging at 13000 rpm for 10 minutes at 4°C (Heraeus
Biofuge Fresco). Supernatant was carefully aspirated and excess alcohol was removed
with the corner of a sterile tissue. Ice-cold ethanol (1ml) was added to each tube and
samples were centrifuged at 13000 rpm at 4°C for lOmins (Heraeus Biofuge Fresco).
Supernatant was removed as previously, and pellets were allowed to air-dry. TE buffer
(50j_il, see Appendix 3) was added to the DNA pellet and incubated for approximately 1-
2 hours at 37°C. DNA loading buffer (see appendix 3) was added to a lx final
concentration and the samples heated for 10 minutes at 65°C. Electrophoresis was
performed on a 1% agarose gel at 50 volts for approximately 2 hours as in section
2.4.2.4.
2.4.2.3. Mini-prep protocol
Approximately lxlO6 cells were lysed in 500pl 7M Guanidine hydrochloride (see
appendix 3) and applied to Wizard SV miniprep columns (Promega, Madison, WI) pre-
wetted with column wash solution (Promega). Columns were centrifuged at 13,000 rpm
for 2 minutes before flowthrough was disposed of and 750pl wash solution was applied
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to the column and re-centrifuged, this was repeated with 250pl wash solution before
eluting DNA with 50pl TE/RNase (50pg/ml). Samples were analysed by
electrophoresis on a 1.8% agarose gel at 50 volts for 2 hours as in Section 2.4.2.4.
2.4.2.4. Agarose gel electrophoresis
Agarose gel electrophoresis was performed on extracted DNA to determine the presence
of oligonucleosomal DNA fragments. Agarose (Seakem, Rockland, ME, USA) was
dissolved in Tris-borate EDTA (TBE) buffer (see appendix 3) by melting in a
microwave. Once cooled to approximately 50°C, 0.5pg/ml ethidium bromide (Sigma)
was added and the gels were poured. The DNA was visualised using a ultraviolet (UV)
light source (UVP Laboratory Products, Upland, CA, USA), images were captured with
a digital camera (UVP Laboratory Products).
2.4.3. Acridine Orange and Ethidium Bromide Staining for Apoptosis
This assay utilises the ability of ethidium bromide and acridine orange to intercalate into
the DNA and fluoresce when viewed by epilumination. All cells will take up acridine
orange, when intercalated it makes DNA appear green, and RNA red. Only non-viable
cells take up ethidium bromide, which makes DNA appear orange. The ethidium
bromide will overwhelm the acridine, enabling distinction between the two dyes.
Apoptosis and necrosis can be monitored by observing the dye taken up by the cell in
combination with nuclear morphology. Viable cells have normal green nuclei,
apoptotic cells have condensed green nuclei and necrotic cells have normal orange
nuclei. Cells that have undergone secondary necrosis have orange condensed nuclei.
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Dye containing 100 pg/ml acridine orange (Sigma) and 100 pg/ml ethidium bromide
(Sigma) was prepared in CMF-PBS and added to the cell media after treatment to
provide a working concentration of 4pg/ml of both dyes. Cells were visualised
immediately by epifluorescent microscopy and the number of viable cells with normal
nuclei (VN), viable cells with condensed nuclei (VA), non-viable cells with normal
nuclei (NVN) and non-viable cells with condensed nuclei (NVA) were determined. A
total of 200 cells were counted per well with each treatment being performed in
duplicate. The apoptotic/necrotic index was determined by the use of the following
equations:
% apoptotic cells = VA+VN . X 100
VN+VA+NVN+NVA
% necrotic cells = NVN ^ X 100
VN+VA+NVN+NVA
2.4.4. Detection of Hypodiploid cells (Sub Go)
During the process of "classical" apoptosis, caspase-activated DNase (CAD) cleaves
DNA into 200bp fragments, which can be gently washed from fixed, permeabilised cells
and the DNA content can be analysed, by flow cytometry. The cells are analysed using
a method termed "pulse processing", when a cell passes through the excitation laser of
the flow cytometer there is a gradual increase in fluorescence, which increases to a peak
when the whole cell is in the laser beam, and then decreases as the cell leaves the laser
beam (Figure 2.3.B). The area and width of this curve is proportional to the amount of
fluorescence, and hence DNA, within the cell. Plotting this data enables the different
stages of the cell cycle to be determined. During the first gap phase (Gi) human cells
contain 46 chromosomes (diploid), which are replicated during S-phase so that cells in
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the second gap phase of the cell cycle (G2) contain twice as much DNA. However,
apoptotic cells that have lost their fragmented DNA after washing will contain less than
the normal amount of DNA (hypodiploid). These cells are detected as a peak to the left
of the Gi peak as they emit less fluorescence (Figure 2.3.D).
Analysis of apoptosis by flow cytometry can be combined with electrophoretic analysis
of fragmented DNA eluted from fixed cells. This enables conformation of apoptosis as
DNA eluted from apoptotic cells displays classical DNA laddering while DNA
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Figure 2.3. SubGj in A549 cells. Apoptosis was determined by monitoring the
number of hypodiploid cells. Fragmented DNA was gently washed from cells,
remaining DNA was stained with propidium iodide and the cells were analysed by
flow cytometry. Apoptotic cells were identified by pulse processing where DNA
content is determined as the cell passes through the excitation laser (A). Plotting
area vs. width (B) enables the identification of cells in each stage of the cell cycle
and those with with less than the normal (G,) amount ofDNA (Sub G,) ( C)
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Method adapted from "Current Protocols in Flow Cytometry, section 7.5.8, basic
protocol 5". Briefly, the cell cycle was synchronized by culturing overnight without
serum prior to treatment. Cells were harvested by trypsinisation, centrifuged at 1000
rpm for 5 minutes (MSE Mistral 3000) and transferred to 1.5ml eppendorfs. Cells were
pelleted once more by centrifugation at 2000 rpm for 4 minutes (Heraeus Biofuge Pico).
Replicate cell pellets were resuspended in 1ml CMF-PBS (approximately 0.5xl06
cells/pellet). Cells were fixed by admixing with a pastette, 1ml of cell suspension with
lOmls ice-cold 70% ethanol and placed on ice for 2 hours. Cells were collected by
centrifugation at 200 g for 10 minutes (MSE Mistral 3000), and ethanol was decanted
and the remainder allowed to evaporate. Cell pellets were resuspended in 50pl DNA
extraction buffer (see appendix 3), transferred to 1.5ml eppendorfs and incubated at
37°C for 1 hour in a shaking incubator (Stuart Scientific). Cells were centrifuged for
lOminutes at 1500 g (Heraeus Biofuge Pico) and supernatant containing low-molecular
weight DNA was removed and stored at 4°C. Cells were resuspended in 1ml PI
staining solution (see appendix 3) and incubated for 30 minutes in the dark. Flow
cytometry was utilized for analysis by pulse processing on the FL-2 channel. Low
molecular weight DNA was analysed by agarose gel electrophoresis. 40pl of
supernatant was placed in a 1.5ml eppendorf, 5pl of DNase-free RNase A (Sigma) was
added and tubes were incubated at 37°C for 30 minutes. 5pi of lmg/ml proteinase K
(Sigma) was added and tubes were returned to the incubator for 30 minutes. DNA was




Cells were lysed in either RIPA lysis buffer or Cell Extract Buffer (CEB, appendix 3;
lxlO6 cells/15pil) and placed on ice for 15 minutes. Lysates were passed through a 21
gauge needle approximately 10 times prior to centrifugation at 13000 rpm for 15
minutes at 4°C. The supernatants were removed and stored at -70°C until needed.
2.4.5.2. Sodium dodccyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
and Western blotting
SDS reducing buffer (see appendix 3) was added to cell lysates and boiled at 96°C for 5
minutes. Denatured samples were applied (controlled for protein concentration) to
either 10% or 12% acrylamide gels with 4% stacking gels (see appendix 3), and
electrophoresed at 125 volts for approximately 1 hour. Protein was then blotted onto
polyvinylidene difluoride (PVDF) membrane (Hybond-P, Amersham, Little Chalfont,
UK) or nitrocellulose (Hybond-ECL, Amersham) in an electroblotting apparatus
(BioRad, Hemel Elempstead, UK). Nitrocellulose membrane was equilibrated in
transfer buffer (see appendix 3), PVDF membrane was pre-wetted in methanol for 10
seconds before being equilibrated in transfer buffer. The gels were placed onto the
membrane and 2 pieces of filter paper, also soaked in transfer buffer, were placed on
either side. Fibre pads soaked in transfer buffer were placed either side of the filter
paper and the entire sandwich was placed into the gel holder cassette with the gel
closest to the grey side of the cassette (see Figure 2.4). The process was repeated for
the second gel. The cassettes were placed in the electrode module, the tank filled with
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cooled lx transfer buffer and the cooling block added. Transfer was performed at
80mA per gel for 90 minutes.
2.4.5.3. Caspase-3
Blots were blocked for 1 hour in CMF-PBS containing 2% caesin (Sigma) at room
temperature on a gyrorocker (Stuart Scientific). Blots were subsequently probed with a
polyclonal rabbit antibody to caspase-3 (Pharmingen, Oxford, UK) diluted 1/1000 in
blocking buffer overnight at 4°C, washed three times in CMF-PBS and detected with a
horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibody (Santa Cruz,
Wembley, UK) diluted 1/5000 in 2% casein/CMF-PBS. Blots were washed three times
in CMF-PBS and the signal was detected by enhanced chemiluminesence (ECL,
Amersham) and X-ray film (MR-1, Kodak, Rochester, NY).
2.4.5.4. Caspase-9
Blots were blocked for 1 hour in CMF-PBS containing 5% non-fat milk powder
(Marvel) at room temperature on a gyrorocker (Stuart Scientific) prior to probing
overnight at 4°C with a polyclonal rabbit antibody to caspase-9 (Pharmingen) diluted
1/2500 in 5% Marvel/CMF-PBS containing 0.05% Tween-20 (Sigma). Blots were
washed three times in CMF-PBS/Tween and detected with an HRP-conjugated goat
anti-rabbit antibody (Dako, Ely, UK) diluted 1/5000 in 5% Marvel/CMF-PBS-Tween.
Membranes were washed three times in CMF-PBS/Tween and once in CMF-PBS. The
signal was detected using ECL (Amersham) and X-ray film (MR-1, Kodak).
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Figure 2.4. Assembly of the gel/membrane sandwich and the gel holder cassette
(From BioRad)
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2.4.5. Assay for caspase-3 activity
The effect of CSC and hydrogen peroxide on caspase-3 activity was determined using
the caspase-3 assay kit (Calbiochem, Nottingham, UK) as per manufacturers
instructions. Briefly, active caspase-3 (30U) was placed into a half-volume 96 well
plate prior to the addition of the inhibitor supplied with the kit, 1, 5 and 10% CSC and
ImM H2O2. The plate was then incubated at 37°C for 1 hour before the addition of the
caspase-3 substrate conjugated to p-nitroalanine. Caspase-3 activity was determined by
measuring the change in absorbance at 405nm over 3 hours.
2.4.6. Release of lactate dehydrogenase (LDH)
The presence of lactate dehydrogenase (LDH) in the media after cell treatment was used
as a marker of necrosis. LDH was detected using the cytotoxicity detection kit (Roche,
Lewes, UK) which, detects LDH in two stages, in the first stage LDH reduces NAD+ to
NADH + H+ by oxidation of lactate to pyruvate; the second stage a formazan salt is
formed by the transfer of H/H+ to tetrazolium salt by a diaphorase catalyst. The
formazan salt can be detected spectrophotometrically at 490nm.
Briefly, cells treated in 96 well plates were centrifuged at 250 g for 10 minutes. lOOpl
of the supernatant was removed with a multichannel pipette, placed in a fresh 96 well
plate and stored at 4°C. LDH reagent was prepared by adding reagent 1 to reagent 2 in
a 1:45 ratio and adding lOOpl to the cell supernatants. The plates were incubated in the
dark for 30 minutes and the absorbance at 490nm with a 730nm reference filter was
determined. In order to ensure plating densities were equivalent in all assays
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supernatants were diluted in fresh media to represent a lesser plating density (section
3.5.1). The percentage cytotoxicity was determined by:
Cytotoxicity (%) = experimental value - low control x 100
high control - low control
2.5 Assays to study stress signalling pathways
2.5.1. Western blotting for phosphorylated and native p38
Cells were lysed in RIPA lysis buffer (see section 2.4.5.1) and the protein concentration
was determined using the BCA protein assay (section 2.3.2). 20pg of protein was
applied to a 10% acrylamide gel with 4% stacking gel (see appendix 3) and
electrophoresed and electroblotted as in sections 2.4.5.2. Blots were blocked in 4%
Marvel in Tris-buffered saline (TBS, appendix 3) overnight at 4°C. Membranes were
probed with anti-phosphorylated p38 [pTpY180/182] (BioSource, Camarillo, CA, USA)
diluted 1/2000 in 5% BSA/TBS-0.05%Tween for 2 hours at room temperature. Blots
were washed three times in TBS/Tween before being probed with HRP-conjugated goat
anti-rabbit antibody (Santa Cruz) diluted 1/5000 in 5% Marvel/TBS-Tween for 1 hour at
room temperature. Unbound antibody was removed by washing three times with TBS-
Tween and once with TBS. The signal was detected using ECL (Amersham) and X-ray
film (MR-1, Kodak). To detect native p38, antibodies were stripped from the blot by
incubating with strip buffer (see appendix 3) at 60°C for 45 minutes. Excess strip
buffer was removed by washing three times with TBS-Tween and blots were blocked in
5% Marvel/TBS-Tween overnight at 4°C. Membranes were probed with anti-native
p38 (Sigma) diluted 1/40000 in 5% Marvel/TBS-Tween for 3 hours at room
temperature. Subsequent steps were as for phosphorylated p38.
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2.5.2. Western blotting for phosphorylated and native ERK
Cells were lysed in RIPA lysis buffer (see section 2.4.5.1) and the protein concentration
was determined using the BCA protein assay (section 2.3.2). lOpg of protein was
applied to a 10% acrylamide gel with 4% stacking gel (see appendix 3) and
electrophoresed and electroblotted as in sections 2.4.5.2. Non-specific binding sites
were blocked by incubation with 5% Marvel/TBS for 4 hours at room temperature or
overnight at 4°C. Membranes were probed with anti-phosphorylated p44/42 (New
England BioLabs, Hitchin, UK) at 1/2000 in 5% Marvel/TBS-Tween overnight at 4°C,
washed three times in TBS-Tween and probed with HRP-conjugated goat-anti rabbit
antibody (New England BioLabs) diluted 1/4000 in 5% Marvel/TBS-Tween for 1 hour
at room temperature. The signal was detected and the blots stripped of antibodies as for
p38. Blots were blocked overnight at 4°C in 5% Marvel/TBS-Tween and probed with
anti-native ERK (Santa Cruz) diluted 1/2000 in 5%Marvel/TBS-Tween for 3 hours.
Subsequent steps were as for native p38
2.5.3. Western blotting for heat-shock proteins (HSP)-27, -70 and -90
Cells were lysed in RIPA lysis buffer (see section 2.4.5.1) and the protein concentration
was determined using the BCA protein assay (section 2.3.2). lOpg of protein was
applied to a 10% acrylamide gel with 4% stacking gel (see Appendix 3) and
electrophoresed and electroblotted as in sections 2.4.5.2. Non-specific binding sites
were blocked by incubation with 5% Marvel in TBS for 1 hour at room temperature
with rocking prior to incubation with anti-HSP-27 (StressGen) diluted 1/5000, anti-
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HSP-70 (StressGen, Victoria, Canada) diluted 1/15000, and/or anti-HSP-90 diluted
1/35000 in 5% Marvel/TBS-Tween overnight at 4°C. Blots were washed three times in
TBS-Tween and probed for 1 hour at room temperature with HRP-conjugated goat-anti
rabbit antibody (StressGen) diluted 1/5000 in 5% Marvel/TBS-Tween. Subsequent
steps were as for phosphorylated p38.
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Chapter 3: Cigarette Smoke Condensate induces epithelial
and endothelial cell necrosis
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3.1. Introduction
Emphysema is characterised by enlargement of distal airspaces due to destruction of
alveolar walls. Apoptosis of alveolar epithelial and endothelial cells has been
implicated in the pathogenesis of emphysema (section 1.2.4.3.).
To determine whether cigarette smoke condensate (CSC) induced apoptosis in epithelial
and endothelial cells in vitro, an alveolar epithelial type II cell line (A549) and primary
human umbilical vein endothelial cells (HUVECs) were used. The data presented in
this chapter shows that CSC does not induce apoptosis in either cell type, but instead
induces necrosis.
3.2. Cigarette smoke condensate appears to induce apoptosis in A549 cells
3.2.1. Cigarette smoke condensate induces a morphological change in A549 cells.
A549 cells grown on coverslips, and treated with CSC, were stained with DiffQuick.
Cells treated with doses of 1% and 5% CSC retained normal morphology (Figure 3.1.B
and C), whilst cells treated with 10% CSC underwent a morphological change. The
cells decreased in overall size and the nuclei appeared smaller and more darkly stained
(Figure 3.1.D). Condensation of nuclei is a hallmark of apoptotic cell death and thus the
smaller, more darkly stained nuclei may represent apoptotic cells. However, condensed
nuclei may also indicate cells that are transcriptionally inactive.
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Figure 3.1. Cigarette smoke condensate induces morphological changes in
A549 cells. Cells were grown on sterile glass coverslips, treated for 24 hours with
either media alone (A), 1% CSC (B), 5% CSC (C), or 10% CSC (D) and stained
with DiffQuick. Magnification x34
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3.2.2. Cigarette smoke condensate induces phosphatidylserine exposure in A549
cells.
Using annexin-V and propidium iodide (PI) staining, cell death was studied in A549
cells after CSC treatment for 4, 8 and 24 hours. An increase in annexin-V positive cells
was detected after exposure to 5% and 10% CSC (Figure 3.2.C and D), this was evident
as a shift to the right in the FL-1 channel. Moreover, a slight increase in PI uptake (FL-
2) was detected (Figure 3.2.C and D), however this increase was not significant (Figure
3.3.B). After further analysis of the results it was evident that no apoptosis was detected
after treatment with 1 and 5% CSC, but that a significant level of apoptosis was seen
after treatment with 10% CSC at all three time points (Figure 3.3.A). Thus, CSC
appeared to be inducing apoptosis in A549 cells. As outlined in section 1.4.5, apoptosis
represents one extreme of a near continuum of cell death, a stimulus may result in
display of some markers but not others. Thus to characterise cell death accurately, it is
necessary to determine the presence of additional hallmarks of cell death. PS exposure
is an early marker of apoptosis and in order to ascertain whether CSC induced
"classical" apoptosis the presence of more advanced markers of apoptosis were studied.
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FL-1: Annexin-V
Figure 3.2. Cigarette smoke condensate induces PS externalisation and
annexin-V binding in A549 ceils. A549 cells were incubated with either media
alone (A), 1% CSC (B), 5% CSC (C), 10% CSC (D) 2pM SS (E) or lOmM H202
(F) Cells were stained with Annexin-V and PI and analysed by flow cytometry to
determine the percentage of viable {green), apoptotic {blue) and necrotic {pink)
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Figure 3.3. Cigarette smoke condensate induces apoptosis in A549 cells detected by
annexin-V/propidium iodide staining. Cells were treated for 4 hours (open bars), 8
hours (grey bars) and 24 hours (closed bars) with either media alone or 1, 5 or 10%
CSC. Treatment with 2|uM staurosporine (SS) or lOmM H202 acted as positive controls
for apoptosis and necrosis respectively. Apoptotic (A) and necrotic (B) cells were
determined by flow cytometry after annexin-V and propidium iodide staining. Results
expressed as mean of two experiments ± SEM. * p<0.05, ** p<0.01, ***p<0.001.
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3.3. A549 CELLS DO NOT DISPLAY ADDITIONAL MARKERS OF APOPTOSIS AFTER CSC
EXPOSURE
3.3.1. Cigarette smoke condensate does not induce apoptosis detected by Sub Gi
When the data were analysed, the cell cycle profiles of cells treated with 1-10% CSC
(Figure 3.4.B-D) did not differ from untreated cells (Figure 3.4.A). The apoptotic
control (Figure 3.4.E) had a similar profile to untreated cells, but only the main Go/Gi
peak was evident in the necrotic control (Figure 3.4.F). This may be due to selective
depletion; fragile cells may have been destroyed during the process of necrosis or,
during the fixation, permeabilisation, and staining method. Few hypodiploid cells were
detected with any of the treatments (Figure 3.5) although staurosporine (SS) treatment
resulted in a slightly more cells in the sub-Gi range than any other treatment. The
presence of only a small peak in the apoptotic control (Figure 3.4.E) was of some
concern; however cells that have undergone apoptosis in the late stages of the cell cycle
may not be detected as a sub-Gi peak as they would contain more DNA than a diploid
cell. Therefore these cells would shift to the left but would be detected in the S phase of
the plot. Synchronising cells in the same stage of the cell cycle prior to stimulation can
overcome this. Therefore, synchronisation of A549 cells by incubation overnight with
mimosine (Wu et al., 1994) was attempted.
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Figure 3.4. Effect of CSC on the cell cycle and determination of apoptosis by
SubGj. Cells were incubated overnight in serum-free media prior to treatment for
4, 8 and 24 hours with either media alone (A), 1% CSC (B), 5% CSC (C), 10%
CSC (D), 2pM SS (E) or lOmM H202 (F). Cells were fixed, permeabilised and
fragmented DNA was eluted. Remaining DNA was stained with propidium iodide
and cells were analysed by flow cytometry. Fluoresence intensity vs. number of
cells was plotted to determine the stages of the cell cycle and to identify the sub G,
peak. Representative plots of 8 hour exposure are shown.
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Figure 3.5. Effect of CSC on apoptosis in A549 cells, detected by SubGj. Cells were
incubated overnight in serum free media prior to treatment for 4 (open bars), 8 {grey
bars) and 24 hours {closed bars). Cells were permeabilised and fragmented DNA was
eluted prior to staining with PI and analysis by flow cytometry. Apoptosis was detected
as a peak to the left of the Go/Gj peak. Results are mean of one experiment performed
in triplicate.
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Synchronisation with mimosine resulted in cell cycle profiles that contained more cells
in G2/M and less in G1/G0 (Figure 3.6.A) than cells incubated in serum-free media alone
(Figure 3.4.A), and an almost identical profile was obtained from cells treated with 1%
CSC after synchronisation with mimosine (Figure 3.6.B). Mimosine arrests cells at the
Gi/S boundary of the cell cycle and the presence of most of the cells in G2/M 8 hours
after mimosine was removed indicates that there is an 8 hour transit time through S-
phase. The profile obtained from cells treated with 5% CSC showed more cells in the
DNA synthesis stage of the cell cycle than in G2/M (Figure 3.6.C), indicating that these
cells are either progressing slower through S-phase or, more likely, were held up for
longer at the Gi/S boundary while the cells affected DNA repair before engaging cell
cycle progression. Almost all cells were retained in Gj/Go after treatment with 10%
CSC (Figure 3.6.D). Suggesting that exposure to 10% CSC had blocked DNA synthesis
and cell proliferation (Figure 3.6D).
A small percentage of cells were detected in the sub-Gi range with all treatments after
synchronisation with mimosine. However, only treatment with 1% CSC for 24 hours
and SS for 8 hours induced an increase in sub-Gi cells compared to the control, albeit
very small (Figure 3.7). A concern was that DNA fragmentation was not occurring in
response to any treatment, therefore the DNA washed from the cells after fixation was
analysed by electrophoresis. No DNA was detected on the gels (data not shown),
indicating that fragmentation was not occurring after any treatment. Therefore,
additional methods were used to determine whether oligonucleosomal fragmentation
was occurring.
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Figure 3.6. Effect of synchronisation on the cell cycle and determination of
apoptosis by SubGr Cells were synchronised overnight with mimosine in serum-
free media prior to treatment for 4, 8 and 24 hours with either media alone (A), 1%
CSC (B), 5% CSC (C), 10% CSC (D), 2pM SS (E) or lOmM H202 (F). Cells were
fixed, permeabilised and fragmented DNA was eluted. Remaining DNA was
stained with propidium iodide and cells were analysed by flow cytometry.
Fluoresence intensity vs. number of cells was plotted to determine the stages of the
cell cycle and to identify the sub G, peak. Representative plots of 8 hour exposure
are shown.
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control 1%CSC 5% CSC 10% CSC SS
Figure 3.7. Effect of CSC on apoptosis in A549 cells after synchronisation with
mimosine, detected by SubG,. Cells were incubated overnight in mimosine prior to
treatment for 4 (open bars), 8 {grey bars) and 24 hours {closed bars). Cells were
permeabilised and fragmented DNA was eluted prior to staining with PI and analysis by
FACS. Apoptosis was detected as a peak to the left of the G0/G, peak. Results are
mean of one experiment performed in triplicate.
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3.3.2. Development of method to monitor oligonucleosomal DNA fragmentation in
A549 cells
Total DNA was extracted from CSC-treated cells and analysed for DNA laddering.
Initially, genomic DNA was extracted after CSC treatment using a genomic DNA
extraction kit (Promega). However, no ladders were detected after any treatment
(Figure 3.8). This could have been due to fragments produced being small, since the
protocol was originally developed for extraction of complex genomic DNA. Therefore,
a protocol developed specifically for the identification of oligonucleosomal fragments,
was used ("Current Protocols in Immunology"). Again no DNA ladders were observed
with any treatment (Figure 3.9). Finally, a protocol that uses mini-prep spin columns to
retain the fragmented DNA was tried. No DNA ladders were detected (Figure 3.10).
This protocol had originally been developed for use with apoptotic neutrophils;
therefore neutrophils were aged for 20 hours in Teflon to induce apoptosis prior to DNA
extraction. Electrophoresis of extracted DNA showed that DNA ladders could be
detected by this method when aged neutrophils were used (Figure 3.10. PMN).
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Figure 3.8. Isolation of oligonucleosomal fragments using the Promega Wizard
genomic DNA isolation kit. A549 cells were treated with either media alone, lOmM
H202, 2|aM SS, 1% CSC, 5% CSC or 10% CSC for 24 hours prior to lysis and
extraction of DNA.
M Cont H202 SS 1% 5% 10%
Figure 3.9. Isolation of oligonucleosomal fragments using the "Current Protocols
in Immunology" method. A549 cells were treated with either media alone, lOmM
H202, 2pM SS, 1% CSC, 5% CSC or 10% CSC for 24 hours prior to lysis and
extraction of DNA.
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M Cont SS H202 1% 5% 10% PMN
Figure 3.10. Isolation of oligonucleosomal fragments using the miniprep protocol.
A549 cells were treated with media alone, 2pM SS, lOmM H202,1%, 5% or 10% CSC
for 24 hours prior to lysis and isolation of DNA. Neutrophils aged overnight in teflon
(PMN) were used as a positive control for DNA laddering.
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3.3.3. CSC does not induce morphological changes in A549 cells as detected by
transmission electron microscopy (TEM)
A549 cells treated with 1, 5 and 10% CSC for 24 hours were analysed by transmission
electron microscopy (TEM) to look for apoptotic changes. No changes indicative of
apoptosis were evident in cells treated with 1 and 5% CSC (Figure 3.11.B,C), such as
chromatin margination or condensation. Moreover, these cells retained morphological
characteristics similar to untreated cells (Figure 3.11.A), except that cells treated with
5% CSC appear to possess swollen endoplasmic reticulum (Figure 3.11C), an early
marker of necrosis (see discussion). Cells treated with 10% CSC contained cytoplasmic
vacuoles (Figure 3.11.D), which occurs during necrosis (section 1.4.4.), and it was
difficult to identify individual organelles. As described in section 1.4.4 cytoplasmic
vacuoles are also characteristic of a necrotic-like or autophagic cell death. Moreover,
during autophagy, autophagolysosomes engulf and degrade intracellular organelles.
This may be what is occurring in cells treated with 10% CSC (Figure 3.11). Thus these
data further indicate that necrotic-like cell death not apoptosis occurs in response to
cigarette smoke exposure.
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Figure 3.11. Cigarette smoke condensate induces morphological changes in
A549 cells detected by transmission electron microscopy (TEM). A549 cells
were treated for 24 hours with either media alone (A), 1% CSC (B), 5% CSC (C) or
10% CSC (D). Cells were trypsinised and pelleted prior to being fixed in
gluteraldehyde and processed for TEM. Nuclei (N), mitochondria (M), Lamellar
bodies (L), multivesicular bodies (MY), swollen ER (swER) and vacuoles (V) are
marked. Magnification, A: x6300, B-D: x8000
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3.4. Phosphitidylserine exposure in response to cigarette smoke
condensate is the result of autofluorescence
Previous studies have shown that cigarette smoke treatment causes cells to
autofluoresce (Skold et al., 1989, 1992, 1993; Streck et al., 1994). As we could not
detect any markers of apoptosis in A549 cells in response to CSC, with the exception of
annexin-V binding the possibility that these results could be due to autofluorescence
was investigated. A549 cells were incubated with media alone or 1-10% CSC for 4, 8
or 24 hours and the cells were stained with annexin-V alone as described in the
materials and methods. The cells were analysed using flow cytometry and FL-1 versus
counts was plotted. A dose-dependent increase in FL-1 was detected in the absence of
annexin-V at all time points (Figure 3.12.A, C, E and Figure 3.13.B), which mimicked
the fluorescence profiles of cells stained with annexin-V (Figure 3.12.B, D, F and
Figure 3.13.A). Moreover, no significant difference in FL-1 was detected between each
treatment, whether stained or unstained. Attempts to quench the autofluorescence with
crystal violet were unsuccessful as the cells were permeabilised during the procedure,
resulting in intemalisation of both dyes, the consequence of which was increased




Figure 3.12. Cigarette smoke condensate induces autofluoresence in A549 cells.
A549 cells were incubated with either media alone (red), 1% CSC (green), 5% CSC
(pink) or 10% CSC (blue) for 4 (A and B), 8 (C and D), or 24 hours (E and F).
Cells were either left with no stain (A,C,E) or stained with annexin-V (B,D,F) prior




Control 1%CSC 5%CSC 10%CSC
B 60 n
Control 1%CSC 5%CSC 10%CSC
Figure 3.13. Cigarette smoke condensate treatment of A549 cells results in
autofluoresence detected by FL-1. Cells were treated with either media alone, 1, 5 or
10% CSC for 4 hours (open bars), 8 hours (grey bars) and 24 hours (closed bars) after
which cells were either stained with annexin-V (A) or left unstained (B), and analysed
by flow cytometry. Results expressed as mean of one experiment performed in
triplicate ± SEM, * p<0.05, *** pO.OOl. No significant difference was seen between
stained and unstained cells for each treatment at each time point.
123
3.5. Cigarette smoke condensate induces necrosis in epithelial cells
3.5.1. Cigarette smoke condensate induces necrosis in A549 cells as detected by
acridine orange / ethidium bromide staining
A549 cells treated with 1, 5 or 10% CSC for 6 and 24 hours were studied for evidence
of apoptosis and necrosis using the acridine orange and ethidium bromide staining
method. Cells treated with 1% and 5% CSC (Figure 3.14 and Figure 3.15.B and C)
remained viable, yet a significant increase in necrotic cell death was seen when cells
were treated with 10% CSC for 24 hours (Figure 3.14 and Figure 3.15.D). This
technique relies on identification of nuclear morphology to distinguish between viable,
apoptotic, necrotic and secondary necrotic cells. The necrosis seen as a result of CSC
exposure was not secondary necrosis, as nuclear pyknosis was not seen prior to loss of
cell membrane integrity (Figure 3.15.D). Nuclear swelling is a well-documented
phenomenon of necrosis (Wyllie et al., 1980), which was not evident in cells that
displayed membrane permeability (Figure 3.15D). However, this mimicked the
morphology seen after incubation with the hydrogen peroxide, the necrotic control
(Figure 3.15F). Treatment of A549 cells with 2pM SS demonstrated that apoptotic
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Figure 3.14. Cigarette smoke condensate induces necrosis in A549 alveolar
epithelial cells. Cells were exposed to 1%, 5% or 10% CSC, 2pM SS, or lOmM H202
for 6 (A) or 24 (B) hours in serum-free media. Cells were stained with acridine orange
and ethidium bromide and the percentage of viable (open bars), apoptotic (grey bars)
and necrotic (closed bars) cells were counted. Results are mean of three experiments ±
SEM. *** pO.OOl
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Figure 3.15. Cigarette smoke condensate induces necrosis not apoptosis in
A549 cells. Cells were treated for 24 hours with either media alone (A), 1% CSC
(B), 5% CSC (C), 10% CSC (D), 2pM SS (E) or lOmM H202 (F) and stained with
acridine orange/ethidium bromide. Viable cells take up acridine orange and appear
green and cells that have lost their cell membrane integrity take up ethidium
bromide and appear orange. Note the nuclear pyknosis after SS treatment not
present in cells treated with CSC or H202. Examples of viable cells (V), apoptotic
cells (Ap), necrotic cells (N) and cells undergoing secondary necrosis (SN) are
marked. Magnification x34
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3.5.2. Development of LDH release assay
Lactate dehydrogenase (LDH) is a cytoplasmic enzyme present in all cells, which upon
loss of membrane integrity during necrosis, escapes from the cell and can be detected in
the cell medium. This method was used to confirm the presence of necrosis after CSC
exposure. The manufacturers instructions required that the optimum plating
concentration be determined for this assay. Therefore a suspension of A549 cells at 2 x
106 cells per ml was used to prepare six replicates of doubling dilutions in a 96 well
plate ranging from 2 x 105 to 100 cells per well. The cells were allowed to adhere
overnight at 37°C before either fresh serum-free media or media containing 1% Triton
X-100 was added in triplicate for each plating density. The cells were incubated at
37°C for 24 hours prior to harvesting as described in materials and methods.
Subtracting the low control from the high control and determining the greatest
difference determined the optimum plating density, which was greatest at 3000 cells per
well (Figure 3.16). Use of over 3000 cells per well was impossible, as total lysis of the
cells released LDH at levels that were above the range of the assay. In order that the
plating density was not altered between experiments (usually 9000 cells per well in a
96-well plate) the harvested supematants of future experiments were diluted threefold in
serum-free media prior to the addition of LDH reagent. As it had been noted that CSC
interfered with other assays, CSC was added to LDH reagent in the absence of cells in
the optimisation experiment, no change in absorbance was evident in either the high or
the low controls (data not shown)
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Cell number
Figure 3.16. Effect of plating density on the LDH assay. Cells were plated at
different densities and cultured O/N at 37°C. Fresh serum-free media (low control) or
1% Triton X-100 (high control) was added and incubated for 24 hours at 37°C. LDH
reagent was added to the supernatants and incubated for 30 minutes at room
temperature in the dark prior to measuring the absorbance at 500nm. The difference
between the high and low control at each plating density was determined. Results
expressed as the mean of one experiment performed in triplicate ± SEM.
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3.5.2. A549 cells release LDH in response to CSC
The release of LDH from A549 cells was monitored after CSC treatment for 2, 4, 8, 24,
28 and 48 hours. Release of LDH from A549 cells treated with doses of 5% CSC and
above was evident as early as 8 hours after exposure (Figure 3.17), which confirmed the
presence of necrosis. LDH release was apparent with all doses of 5% CSC and above,




Figure 3.17. Cigarette smoke condensate induces necrosis in A549 alveolar
epithelial cells, measured by LDH release. Cells were exposed to either media alone
(iclosed diamonds) 1% (closed squares), 2.5% (open triangles), 5% (crosses), 7.5%
(open diamonds) or 10% (closed circles) CSC for up to 48 hours in serum-free media.
Supernatants were collected and amount of LDH released from the cells was determined
and expressed as percentage of total lysis with 1% Triton X-100. Results are expressed
as mean of three experiments performed in triplicate ± SEM. * p<0.05, ** p<0.01, ***
pO.OOl
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3.6. Cigarette smoke condensate induces necrosis in human umbilical vein
endothelial cells (HUVEC's)
Apoptosis of both epithelial cells and endothelial cells has been implicated in the
pathogenesis of emphysema (Kasahara et al., 2000, 2001). Primary human umbilical
vein endothelial cells (HUVEC's) were used to study the effect of CSC on endothelial
cells. HUVECs underwent similar morphological changes to A549 cells (section 3.2.1)
after exposure to 10% CSC (Figure 3.18.D). These morphological changes also
occurred at the lower dose of 5% CSC (Figure 3.18.C), indicating that HUVECs are
more susceptible to the deleterious effects of CSC. Moreover, acridine orange and
ethidium bromide staining showed that, like A549 cells, HUVEC's underwent necrosis
and not apoptosis in response to CSC exposure. Again, necrosis was detected at lower
doses than in A549 cells, they underwent necrosis after 24 hour treatment with both 5%
and 10% CSC (Figure 3.19), detected as uptake of ethidium bromide with the absence
of any nuclear changes (Figure 3.20.C and D). Like treatment of A549 cells no nuclear
swelling was observed, in fact the nuclei of permeable cells appeared smaller (Figure
4.20C, D) but still resembled the morphology of cells treated with H2O2, (Figure 3.20F;
necrotic control). 2pM SS was used as an apoptotic control to demonstrate that
classical morphological changes indicative of apoptosis could be obtained in this cell
type (Figure 3.20E). To confirm CSC-induced necrosis in HUVECs, release of LDH
was monitored. In accordance with preceding data, LDH was detected in the media
from cells treated with doses greater than 5% CSC for 24 hours (Figure 3.21).
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Figure 3.18. Cigarette smoke condensate induces necrosis not apoptosis in
human umbilical vein endothelial cells (HUVEC's). Cells were grown on sterile
glass coverslips, treated for 24 hours with either media alone (A), 1% CSC (B), 5%
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Figure 3.19. Cigarette smoke induces necrosis in human umbilical vein endothelial
cells (HUVEC's). HUVEC's were treated in full media containing 1, 5 and 10% CSC,
2pM SS or 5mM H202 for 2 hours (open bars), 4 hours (grey bars), 8 hours (hatched
bars) and 24 hours (closed bars). Cells were stained with acridine orange and ethidium
bromide and the percentage of viable, apoptotic (A) and necrotic cells (B) were counted.
Results are mean of three experiments performed in duplicate ± SEM. *** p< 0.001
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Figure 3.20. Cigarette smoke condensate induces necrosis not apoptosis in
human umbilical vein endothelial cells (HUVEC's). Cells were treated for 24
hours with either media alone (A), 1% CSC (B), 5% CSC (C), 10% CSC (D), 2pM
SS (E) or lOmM H202 (F) and stained with acridine orange/ethidium bromide.
Viable cells take up acridine orange and appear green and cells that have lost their
cell membrane integrity take up ethidium bromide and appear orange. Note the
nuclear pyknosis after SS treatment not present in cells treated with CSC or H202.
Examples of viable cells (V), apoptotic cells (Ap), necrotic cells (N) and cells
undergoing secondary necrosis (SN) are marked. Magnification x34
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Figure 3.21. Cigarette smoke condensate induces necrosis in HUVEC's, measured
by LDH release. HUVEC's were treated in full media alone (closed diamonds) or
containing 1% (closed squares), 2.5% (open triangles), 5% {crosses), 7.5% {open
diamonds) and 10% CSC {closed circles) for 2, 4, 6, 8 and 24 hours. Supernatants were
harvested and the amount of LDH released from the cells was determined and expressed
as percentage of total lysis with 1% Triton X-100. Results are mean of three
experiments performed in triplicate ± SEM. *** p <0.001
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3.7. Discussion
Although the predominant hypothesis is that emphysema results from loss of alveolar
epithelial and endothelial cells by apoptotic cell death, the data obtained in this chapter
did not support this hypothesis. This chapter demonstrated that apoptotic changes did
not occur in either epithelial or endothelial cells after CSC treatment, in fact CSC
induced necrotic cell death in both cell types. Studies by Kasahara et al. (2000, 2001),
provided the foundations for this thesis, however the authors concentrated on the role of
VEGF and VEGF-R in the pathogenesis of emphysema, not on cigarette smoking itself.
Study of the lungs of emphysema patients showed that increased numbers of terminal
deoxytransferase-mediated dUTP nick end labelling (TUNEL) positive cells were
evident as compared with healthy non-smokers. Moreover, increased levels of
oligonucleosomal DNA fragmentation were evident when compared with normal
subjects. No significant increase in TUNEL positive cells or DNA fragmentation was
evident in the lungs of healthy smokers (Kasahara et al., 2001). Thus, while these
studies propose a role for apoptosis in the development of emphysema, they do not
provide evidence that cigarette smoking induces apoptotic cell death. However, a
number of previous studies have demonstrated that cigarette smoke induces apoptosis
both in vivo and in vitro (Aoshiba et al., 2001; Carnevali et al., 2003; D'Agostini et al.,
2000, 2001; Hoshino et al., 2001; Ishii et al., 2001; Ma et al., 1999; Rajpurkar et al,
2002; Vayssier et al., 1998; Wang et al., 2000, 2001)
Direct comparisons between the majority of these studies with the data presented in this
chapter is not appropriate as different cell types and/or smoke exposure methods were
used both in vitro and in vivo. However, two of these studies observed cigarette smoke-
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induced apoptosis in the cell lines used in this chapter, A549 cells (Hoshino et al., 2001)
and HUVECs (Wang et al., 2001). Both studies treated cells with cigarette smoke
condensate, however different preparation methodologies were used compared to this
thesis. Although the use of condensate is a common method for cigarette smoke
exposure in vitro, no standardised protocol exists for its production. Each procedure
can isolate a slightly different spectrum of components, which may account for the
inconsistencies in results between laboratories (discussed further in chapter 5).
CSC-induced apoptosis has been documented in A549 cells using DNA laddering and a
variation of the acridine orange/ethidium bromide assay (Hoshino et al., 2001), however
use of these methods in this chapter provided no evidence of apoptosis in response to
CSC. However, like many carcinoma cell lines, A549 cells are a non-homogeneous cell
population that consist of multiple sub-populations (Croce et al., 1999; Watanabe et al.,
2002). In such cultures, subpopulations can become prevalent with relative ease. For
example, in both studies a population with a significantly lower doubling time was
isolated, thus frequent sub-culturing of the heterogeneous population may result in
slower growing subpopulations being eliminated from the culture. A549
subpopulations have demonstrated variability in response to toxicological agents
(Watanabe et al., 2002). Thus, laboratory-specific subpopulations, as a result of
different culture methodologies, may explain the inconsistency in results when using
A549 cells.
Although cell cycle analysis was primarily undertaken to investigate the occurrence of
apoptotic cells by the presence of a Sub Gi peak, these experiments revealed interesting
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information about the effect of cigarette smoke on the cell cycle. Treatment with 10%
CSC for 8 hours after removal of mimosine resulted in profiles where the cells remained
in Gi/S. This indicated that cigarette smoke had induced an arrest at this stage of the
cell cycle. A number of studies have demonstrated that oxidative stress induces cell
cycle arrest at Gj/S (Chen and Ames, 1994; Chen et al., 1998, 2000), with a phenotype
resembling senescence (Chen and Ames, 1994; Chen et al., 1998, 2000). Moreover,
increased expression of p53, p21 and under-phosphorylated retinoblastoma (Rb) protein
was observed (Chen et al., 1998). DNA strand breaks occur in response to oxidative
stress (Leanderson, 1993; Schraufstatter et al., 1986), and such damage can induce p53.
Expression of p53 results in induction of p21, which acts to inhibit cyclin-dependent
kinases (CDKs). CDKs act to phosphorylate Rb resulting in the release of the
transcription factor E2F, which then activates transcription of early S-phase genes,
inadequate phosphorylation of Rb results in cell cycle arrest in Gi. Thus, oxidative
stress-induced cell cycle arrest may be a direct consequence of DNA damage, activation
of p53 and under-phosphorylation of Rb.
When investigating a hypothesis it is important to apply appropriate techniques and to
understand the limitations of the assay of choice. Moreover, improper interpretation of
data can produce misleading results. Thus, care must be taken to ensure the technique is
applied appropriately and data are analysed properly. Many of the investigations that
documented apoptosis in response to cigarette smoke identified apoptotic cells by
TUNEL or, in situ end labelling (ISEL) (Aoshiba et al., 2001; D'Agostini et al., 2000,
2001; Ma et al., 1999; Rajpurkar et al., 2002; Wang et al., 2001). During apoptosis
caspase-activated DNase (CAD) cleaves DNA into 200bp fragments, or multiples
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thereof (Enari et al., 1998; section 1.4.2.4), producing classical "DNA ladders" upon
electrophoresis. TUNEL and ISEL are widely used, simple and sensitive techniques
that enable monitoring of this phenomenon quantitatively, at the single-cell level. These
techniques use the enzyme terminal deoxytransferase (TdT), or DNA polymerase I in
the case of ISEL, to incorporate labelled nucleotides into the 3' OH-terminal of DNA
strand breaks (Gavrieli et al., 1992). However, these methods are not specific for DNA
strand breaks obtained through apoptosis, and may detect damage induced by other
mechanisms. DNA fragmentation also occurs during necrosis, although a spectrum of
fragments of low molecular mass are produced, often resulting in a smear when
analysed by electrophoresis (Bicknell and Cohen, 1995). Moreover, DNA strand breaks
that arise during necrosis reveal a 3'-OH terminus and consequently are detected by
TUNEL (Hayashi et al., 1998). DNA strand breaks occur during situations of oxidative
stress (Leanderson, 1993; Schraufstatter et al., 1986), which can also be detected by
TUNEL. For example, exposure of lung fibroblasts to cigarette smoke results in
TUNEL positive cells that display no additional markers of apoptosis (Kim et al.,
2003). This was the result of reversible oxidative damage not cell death, the cells
continued to proliferate and were TUNEL negative following removal of smoke and
application of fresh media. Thus, false positives can be obtained when oxidative stress
is the stimulus or necrosis the outcome. Additionally, TUNEL is unreliable as the
preservation methods used to prepare cells can have a dramatic effect on detection of
strand breaks (Labat-Moleur et al., 1998; Negoescu et al., 1998). Thus, care must be
taken when interpreting the results of TUNEL and additional identification of apoptosis
is required. D'Agostini et al. (2000) observed increased TUNEL positive cells in the
skin of mice after whole-body exposure to cigarette smoke, which was associated with
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areas of alopecia, however no further analysis into the cause of DNA damage was
undertaken.
Ma et al. (1999) also relied solely on TUNEL to detect apoptotic cells in the gastric
mucosa after whole body exposure to smoke. It cannot be assumed that TUNEL
positive cells in the gastric mucosa are apoptotic in this study without additional
investigation. However, a more recent study from the same laboratory, confirmed
apoptosis in the gastric mucosa after cigarette smoke exposure, detected by both
TUNEL and western blotting for caspase-3 cleavage (Wang et al., 2000). In this study
the gastric mucosa is not directly exposed to cigarette smoke and thus different
mechanisms may be involved in cell death than presented in this chapter.
CSC exposure has been documented to induce apoptosis in fibroblasts (Ishii et al.,
2001) detected by annexin-V-PE/7-amino-actinomycin D (7-AAD) staining. However,
careful examination of the data shows that, in fact, necrosis was the predominant form
of cell death not apoptosis. Moreover, apoptosis was overestimated in these studies.
The percentage of apoptotic cells was determined as a percentage of 7-AAD negative
cells, discounting necrotic cells, which in some cases was over half the population.
Therefore, this study in reality supports the data presented in this chapter. However, as
cell death was evaluated by flow cytometry alone in this study the occurrence of
autofluorescence must be considered. In this chapter autofluorescence was observed
when annexin-V binding was analysed by FL-1 (emission wavelength 507nm). This
study employed annexin-Y detected by FL-2 (emission wavelength 570nm) and 7-AAD
detected by FL-3 (emission wavelength 660nm), autofluorescence may not interfere
140
with the signal at these wavelengths. However, it appears that no investigations were
undertaken to determine whether autofluorescence occurred in this study, and therefore
care must be taken when interpreting this paper.
Cellular autofluorescence has been documented in macrophages isolated from the lungs
of smokers (Skold et al., 1989; Streck et al., 1994) and from rats exposed to smoke
(Skold et al., 1993). In vitro studies demonstrated that macrophages endocytose CSC-
derived fluorescent material (Skold et ah, 1992). Endocytosis is a universal mechanism
by which cells can non-specifically internalise material dissolved in the extracellular
fluid (Lodish et al., 1995). Thus, all cells have the capability to internalise fluorescent
material from cigarette smoke. Quenching of cigarette smoke-mediated
autofluorescence with crystal violet prior to staining has been successful in some studies
(Hallden et al., 1991; Skold et al., 1996; Umino et al., 1999). However, this method
was developed to study intracellular staining and preservation of the cell membrane
integrity was not a concern. Annexin-V/PI staining depends on the preservation of cell
membrane integrity, use of crystal violet resulted in membrane permeabilisation, and all
cells taking up both stains. Thus it was not possible to use this method to study
apoptosis in cells exposed to CSC in this chapter.
As discussed in section 1.4.4, the basic description of necrosis is defined as osmotic
swelling of the cell and organelles, cytoplasmic vacuolisation and eventually cell lysis
(Wyllie et al., 1980). Early and late characteristics can be detected morphologically;
early abnormalities include marginal clumping of chromatin, nuclear swelling,
dilatation of the endoplasmic reticulum, and gross swelling of the mitochondria. The
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later stages of necrosis can be detected by rupture of nuclear, organelle and plasma
membranes (Wyllie et al., 1980). In this chapter necrosis was determined by loss of
plasma membrane integrity, detected by uptake of ethidium bromide and release of
LDH with no morphological changes of the nucleus reminiscent of apoptosis. However,
these methods only monitor the end point of necrotic cell death, loss of plasma
membrane integrity. Other forms of cell death may result in loss of plasma membrane
integrity, either directly or due to lack of phagocytic clearance in an in vitro system.
Therefore it should not be assumed that loss of plasma membrane integrity indicates the
cells have died in a necrotic manner. Interestingly, other markers of necrosis were not
evident after cigarette smoke exposure, no nuclear swelling was evident either by TEM
or light microscopy, however TEM analysis of cells treated with doses of 5%CSC
appear to possess swollen mitochondria. In fact, TEM showed that 10% CSC treatment
may induce an autophagic-like cell death of A549 cells. The absence of
oligonucleosomal DNA fragmentation confirmed that cigarette smoke was not inducing
apoptosis however, as discussed earlier, DNA fragmentation also occurs in necrotic cell
death. The absence of necrotic smears after electrophoresis indicates that "classical"
necrotic cell death may not be occurring and further studies are required to characterise
the form of cell death induced by cigarette smoke in more detail.
Studies exist in the literature, however, which support the observation that necrosis
occurs in response to cigarette smoke (Ambalavanan et al., 2001; Hopkin and Steel,
1980; Pouli et al., 2003). Exposure of neonatal porcine vascular smooth muscle cells to
CSC resulted in necrotic cell death with no evidence of apoptosis, using a modified
TUNEL method (Ambalavanan et al., 2001). In addition, exposure of mouse lung
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epithelial cells to vapour phase CSC resulted in LDH release within 6 hours of exposure
to 2.5 (35ml) puffs of smoke (Pouli et al., 2003). Blood derived lymphocytes were
unable to exclude a vital dye in a dose-dependent manner after CSC exposure (Hopkin
and Steel, 1980). Exposure of rats to cigarette smoke resulted in a significant increase
in TUNEL positive cells in the bronchial epithelium, however TEM analysis revealed
cytoplasmic vacuolisation and organelle swelling, indicating necrotic, not apoptotic, cell
death (Jung et al., 2000).
This chapter does not support previous hypotheses that emphysema results from
cigarette smoke-induced apoptosis of alveolar epithelial and endothelial cells, however
it provides evidence that destruction of alveolar septa may result from cigarette smoke-
induced necrosis. Loss of these cells by any means would result in loss of alveolar
fepithelium and endothelium, which may not be repaired due to the inhibitory effect of
cigarette smoke on repair mechanisms (section 1.2.5). Of great importance however, is
the finding that type II lung epithelial cell death occurs (Kasahara et al., 2001; Hoshino
et al., 2001). As discussed previously, among many other important functions these
cells are considered the "stem-cell" of the alveoli, as the gas-exchange type I cells are
replenished by division and differentiation of the type II cells. Thus loss of these cells
results in a further inability of the alveolar epithelium to regenerate itself and would
therefore result in loss of alveolar walls.
Apoptosis enables removal of dying cells with little damage to the surrounding tissue if
effectively cleared by phagocytes. However, necrosis ultimately results in cell lysis and
the release of intracellular hydrolytic enzymes and lysosomal contents. This may
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amplify local tissue damage by causing additional cells to undergo necrosis and also by
recruiting inflammatory cells to the site of injury. It is well documented that
inflammation occurs in smokers and individuals with emphysema/COPD. Retamales et
al (2001) recruited patients undergoing lung volume reduction surgery (LVRS) and
using computed tomography (CT) determined severity of emphysema. The numbers of
inflammatory cells present in tissues and airspaces were determined, increased
inflammation was associated with increased severity of emphysema. Thus, although
much interest has been generated on the involvement of apoptosis, necrosis and
subsequent inflammatory responses are more likely candidates in the pathogenesis of
emphysema.
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Chapter 4: Cigarette Smoke Condensate inhibits caspase
activation and switches apoptosis to necrosis
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4.1. Introduction
In the previous chapter it was shown that treatment of A549 cells and HUVECs with
CSC resulted in necrotic cell death. As discussed in section 1.2.4.2, the cigarette
smoking habit places a high oxidative burden on the smoker both systemically and
directly to the lung, which is thought to cause many of the toxic effects of cigarette
smoke. Studies of the effect of oxidants on cell death in vitro have demonstrated that
oxidative stress inhibits apoptosis and induces necrosis, in Jurkat, U937, Burkitts
lymphoma, and HepG2 cells (Hampton and Orrenius, 1997; Lee and Shacter, 1999,
2000; Palomba et al., 1996; Samali et al., 1999). It was hypothesised that cigarette
smoke may be inhibiting apoptosis in addition to inducing necrosis, therefore the effect
of CSC on apoptosis was studied.
A549 epithelial cells and HUVEC endothelial cells were not used to study the cell death
pathway for a number of reasons. It was exceedingly difficult to induce A549 cells to
undergo classical apoptosis; staurosporine (SS) induced phosphatidylserine (PS)
externalisation with a morphology that vaguely resembled apoptosis, however many
other markers of apoptosis were absent (Chapter 3). It was also not possible to use
HUVEC cells to study the cell death pathway in great detail, due to a difficulty in
obtaining sufficient numbers of cells on a regular basis. Jurkat T-cells undergo
apoptosis readily and display classical apoptotic markers such as oligonucleosomal
DNA fragmentation, chromatin condensation, caspase activation, and cell shrinkage,
and therefore are often used as a model to elucidate the mechanism of cell death in
response to various stimuli (Hampton et al., 2002; Hampton and Orrenius, 1997; Leist
et al., 1997; Malhotra et al., 2001; Saleh et al., 2000; Tepper et al., 1999). It has also
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been shown that the cellular mechanisms that execute the apoptotic process are neither
cell-type, nor species, specific (Zamzami et al., 1996). Therefore Jurkat cells were used
in this chapter as a model system to investigate the effect of CSC exposure on apoptosis.
4.2. CSC INHIBITS APOPTOSIS AND INDUCES NECROSIS IN JURKAT T-CELLS.
Jurkat cells treated with 10% CSC underwent necrosis as detected morphologically
(Figure 4.1C and 4.2.A) and confirmed by LDH release (Figure 4.3). Cells treated with
SS displayed the classical features of apoptosis, shrunken cells with pyknotic nuclei
(Figure 4.IB), and oligonucleosomal DNA fragmentation (Figure 4.2.B SS). A small
increase in LDH release was observed after longer treatments with SS (Figure 4.3),
however this was attributed to secondary necrosis in the absence of phagocytic
clearance. Interestingly, cells cultured with a combination of SS and CSC displayed a
necrotic-like morphology (Figure 4.ID), swollen nuclei with no definite edge to the
cytoplasm, indicating that plasma membrane integrity had been lost. SS/CSC treated
cells also displayed no evidence of apoptosis, either by morphology (Figure 4.ID), or
DNA laddering (Figure 4.2.B SS/CSC). Like A549 cells, the absence of necrotic
smears after electrophoresis indicated that these cells were not undergoing a classical
necrotic death.
It has been shown that apoptosis and necrosis can be induced by the same stimulus
dependent on its intensity (Lennon et al., 1991). However, cells treated for shorter
incubations with CSC showed no evidence of apoptosis prior to undergoing necrosis
(Figure 4.4). In addition, apoptosis was not observed when cells were treated with
lower doses of CSC, cells treated with 1% CSC remained viable and those treated with
5% CSC underwent necrosis (Figure 4.5). Moreover, there was no significant
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difference between the levels of necrosis induced by 5% and 10% CSC. Treatment with
1% CSC in combination with SS did not prevent apoptosis, however co-culture with 5%
CSC prevented apoptosis and induced necrosis to a similar extent as with 10% CSC
(Figure 4.5).
SS is a broad-ranging inhibitor of protein kinases that induces apoptosis of numerous
cell types by activation of the intrinsic apoptotic pathway (section 1.4.2.3). Using anti-
Fas activating antibody (CH-11) as a stimulus, the effect of CSC on the extrinsic
pathway was studied. CH-11 treatment of Jurkat cells resulted in classical apoptotic
morphological changes and induced oligonucleosomal DNA fragmentation (Figure 4.6),
which was prevented by co-culture with CSC resulting in necrosis (Figure 4.6). Thus,
CSC affects both the intrinsic and extrinsic apoptotic pathways.
To further clarify the stage of the apoptotic process CSC was affecting, cells were
induced to undergo apoptosis with SS, exposed to 10% CSC at hourly intervals and co-
cultured for the remainder of the experiment. Whereas, the predominant form of cell
death was necrosis when CSC was added at early time points, this decreased when CSC
was added more than 1 hour after SS and increasing levels of apoptosis occurred with
each, later addition, of CSC (Figure 4.7A). This was coupled with increased
oligonucleosomal DNA fragmentation as apoptosis became more predominant (Figure
4.7B).
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Figure 4.1: Cigarette smoke condensate inhibits apoptosis and induces necrosis
in Jurkat cells. Cells were treated for 6 hours with either media alone (A), 2pM SS
(B), 10% CSC (C) or a combination of 2pM SS and 10% CSC (D). Cytospins were
prepared and stained with DiffQuick and the percentage of viable (V), apoptotic
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Figure 4.2. Cigarette smoke condensate prevents apoptosis and induces necrosis in
Jurkat cells. Jurkat cells were incubated for 6 hours at 37°C with either normal media,
2pM SS, 10% CSC or a combination of SS and CSC. Cytospins were prepared and the
percentage of viable (open bars), apoptotic {grey bars) and necrotic {closed bars) cells
were determined (A). Results expressed as the mean of three experiments where at least
200 cells were counted per slide ± SEM. *** p<0.001 compared to control. Apoptosis
was confirmed by the presence of oligonucleosomal DNA fragmentation (B).
Representative gel of three experiments is shown.
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Figure 4.3. Cigarette smoke condensate induces necrosis in Jurkat cells, measured
by LDH release. Jurkat cells were incubated for up to 24 hours at 37°C with either
normal media (closed diamonds), 2pM SS (closed squares), 10% CSC (closed triangles)
or a combination of SS and CSC (open circles). Cells were centrifuged at 250g, the
media was collected and analysed for LDH content. Results expressed as the mean of
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Figure 4.4. Time course of apoptosis and necrosis induced by SS and CSC. Jurkat
cells were incubated for 2 hours (A), 4 hours (B) or 6 hours (C) at 37°C with either
normal media, 2pM SS, 10% CSC or a combination of SS and CSC. Cytospins were
prepared and the percentage of viable (open bars), apoptotic {grey bars) and necrotic
{closed bars) cells were determined. Results expressed as the mean of three
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Figure 4.5. Dose response to CSC. Jurkat cells were incubated for 6 hours at 37°C with
either normal media, 2pM SS, 1% CSC, 5% CSC 10% CSC or a combination of SS and
1%, 5% or 10% CSC. Cytospins were prepared and the percentage of viable (open
bars), apoptotic (,grey bars) and necrotic (closed bars) cells were determined. Results
expressed as the mean of three experiments where at least 200 cells were counted per
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Figure 4.6. Cigarette smoke condensate inhibits apoptosis induced by Fas ligation.
Jurkat cells were incubated with either normal media, 50ng/ml CH-11, 10% CSC or a
combination of CH-11 and CSC for 10 hours at 37°C. Cytospins were prepared and the
percentage of viable (open bars), apoptotic {grey bars) and necrotic {closed bars) cells
were determined (A). Results expressed as the mean of three experiments where at least
200 cells were counted per slide ± SEM. *** p<0.001 compared to control. Apoptosis
was confirmed by the presence of oligonucleosomal DNA fragmentation (B).
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Figure 4.7. Cigarette smoke condensate inhibits an early stage in the apoptotic
pathway. Jurkat cells were incubated with either normal media, 2pM SS or 10% CSC
and incubated at 37°C for 6 hours. Apoptosis was initiated in 5 separate flasks with
2pM SS and 10% CSC was added at hourly intervals. Cells were incubated at 37°C for
a total of 6 hours from the addition of SS. Cytospins were prepared and the percentage
of viable, apoptotic (grey bars) and necrotic (closed bars) cells were counted (A)
Results expressed as mean of three experiments ± SEM. *** p<0.001 compared to
control. Apoptosis was confirmed by the presence of DNA ladders (B). Representative
gel of three experiments shown..
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4.3. Inhibition of apoptosis and induction of necrosis by CSC does not
involve poly (ADP-ribose) polymerase (PARP) activation.
Inhibition of apoptosis by oxidants has been shown to involve the activation of the
DNA repair enzyme poly (ADP-ribose) polymerase (PARP) in response to oxidant-
induced DNA strand breaks (Lee and Shacter, 1999; Palomba et al., 1996). Moreover,
PARP activation was higher in lymphocytes from patients with COPD compared to
healthy controls (Hageman et al., 2003). As outlined in section 1.4.4, activation of
PARP in situations of large scale DNA damage may result in ATP depletion, and an
inability to execute the apoptotic program. In Chapter 3 it was suggested that CSC may
in fact induce significant DNA damage as evidenced by the Gl/S cell cycle block.
Inhibition of PARP activity prevented oxidant-mediated necrosis and resulted in
apoptotic cell death (Lee and Shacter, 1999; Palomba et al., 1996).
Therefore, the involvement of PARP in CSC-induced necrosis and inhibition of
apoptosis was determined. Jurkat cells were pre-treated with the PARP inhibitor, 3-
aminobenzinamide (3-AB) for 30 minutes prior to addition of SS and/or CSC. There
was no significant difference in the apoptotic and necrotic profiles of the cells after
treatment in the presence or absence of 3-AB (Figure 4.8). Therefore it was deduced
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Figure 4.8. 3-aminobenzinamide pre-treatment does not prevent CSC-induced
necrosis or apoptosis inhibition. Jurkat cells were incubated with ImM 3-AB for 30
minutes at 37°C prior to treatment with 2pM SS, 10% CSC or a combination of SS and
CSC (S/C) at 37°C for 6 hours. Cytospins were prepared and the percentage of viable
{open bars), apoptotic {grey bars) and necrotic {closed bars) cells were counted (A)
Results expressed as mean of three experiments ± SEM. *** p<0.001 compared to
appropriate control. Apoptosis was confirmed by the presence of DNA ladders (B)
representative gel of three experiments shown..
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4.4. Inhibition of apoptosis and induction of necrosis can be prevented by
some antioxidants but not others.
In order to investigate the involvement of oxidants in CSC-mediated necrotic cell death
and apoptosis inhibition, antioxidants were added to the media prior to the addition of
SS and/or CSC, in order to quench the reactive oxygen species (ROS) from the smoke.
4.4.1. Vitamin-E and mannitol do not protect against CSC-induced necrosis
Vitamin-E (a-tocopherol) is a chain breaking antioxidant, which scavenges peroxyl
radicals and prevents lipid peroxidation (Wang and Quinn, 1999). Lipid peroxidation is
induced after cigarette smoking (section 1.3.3.1 and 1.2.4.2) and therefore the role of
the peroxyl radical in CSC-mediated necrosis was investigated. Pre-treatment with
ImM vitamin-E for 30 minutes prior to the addition of stimuli did not protect against
CSC-induced necrosis. Cells exposed to SS in the presence of vitamin-E did not
undergo apoptosis (Figure 4.9), and as a result it was difficult to evaluate the role of
oxidants in inhibition of apoptosis caused by CSC using vitamin-E as an antioxidant.
However, the presence of vitamin-E did not prevent necrosis induced by CSC and thus






















Figure 4.9. Vitamin-E pre-treatment does not prevent CSC-induced necrosis or
apoptosis inhibition. Jurkat cells were incubated with ImM vitamin-E for 1 hour at
37°C prior to treatment with 2pM SS, 10% CSC or a combination of SS and CSC (S/C)
at 37°C for 6 hours. Cytospins were prepared and the percentage of viable (open bars),
apoptotic (grey bars) and necrotic (closed bars) cells were counted (A) Results
expressed as mean of three experiments ± SEM. *** p<0.001, ** p<0.01 compared to
appropriate control; # p<0.001 compared to media only. Apoptosis was confirmed by
the presence of DNA ladders (B) representative gel of three experiments shown..
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Mannitol is a hydroxyl radical (OH) scavenger, but in doing so is itself converted to a
free radical. Hence it acts as a protective agent only if its radical is less damaging than
the radical it quenched (Gillbe et al., 1996). The presence of 5mM mannitol in the
media had no effect on SS-, or CH-11-induced apoptosis or CSC-induced necrosis
(Table 4.1 and 4.2). A small number of apoptotic cells were detected after exposure to
the combination of SS and CSC in the presence of mannitol but the level of necrosis
was not affected (Table 4.1). Similarly, mannitol did not protect against CSC-induced
necrosis when added in combination with CH-11, however unlike in response to
SS/CSC no apoptotic cells were detected (Table 4.2). Morphological analysis of
apoptosis was supported by analysis of oligonucleosomal DNA fragmentation, which
was only seen after treatment with the apoptosis inducers, SS and CH-11 in the presence
of mannitol (Figure 4.10 C and F).
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Table 4.1. Inhibition of apoptosis and induction of necrosis mediated by CSC is
prevented by DTT and GSH. Jurkat cells were incubated with either normal media,
5mM mannitol, ImM DTT or ImM GSH containing 2pM SS, 10% CSC or a
combination of 2pM SS and 10% CSC for 6 hours at 37°C. Cytospins were prepared
and the percentage of viable, apoptotic and necrotic cells were determined. Results are
mean of three experiments ± SEM. *** p<0.01 compared to appropriate control; #
p<0.001 compared to no-antioxidant control.
% Apoptosis % Necrosis
No-antioxidants 0.3 ±0.1 0.1 ±0.1
Control Mannitol 0.3 ±0.2 0.2 ±0.1
DTT 2.4 ± 1.3 0.7 ± 0.4
GSH 0.4 ±0.2 0.2 ±0.2
No-antioxidants 94.9 ± 2.6 *** 0.4 ±0.2
Mannitol 97.4 +1.2 *** 0.9 ±0.7
SS
DTT 90.3 ± 4.2 *** 0.1 ±0.1
GSH 93.4 ±4.5 *** 0.2 ±0.1
No-antioxidants 0.0 ±0.0 74.6 ±5.0 ***
Mannitol 0.0 ±0.0 75.4 ± 11.8 ***
CSC
DTT 0.4 ± 0.3 16.3 ± 1.7#
GSH 12.9 ±4.7 0.3 ±0.3#
No-antioxidants 0.0 ± 0.0 69.5 ±4.9 ***
Mannitol 23.2 ± 18.4# 61.4 ± 18.5 ***
ss/csc
DTT 79.5 ±11.4***# 0.6 ±0.4#
GSH 98.5 ±0.5 ***# 0.3 ±0.2#
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4.4.2. GSH and DTT protect against CSC-induced necrosis
GSH is a thiol antioxidant, which scavenges free radicals by sacrificing its sulfydryl
group resulting in the formation of glutathione disulphide (GSSG) (Meister and
Anderson, 1983; section 1.1.1.3.). The level of apoptosis in cells incubated with SS, or
CH-11 was unaffected by the presence of GSH, however necrosis was abolished in
response to CSC with a small percentage of cells undergoing apoptosis. Co-culture with
the apoptosis inducers and CSC in the presence of GSH again prevented necrosis with
98 percent of cells undergoing SS-induced apoptosis and 81 percent undergoing CH-11-
induced apoptosis (Table 4.1 and 4.2 respectively). Moreover, oligonucleosomal DNA
fragmentation, absent after co-culture with CSC and SS/CH-11 alone (Figures 4.2B and
4.6B respectively), occurred when treated in the presence of GSH (Figure 4.1 OB and E).
Therefore, the presence of GSH prevented both the induction of necrosis and the
inhibition of the apoptotic pathway as a result of CSC exposure.
DTT, also a thiol antioxidant, was used to study the role of oxidants in CSC-induced
necrosis and apoptosis inhibition. DTT did not affect control cells or affect apoptosis
induced by SS, but did significantly reduce the level of necrosis seen after CSC
exposure. SS-induced apoptosis occurred with no evidence of necrosis in cells co-
cultured with SS and CSC in the presence of DTT (Table 4.1). However, DTT itself
prevented apoptosis induced by CH-11, and cells treated with CSC in the presence of
DTT underwent equivalent levels of necrosis as when no-antioxidants were used (Table
4.2). These results were confirmed by electrophoresis of DNA, figure 4.1 OA shows that
DNA fragmentation occurred after treatment with SS but not CSC alone, and unlike
after treatment with SS and CSC without antioxidants (Figure 4.2B) cells treated with
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SS and CSC in the presence of DTT demonstrated DNA fragmentation (Figure 4.1 OA).
No DNA fragmentation was seen with CH-11, CSC or CH-11/CSC in the presence of
DTT (Figure 4.10D), mimicking the absence of morphological apoptosis observed.
This indicated that both DTT and GSH may be quenching a component(s) of CSC
responsible for inducing necrosis while preventing apoptosis induced by SS, but only
GSH was effective at attenuating the effects when CH-11 was the stimulus.
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Table 4.2. Inhibition of apoptosis and induction of necrosis mediated by CSC is
prevented by DTT and GSH. Jurkat cells were incubated with either normal media,
5mM mannitol, ImM DTT or ImM GSH containing 50ng/ml CH-11, 10% CSC or a
combination of 50ng/ml CH-11 and 10% CSC for 9 hours at 37°C. Cytospins were
prepared and the percentage of viable, apoptotic and necrotic cells were determined.
Results are expressed as the mean of two experiments ± SEM. *** p<0.01 compared to
appropriate control; # p<0.001 compared to no-antioxidant control.
% Apoptosis % Necrosis
No-antioxidants 0.6 ±0.2 0±0
Control Mannitol 0.6 ±0.6 0±0
DTT 4.2 ± 0.4 6.0 ±0.3
GSH 0.7 ±0.4 0±0
No-antioxidants 49 ± 5.1 *** 0.1 ±0.1
Mannitol 49.1 ± 0.9 *** 0±0
CH-11
DTT 8.4 ±1.2# 5.9 ±3.4
GSH 56.9 ±2.6 *** 0±0
■' No-antioxidants 0±0 84.2 ±12.5 ***
Mannitol 0±0 94 ± 1.1 ***
CSC
DTT 0±0 72.1 ± 18.1 ***
GSH 8.9 ±6.1 0±0#
No-antioxidants 0±0 87.2 ± 10.5 ***
CH-11 Mannitol 0±0 91.3 ±0.3 ***
/CSC DTT 2.1 ±2.1 92.9 ±5.5 ***
GSH 81.7 ±0.4 *** # 0±0#
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Figure 4.10. Oligonucleosomal DNA fragmentation in response to SS and/or CSC
in the presence of antioxidants. Jurkat cells were incubated with media containing
ImM DTT (A, D), ImM GSH (B, E) or 5mM mannitol (C, F) with 2pM SS, 10% CSC
or a combination of 2pM SS and 10% CSC for 6 hours (A-C) or 50ng/ml CH-11, 10%
CSC or a combination of 50ng/ml CH-11 and 10% CSC (D-F). Representative gels of
three experiments (A, B, C) and two experiments (D, E, F) data are shown.
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4.4.3. CSC conjugates directly with GSH
In vivo, in addition to its antioxidant properties, GSH acts as a detoxifying agent
conjugating to electrophilic compounds via its thiol group both spontaneously and with
the aid of GSH transferases (Meister and Anderson, 1983; Section 1.1.1.3.). In order to
determine whether GSH-CSC conjugates occur in vitro, in the absence of the enzyme,
various concentrations of CSC were incubated with GSH at 37°C (Figure 4.11). A dose
dependent decrease in GSH was observed, indicating that GSH may be forming
conjugates with the many electrophilic compounds present in cigarette smoke and
would thus not be detected by the GSH assay.
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Figure 4.11. Cigarette smoke condensate conjugates with GSH in a non-enzymatic
manner. Glutathione was incubated either alone (closed diamonds) or with 1% CSC
(closed squares), 5% CSC (crosses) or 10% CSC (closed circles) for 1 hour at 37°C.
The level of detectable GSH was determined using the "Tietze" GSH assay. Results
expressed as mean of three experiments performed in triplicate ± SEM. ***p<0.001.
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4.5. Inhibition of apoptosis is coupled with an inhibition of caspase
activation
4.5.1. Cigarette smoke condensate prevents caspase activation in Jurkat cells
Caspases are the main effectors of the apoptotic pathway thus, as cigarette smoke was
shown to affect early stages of apoptosis, the caspase pathway was studied in more
detail. Procaspase-3 cleavage was monitored by western blot in cytoplasmic lysates
from Jurkat cells treated with SS and/or CSC (Figure 4.12A), although the antibody
detects both the proform and the active subunits of caspase-3 it was difficult to detect
the subunits under the conditions of this assay, possibly as a result of ubiquitination and
proteolytic degradation. As a result, processing of procaspase-3 was detected by a
decrease in intensity or total loss of the 37kDa band, representative of procaspase-3, by
Western blot. In support of the previous data, cleavage of caspase-3 proform was only
observed in cells exposed to SS, not in cells exposed to either CSC or a combination of
SS and CSC (Figure 4.12A). This indicated that in addition to preventing the
morphological features of apoptosis, CSC prevented the activation of caspases.
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Figure 4.12. Cigarette smoke condensate prevents caspase-3 cleavage in Jurkat
cells. Jurkat cells were treated for 6 hours with either normal media (A) or media
containing, ImM DTT (B), ImM GSH (C), 5mM mannitol (D) in the presence of media
alone (cont), 2pM SS, 10% CSC or with a combination of 2pM SS and 10% CSC (S/C).
Whole cell lysates were prepared and caspase-3 cleavage was determined by Western
blot. Representative blots of three experiments are shown.
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4.5.2. GSH and DTT protect against CSC-induced caspase inhibition
The antioxidants GSH and DTT prevented the inhibition of apoptosis induced by CSC
in addition to preventing CSC-induced necrosis, and therefore their role in preventing
caspase inhibition was investigated. Jurkat cells were incubated with SS and/or CSC in
the presence of ImM GSH, ImM DTT or 5mM mannitol and the effect on procaspase-3
cleavage was determined (Figure 4.12). In the presence of mannitol (Figure 4.12D)
activation of caspase-3 was observed in cells treated with SS but not in cells treated
with CSC. However, a small proportion of procaspase-3 was activated after treatment
with SS and CSC in the presence of mannitol, which correlates with the small
percentage of apoptotic cells observed morphologically (Table 4.1). However, in
contrast to cells treated without antioxidants, procaspase-3 cleavage occurred in cells
treated with SS and CSC in the presence of both DTT (Figure 4.12B) and GSH (Figure
4.12C), reflecting the morphological apoptosis seen in cells treated with SS and CSC in
the presence of DTT or GSH (Table 4.1).
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4.6. Cigarette smoke does not affect caspase activity directly
4.6.1. Cigarette smoke condensate does not affect recombinant caspase-3 activity
Caspases contain a thiol group in the active site, which is essential for function and is
sensitive to inactivation by oxidation, nitrosylation or alkylation (Melino et al., 1999).
Previous studies have demonstrated that oxidative stress decreases the activity of
caspases (Borutaite and Brown, 2001; Hampton et al., 2002; Lee and Shacter, 1999,
2000; Samali et al., 1999). In addition, in a similar manner to that observed with GSH
(Figure 4.10), CSC may conjugate to the thiol group in the caspase active site resulting
in inactivation of the enzyme. To determine whether this was occurring, recombinant
caspase-3 was incubated with various concentrations of CSC and the activity of the
enzyme was determined by its ability to cleave a colorimetric caspase substrate. CSC
did not directly affect caspase-3 activity as no decrease in absorbance was observed
(Figure 4.13). This indicated that the inhibition of apoptosis observed in the presence of
smoke was not due to a direct effect on caspase activity. A positive control of ImM
H2O2 significantly decreased recombinant caspase-3 activity, in accordance with the
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Figure 4.13. Cigarette smoke condensate does not inhibit recombinant caspase-3
activity directly. Recombinant caspase-3 was incubated either alone (closed diamonds)
or with 1% CSC (closed squares), 5% CSC (crosses), 10% CSC (closed circles) ImM
H202 (open squares) or a caspase inhibitor (open circles) in the presence of a
colorimetric caspase-3 substrate. Absorbance at 405nm was measured at determined
time intervals. Results expressed as mean of three experiments ± SEM. * p<0.05
***p<0.001.
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4.6.2. Cigarette smoke condensate does not affect caspase activation in a cell-free
system
Although CSC was not directly affecting caspase activity, caspase-3 cleavage did not
occur in the presence of CSC; therefore an investigation into the direct effect of CSC on
activation of the caspase pathway was performed. The caspase pathway was activated
artificially in lysates from Jurkat cells by initiating formation of the apoptosome with
lOOpM cytochrome-c and ImM dATP (Slee et al., 1999). Subsequent caspase
activation was detected by monitoring processing of procaspases-3 and -9 by Western
blot. CMF-PBS was added to the lysates to a final concentration of 10%, as a negative
control, and after addition of cytochrome-c and dATP, caspase activation was observed
(Figure 4.14A and C). However, addition of 10% CSC to cytoplasmic lysates did not
prevent processing of caspases-3 or -9 (Figure 4.14B and D), which taken alongside the
effect of CSC on recombinant caspase-3, it was evident that CSC did not directly
prevent caspase activation.
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Figure 4.14. Cigarette smoke condensate does not directly inhibit caspase
activation. Cytoplasmic extracts were prepared from Jurkat cells and either 10% CMF-
PBS (A and C) or 10% CSC (B and D) was added. Apoptosome formation was
initiated by addition of cytochrome-c and dATP at 37°C and samples were taken at
hourly intervals and boiled for 5 minutes in laemmli buffer. Cleavage of caspase-3 (A
and B) or caspase-9 (C and D) was monitored by Western blotting. Result is
representative of three experiments.
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4.7. Cigarette smoke condensate indirectly affects caspase activation
4.7.1. Pre-incubation with cigarette smoke condensate prevents caspase-3
activation in a cell-free system
Given that CSC treatment prevented activation of the caspase cascade, but did not affect
caspase activity or activation directly, the indirect effect of CSC on caspase activation
was investigated. Jurkat cells were incubated with either media alone or media
containing 10% CSC for 2 hours prior to preparation of cytoplasmic lysates and
formation of the apoptosome. Caspase-3 processing was evident in lysates from cells
incubated with media alone (Figure 4.15A). However, in lysates from cells treated with
10% CSC no caspase-3 processing was observed after addition of dATP and
cytochrome-c (Figure 4.15B). This indicates that CSC prevents caspase activation at a
point upstream of caspase-3 cleavage.
4.7.2. Pre-incubation with cigarette smoke condensate prevents caspase-9
activation in a cell-free system
As outlined in section 1.4.2.2 and 1.4.2.3, the extrinsic apoptotic pathway can activate
the intrinsic apoptotic pathway via Bid. In this situation both pathways have a common
effector caspase upstream of caspase-3 activation, caspase-9. As CSC prevents
apoptosis induced by both of these pathways (section 4.2), caspase-9 activation was
studied. Western blot analysis of cell-free extracts revealed that caspase-9 activation
was prevented following a 2 hour incubation with 10% CSC (Figure 4.15D). Therefore,
it was evident that CSC was preventing the activation of the caspase cascade at the level
of caspase-9 activation.
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Figure 4.15. Cigarette smoke condensate inhibits caspase activation. Jurkat cells
were treated for 2 hours with normal media (A and C) or 10% CSC (B and D) and
cytoplasmic extracts were prepared. Apoptosome formation was initiated by addition of
cytochrome-c and dATP at 37°C and samples were taken at hourly intervals and boiled
for 5 minutes in laemmli buffer. Cleavage of caspase-3 (A and B) or caspase-9 (C and
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4.8. Inhibition of caspase activation by cigarette smoke is not the result
of a redox imbalance.
Caspases are redox sensitive enzymes that require reducing conditions to function
(Melino et al., 1997). It is possible that CSC treatment prevents caspase activation by
inducing an oxidative intracellular environment. Therefore an antioxidant was added to
the lysates prior to the addition of cytochrome-c and dATP. GSH is an important
cytosolic antioxidant, which was effective at preventing the effects of CSC in earlier
experiments. Either ImM GSH, or an equivalent volume of cell extract buffer (CEB),
was added to the lysates of Jurkat cells treated with either media alone or 10% CSC for
2 hours. However, the presence of GSH did not reverse CSC-induced inhibition of
caspase-3 activation (Figure 4.16).
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Figure 4.16: Addition of GSH does not prevent CSC induced caspase inhibition.
Jurkat cells were treated for 2 hours with normal media or 10% CSC and cytoplasmic
extracts were prepared. Either an equivalent volume of CEB (A) or, ImM GSH (B) was
added to the lysates, apoptosome formation was initiated by addition of cytochrome-c
and dATP at 37°C and samples were taken at hourly intervals and boiled for 5 minutes
in laemmli buffer. Cleavage of caspase-3 was monitored by Western blotting. Result is
representative of two experiments
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4.9. Inhibition of caspase activation by cigarette smoke is not the result
of MAP kinase activation.
As discussed in section 1.4.2.5, phosphorylation of caspase-9 can prevent its activation.
Cardone et al. (1998) has demonstrated that this can be mediated by PI3-kinase
therefore this pathway was investigated initially. Jurkat cells were pre-treated with the
PI3-kinase inhibitor, LY294002 (50pM) for 1 hour at 37°C. CSC was added to a final
concentration of 10% and cells were incubated for a further 2 hours at 37°C. Analysis
of apoptosome formation in lysates from these cells revealed that inhibition of PI3-
kinase did not prevent caspase inhibition induced by CSC (Figure 4.17). More recently
the ERK1/2 pathway has been implicated in caspase-9 phosphorylation (Allan et al.,
2003) and phosphorylation of ERK was observed in A549 cells in response to CSC
(Figure 4.18). The inhibitor PD98059, inhibits the ERK pathway by inhibiting the
kinase responsible for phosphorylation of ERK1/2, MEK1/2. However, CSC-mediated
inhibition of caspase activation was not prevented in the presence of this inhibitor
(Figure 4.19).
These experiments indicated that CSC-mediated caspase inhibition did not result from
phosphorylation of caspase-9 by currently known mechanisms. Numerous
phosphorylation sites may be present in caspase-9, therefore phosphorylation by other
kinase pathways was considered. Phosphorylation of p38 was observed when A549
cells were treated with CSC (Figure 4.20), therefore this experiment was repeated using
the p38 inhibitor SB203580. Caspase-3 cleavage was not detected after addition of
cytochrome-c and dATP to lysates from cells treated with SB203580 and CSC (Figure
4.21), indicating that p38 was not involved in inhibition of caspase activation by CSC.
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Figure 4.17: Inhibition of the P-I-3 kinase pathway does not prevent CSC induced
caspase inhibition. Jurkat cells were pre-treated with 50pM LY294002 for 1 hour at
37°C prior to treatment for 2 hours with normal media (A) or 10% CSC (B) and
cytoplasmic extracts were prepared. Apoptosome formation was initiated by addition of
cytochrome-c and dATP at 37°C and samples were taken at hourly intervals and boiled
for 5 minutes in laemmli buffer. Cleavage of caspase-3 was monitored by Western
blotting. Result is representative of two experiments
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Figure 4.18: Cigarette smoke condensate induces ERK1/2 phosphorylation in A549
cells. A549 cells were treated for 2, 4 and 6 hours with either media alone, 1% CSC, 5%
CSC or 10% CSC. Whole cell lysates were prepared and the levels of phosphorylated
ERK was determined by Western blot (A, C). To ensure increases were not due to
increased expression of ERK, blots were stripped and reprobed with an antibody to
native ERK (B, D). Treatment with lOOng/ml 12-O-Tetradecanoylphorbol 13-acetate
was used as a positive control for phosphorylation (TPA). Result representative of two
experiments.
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Figure 4.19: Inhibition of the ERK pathway does not prevent CSC induced caspase
inhibition. Jurkat cells were pre-treated with 10pM PD98059 for 30 minutes at 37°C
prior to treatment for 2 hours with normal media (A) or 10% CSC (B) and cytoplasmic
extracts were prepared. Apoptosome formation was initiated by addition of
cytochrome-c and dATP at 37°C and samples were taken at hourly intervals and boiled
for 5 minutes in laemmli buffer. Cleavage of caspase-3 was monitored by Western
blotting. Result is representative of two experiments
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Figure 4.20: Cigarette smoke condensate induces p38 phosphorylation in A549
cells. A549 cells were treated for 2, 4 and 6 hours with either media alone, 1% CSC, 5%
CSC or 10% CSC. Whole cell lysates were prepared and the levels of phosphorylated
p38 was determined by Western blot (A, C). To ensure increases were not due to
increased expression of p38, blots were stripped and reprobed with an antibody to native
p38 (B, D). Treatment with ImM Anisomycin was used as a positive control for





















Figure 4.21: Inhibition of the p38 pathway does not prevent CSC induced caspase
inhibition. Jurkat cells were pre-treated with lOpM SB203580 for 30 minutes at 37°C
prior to treatment for 2 hours with normal media (A) or 10% CSC (B) and cytoplasmic
extracts were prepared. Apoptosome formation was initiated by addition of
cytochrome-c and dATP at 37°C and samples were taken at hourly intervals and boiled
for 5 minutes in laemmli buffer. Cleavage of caspase-3 was monitored by Western
blotting. Result is representative of two experiments
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4.10. Cigarette smoke condensate does not affect expression of HSP-27, -70
or-90
As outlined in section 1.4.2.5, the molecular chaperones heat-shock proteins-27, -70 and
-90 can regulate caspase activation by binding and sequestering components of the
apoptosome. Western blot analysis of HSP-27, -70 and -90 levels in lysates from Jurkat
cells treated for 1, 2, 4 and 6 hours with either normal media, SS, CSC or the
combination of SS and CSC showed that the expression of these proteins was not
affected by any of these treatments (Figure 4.22).
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Figure 4.22: HSP-27 -70 or -90 are not increased by CSC treatment. Jurkat cells
were treated for 1,2 (A, C. E), 4 and 6 hours (B, D, F) with normal media, 2pM SS,
10% CSC or a combination of SS and CSC prior to preparation of cytoplasmic extracts.
Levels of HSP-27 (A, B), HSP-70 (C, D) and HSP-90 (E, F) were monitored by






4.11. Cigarette smoke condensate inhibits caspase activation and
apoptosis in A549 cells.
The studies in this chapter demonstrate that CSC inhibits caspase activation and
apoptosis in a Jurkat model system. However this thesis was aimed at elucidating the
effects of CSC on cell death in the lung with the intention of providing insight into the
pathogenesis of emphysema. Therefore these experiments were repeated using lung
epithelial cells. A549 cells were treated with 2pM SS and 1, 5, or 10% CSC for 24
hours, prior to staining with acridine orange/ethidium bromide to monitor levels of
apoptosis and necrosis. In accordance with data obtained in the Jurkat model, CSC
prevented SS-induced apoptosis, promoting necrosis (Figure 4.23). Moreover,
treatment of A549 cells with 10% CSC prior to preparation of cytoplasmic extracts,
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Figure 4.23. Cigarette smoke condensate prevents apoptosis and induces necrosis
in A549 cells. A549 cells were incubated with either media alone, or media containing
CSC, SS, H202 or a combination of SS and CSC for 24 hours. Acridine Orange and
ethidium bromide were added and the percentage of viable (open bars), apoptotic {grey
bars) and necrotic {closed bars) cells were counted. Results expressed as the mean of 3
experiments ± SEM performed in duplicate where at least 300 cells were counted per
well. *** p<0.001 compared to control, NS non-significant; ### p<0.001, compared to







Figure 4.24: Cigarette smoke condensate prevents caspase-3 activation in A549
cells. A549 cells were exposed to CSC for 2 hours prior to preparation of cytoplasmic
lysates. Apoptosome formation was initiated by addition of cytochrome-c and dATP at
37°C. Samples were taken at 0 and 180 minutes and boiled for 5 minutes in laemmli
buffer. Cleavage of caspase-3 was monitored by Western blotting. Result is
representative of 2 experiments
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4.12. Discussion
Chapter 3 showed that that CSC induced necrosis in the alveolar epithelial type II cell
line (A549) and primary endothelial cells (HUVEC's) with no evidence of apoptosis.
Cigarette smoking results in cellular oxidative stress and previous studies have shown
that oxidative stress induces necrosis (Hampton and Orrenius, 1997; Lee and Shacter,
1999, 2000; Palomba et al., 1996; Samali et al., 1999). Moreover, in these studies
oxidative stress prevented caspase activation and apoptosis induced by classical stimuli.
Therefore it was hypothesised that CSC may act via a similar mechanism. Thus this
chapter aimed to elucidate the effects of CSC on the apoptotic machinery in Jurkat cells.
That Jurkat cells also underwent necrosis in response to CSC, associated with an
inhibition of apoptosis induced by SS or CH-11, was similar to results obtained by
previous researchers investigating the effect of oxidative stress on cell death (Lee and
Shacter, 1999, 2000; Palomba et al., 1996; Samali et al., 1999). Many cellular
mechanisms are redox sensitive and it is assumed that the oxidants in cigarette smoke
are responsible for many of the cellular responses to smoke (MacNee, 2000). However,
in contrast to the previous studies (Lee and Shacter, 1999; Palomba et al., 1996), CSC-
induced necrosis was not a result of oxidant-induced PARP activation. In order to
elucidate further the possible role of oxidative stress in CSC-mediated inhibition of
apoptosis and induction of necrosis, the antioxidants mannitol, vitamin-E, GSH and
DTT were used.
That CSC-mediated necrosis was not prevented by mannitol, and thus not driven by the
hydroxyl radical, was a unexpected outcome given that numerous studies of the effects
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of hydrogen peroxide had demonstrated almost exactly the same results as seen with
CSC (Lee and Shacter, 1999, 2000; Palomba et al., 1996). Hydrogen peroxide can
easily break down, catalysed by the presence of reduced iron (appendix 1), to produce
the most reactive oxygen radical, the hydroxyl radical (Cheesman and Slater, 1993;
Nordberg and Arner, 2001). As outlined in section 1.3.3.1, hydroxyl radicals are
generated in the tar phase of cigarette smoke. Therefore, the hydroxyl radical was
expected to be responsible for the effects of CSC. Mannitol had little effect on CSC-
mediated necrosis. However a significant increase in apoptotic cells was observed in
the co-culture experiments when SS, but not CH-11, was the apoptotic stimulus. This
may indicate that removal of -OH radicals partly restores the ability of the cell to
undergo apoptosis in the presence of CSC. However this appears not to be sufficient for
longer incubations. This chapter concentrated on the effects of CSC on the intrinsic
apoptotic pathway, the contrasting effects of -OH removal on apoptosis inhibition
executed by the intrinsic (SS) and extrinsic (CH-11) pathway may indicate that different
components of CSC prevents activation of each apoptotic pathway.
One of the consequences of hydroxyl radical production is lipid peroxidation resulting
in the production of peroxyl radicals (Cheesman and Slater, 1993). Therefore peroxyl
radicals could be responsible for hydrogen peroxide-mediated apoptosis inhibition and
necrotic cell death (Lee and Shacter, 1999, 2000; Palomba et al., 1996; Samali et al.,
1999). Cigarette smoke contains peroxyl radicals (section 1.3.3.1), and markers of lipid
peroxidation are increased in response to cigarette smoking (Koul et al., 2001; section
1.2.4.2), which can be reduced by treatment with vitamin-E (Koul et al., 2001).
However, the use of vitamin-E revealed that production of radicals by lipid peroxidation
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was not responsible for cigarette smoke-mediated necrosis. Apoptosis induced by SS
was prevented by addition of vitamin-E, which made determining the role of peroxyl
radicals in CSC-mediated apoptosis inhibition difficult. This phenomenon has been
observed previously (Ahlemeyer and Krieglstein, 2000; Krohn et al., 1998), however no
mechanistic explanation has been provided.
The thiol antioxidants GSH and DTT prevented the inhibition of caspases and induction
of necrosis by CSC when SS was the stimulus. However, DTT was ineffective at
preventing necrosis in the CH-11 studies. This may be due to the nature of the CH-11
molecule, an anti-Fas activating antibody of the IgM class. The antibody molecule
consists of two heavy and light chains held together by interchain disulphide bonds.
IgM molecules are polymers of five antibody molecules held together by a cysteine-rich
J-chain. Binding of the pentameric IgM molecule to multiple Fas receptors on the cell
surface mimics trimerisation, resulting in activation of caspase-8. The presence of DTT
may separate the heavy and light chains of the antibody by reduction of the disulphide
bonds (Roitt, 1994), disrupting the pentamer and preventing Fas ligation.
Although GSH is a scavenger for most ROS, it also functions as a detoxification agent,
conjugating to electrophilic compounds via its thiol group (section 1.1.1.3.). This
conjugation function was demonstrated by the ability of CSC to cause a dose-dependent
decrease in total GSH, which was not purely due to oxidation, as glutathione reductase
was present to convert any GSSG formed to GSH. Conjugation of GSH with
components of cigarette smoke has been observed previously, the electrophilic a,P-
unsaturated aldehydes, acrolein and crotonaldehyde, were identified as the predominant
192
compounds conjugating with GSH (Reddy et al., 2002). Inhibition of the caspase
pathway by electrophilic compounds has also previously been reported (Lawson et al.,
1999; Nobel et al., 1997). Therefore, that GSH prevented CSC-mediated apoptosis
inhibition and necrosis, implicated electrophilic compounds in the effects of CSC.
Acrolein, which as stated earlier, is an a,P-unsaturated aldehyde that conjugates readily
to thiol-containing compounds such as GSH (Chasseaud, 1979; Reddy et al., 2002), has
been shown to inhibit caspase activation and apoptosis (Finkelstein et al., 2001; Kern
and Kehrer, 2002). However, acrolein inhibited caspase activation by direct interaction
with the enzyme (Kern and Kehrer, 2002), which was not seen in response to CSC.
Therefore, it is not likely that the inhibitory effects of CSC are mediated via acrolein.
As discussed earlier, cigarette smoke posseses major oxidative potential, which can be
illustrated by the ability of cigarette smoke to induce oxidative modification of
biological molecules (Asami et al., 1999; Cross et al., 1993, Reznick et al., 1992).
Comprehensive studies by Panda et al. (1999, 2001) showed that whole-phase and tar-
phase cigarette smoke induces oxidation of guinea pig microsomal proteins and bovine
serum albumin as detected by the formation of protein carbonyls. Such, oxidative
modification induced subsequent proteolytic degradation of these proteins. Oxidative
modification by cigarette smoke was completely prevented by the addition of ascorbate,
partially prevented by GSH but not affected by mannitol or vitamin-E. The authors also
determined that the oxidative potential resided in the tar fraction, which possesses the
long-lived radicals present in cigarette smoke (section 1.3.3.1). These studies have a
very similar protection profile as observed in this chapter for cigarette smoke-induced
inhibition of apoptosis. Thus it may be hypothesised that the apoptosis-inhibitory
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potential observed may also reside in the tar fraction. However, in order to confirm this,
fractionated smoke extracts would need to be utilised.
Although oxidative stress is a major mechanism for many of the effects of cigarette
smoke, nicotine, a major constituent of cigarette smoke, has also been shown to inhibit
apoptosis. Nicotine can prevent apoptosis induced by UV-light (Sugano et al., 2001;
West et al., 2003; Wright et al., 1993), hydrogen peroxide (Sugano and Ito, 2000; West
et al., 2003), dexamethasone (Hakki et al., 2002), etoposide (West et al., 2003) and
chemotherapy agents (Heusch and Manakjee, 1998). Moreover, incubation with
nicotine has been shown to prevent caspase activation (Sugano and Ito, 2000; Sugano et
al., 2001; Hakki et al., 2001, 2002). Treatment of cells with nicotine results in
increased oxidative stress and depletion of intracellular GSH (Chang et al., 2003).
However none of the above studies investigated the role of oxidative stress in nicotine
mediated inhibition of apoptosis. Sugano et al. (2001) demonstrated that nicotine
prevents apoptosis at the level of cytochrome-c release. However, it is unlikely that
nicotine is responsible for caspase inhibition seen in response to CSC, although
cytochrome-c release was not monitored in response to CSC, inhibition of the apoptotic
machinery was observed downstream of mitochondrial involvement.
In addition to preventing the morphological aspects of apoptosis, CSC treatment
prevented activation of the caspase pathway. Caspases contain an active site thiol
which, when modified by alkylation, oxidation or s-nitrosylation, affects their activity
(Melino et al., 1997). In addition to being a potent oxidising agent, cigarette smoke
contains nitric oxide (Pryor and Stone, 1993) and therefore has the potential to
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nitrosylate proteins. Thus, it was hypothesised that CSC may directly inactivate
caspases by direct conjugation, oxidation, or nitrosylation. However, no direct effect of
CSC was evident on both recombinant caspase-3 or, apoptosome formation and
subsequent caspase activation. Incubation of Jurkats with CSC prior to preparation of
lysates prevented activation of caspases-9 and -3, which indicated that additional factors
were required to prevent caspase activation.
The caspase pathway is regulated at many stages, however few known inhibitors act at
the level of caspase-9 activation. The members of the Bcl-2 family act to prevent
release of cytochrome-c from the mitochondria (section 1.4.2.5). In studies in this
chapter, involvement of the mitochondria was bypassed as exogenous cytochrome-c
was added to the lysates, therefore the possibility that inhibition was as a result of the
actions of Bcl-2 proteins was unlikely. The Inhibitor of Apoptosis Proteins (LAP's) act
upon active caspase-9 and prevent activation of downstream caspases (section 1.4.2.5).
As CSC treatment prevented the activation of caspase-9 it was assumed that IAP's were
not involved. It was hypothesised that CSC treatment prevented formation of a
functional apoptosome complex. The molecular chaperones, heat-shock proteins
(HSPs) -27, -70 and -90 sequester components of the apoptosome and prevent its
formation (section 1.4.2.5). Although named for their induction during the heat-shock
response, these proteins are also expressed during many other situations of cellular
stress, such as oxidative stress. Western blot analysis demonstrated that the expression
of these proteins was not altered after CSC exposure and thus may not be involved in
the prevention of caspase activation by CSC. However, while most studies that
document the role of HSPs in apoptosis inhibition have monitored only upregulation or
195
have used overexpression studies, the ATPase function of these proteins may be
necessary (Jaattella, 1999). In addition, it is also thought that co-chaperones from the
DNA-J, TPR and BAG families may be required for HSP function (reviewed in
Takayama et al., 2003). Thus in order to exclude HSPs from CSC-mediated caspase
inhibition, further investigation into the activity of the protein or presence of co-
chaperones would be necessary. It has been shown that phosphorylation of procaspase-
9 can prevent its activation (Allan et al., 2003; Cardone et al., 1998). In the
experiments by Cardone et al. (1998) the phosphatidylinositol 3-kinase (PI3-K)
pathway was acting via Akt to phosphorylate caspase-9. Whereas in the studies by
Allan et al. (2003) procaspase-9 was phosphorylated by ERK. However the use of
inhibitors revealed that neither pathway was responsible for the prevention of caspase
activation by CSC. Few other endogenous inhibitors of caspase activation are known,
thus CSC-mediated caspase inhibition may involve a yet unknown inhibitor, or
mechanism.
Prevention of caspase activation does not always result in necrosis, in some cases
inhibition of caspases enables cell survival (Chen et al., 2002; Detjen et al., 2001; Ko et
al., 2000; Lawson et al., 1999; Marzo et al., 2001). However, in many other situations
inhibition of caspases is not sufficient to prevent death, it simply occurs via another
mechanism (Coelho et al., 2000; Kim et al., 2000; Lemaire et al., 1998; Sane and
Bertrand, 1999; Uzzo et al., 2001). Cigarette smoke contains many compounds and
radicals, of which individual components have cytotoxic actions, thus although cigarette
smoke prevents caspase activation, survival may not be possible as a result of additional
insult by other components and necrosis occurs. It may also be possible that while one
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component of cigarette smoke is responsible for caspase inhibition, another may induce
another pathway that also leads to cell death. Cell death in response to cigarette smoke
appears to be occurring via necrosis, however many forms of necrosis-like, caspase-
independent, cell death occur (Leist and Jaattella, 2001) and further investigation is
needed to establish the exact mode of cell death.
An inhibition of caspase activation and apoptosis by cigarette smoke is an interesting
finding however, as discussed in section 3.7, previous studies have shown an apoptotic
form of cell death in response to smoke (Aoshiba et al., 2001; D'Agostini et al., 2000,
2001; Hoshino et al., 2001; Ishii et al., 2001; Ma et al., 1999; Vayssier et al., 2001;
Wang et al., 2000, 2001). Remarkably, although these studies claim that cell death
occurs via apoptosis, which by definition involves the activation of caspases, only four
Pf these studies investigated caspase activation (Aoshiba et al., 2001; Hoshino et al.,
2001; Wang et al., 2000, 2001). The study by Wang et al. (2000) monitored the level of
apoptosis in the gastric mucosa of the rat after a whole body exposure of smoke for up
to nine days. They demonstrated increased apoptosis in a time- and dose- dependent
manner as detected by terminal deoxytransferase-mediated dUTP nick end labelling
(TUNEL) and Western blotting for caspase-3 processing. In this investigation the
tissues involved were not directly exposed to cigarette smoke, but were affected
systemically after smoke inhalation by the rat. Caspase activation and apoptosis may be
occurring in sites distant from the lung, either as a result of systemic oxidative stress, or
the presence of elevated pro-apoptotic factors. For example, as discussed in section
1.2.2.2, increased plasma TNF-a is observed in smokers and COPD patients, which in
addition to its pro-inflammatory effects, induces apoptotic cell death (reviewed in
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Aggorwal, 2003). Cigarette smoke-mediated caspase inhibition is not observed in this
study. This may be due to the responsible component(s) not being absorbed into the
body, or not in sufficient quantities to affect other tissues. Otherwise they may have a
short half-life and consequently are not present in the body for a sufficient length of
time to be effective systemically. This is supported by the study by Hoshino et al.
(2001) where CSC aged in air was no longer cytotoxic.
In the study by Wang et al (2001) HUVEC's were exposed to cigarette smoke extract
(CSE), prepared by bubbling the smoke from 1 filter-less medium tar cigarette
(8mg/cigarette) through lOmls of media (DMEM). Apoptosis was determined by
oligonucleosomal DNA fragmentation, TUNEL and a caspase-3 activity assay. DNA
fragmentation was observed after cigarette smoke exposure, however the data were not
presented in the paper. The method used to monitor caspase activity in this study is
susceptible to false interpretation; these compounds are based chemically on caspase
inhibitors, which vary in their specificity (Chang and Yang, 2000). Ideally caspase
activation should have been confirmed by additional methods such as Western blotting.
Although the form of cell death is classified as apoptotic, two studies support the data
presented in this chapter. Alveolar macrophages treated with CSC underwent
morphological changes associated with apoptosis and stained positive by TUNEL,
however cell death was independent of caspase activation (Aoshiba et al., 2001).
Moreover, although chromatin condensation at the nuclear periphery occurred, nuclear
fragmentation was rare. As outlined in section 1.4.3, caspase-independent cell death
displays similar morphological changes to classical apoptosis, but with subtle
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differences. In particular, AIF induces such nuclear changes however caspase
activation is required for further chromatin condensation and formation of nuclear
bodies (Daugas et al., 2000b). Therefore, CSC treatment may have resulted in caspase-
independent cell death, possibly via AIF translocation in this study.
CSC-induced apoptosis of A549 cells, detected by morphological changes, could not be
prevented by treatment with the broad-spectrum caspase-inhibitor, ZVAD-fmk
(Hoshino et al., 2001). Therefore the authors proposed that caspase-independent cell
death was occurring. However, they report oligonucleosomal DNA fragmentation in
response to smoke, a marker that is deemed to be caspase-dependent. Additional
similarities between the findings of this chapter and the data presented by Hoshino et al.
(2001) are on the effects of quenching the cytotoxic effect of smoke. The GSH
precursor, N-acetyl-L-cysteine (NAC) and an aldehyde scavenger, aldehyde
dehydrogenase, completely abolished the cytotoxic effects of CSC. Thus this
corroborates the hypothesis presented by this chapter that the electrophilic compounds
in cigarette smoke may be responsible for its effects on cell death.
In conclusion, this chapter demonstrated that in addition to inducing necrotic cell death,
CSC treatment prevented caspase activation and apoptosis. However, although many
possible explanations were investigated, no insight into the mechanism of CSC-
mediated inhibition was elucidated and further study into this area is needed. The
results in this chapter were primarily obtained in a model system using Jurkat T-cells,
yet emphysema is a disease of the alveoli. Although execution of the apoptotic
machinery is neither cell type, nor species, specific (Zamzami et al., 1996), data
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obtained in a T-cell model system may not be relevant to disease pathogenesis in the
lung epithelium. Therefore it was confirmed that inhibition of caspase activation and
apoptosis also occurred in lung epithelial cells (A549). Consequently the effects of
CSC on the Jurkat cell death machinery may also be occurring in lung epithelium, and
contributing to the development of emphysema.
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Chapter 5: General Conclusions and Future Work
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This thesis initially aimed to elucidate the mechanisms of CSC-induced apoptosis in
vitro. However, contrary to expectation, CSC did not induce apoptosis in A549,
HUVEC or Jurkat cells, but instead promoted a necrotic form of cell death. Moreover,
treatment of cells with CSC prevented caspase activation and apoptosis induced by
classical stimuli, resulting in necrosis.
The initial hypothesis arose from previous studies demonstrating increased apoptotic
cells in the lungs of emphysema patients (Kasahara et al., 2001; Segura-Valdez et al.,
2000), which was supported by observed increases in apoptotic cells both in vitro and in
vivo after smoke exposure (Aoshiba et al., 2001; D'Agostini et al., 2000, 2001; Hoshino
et al., 2001; Ishii et al., 2001; Ma et al., 1999; Vayssier et al., 2001; Wang et al., 2000,
2001). Discussion of the data within this thesis in the context of these previous studies
is complicated, as the study of cigarette smoking both in vivo and in vitro has its
limitations. Among these is the fact that human smokers only develop clinical
symptoms after many years of smoking, yet animals are only exposed to smoke for a
matter of weeks, and cell cultures for a matter of hours. Additionally, as discussed in
section 1.2.7, only a proportion of smokers develop COPD suggesting there is a
susceptibility to acquire the disease, which is difficult to incorporate into in vivo and in
vitro model systems.
The use of in vitro cigarette smoke exposure models is further complicated by the
various delivery systems. Condensate is a common surrogate for cigarette smoke
exposure in vitro, however its production is not standardised (also discussed in section
3.7). Many different protocols are used, with each one isolating a slightly different
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spectrum of components. This is dependent on a number of factors; the type of fluid the
smoke is dissolved in, the volume of fluid used per cigarette, and the preparation
method. The system used by many researchers involves bubbling cigarette smoke
through fluid. The method of exposing cells to CSC in this thesis was used to replicate
the situation in a smoker's lung, whereby passing the smoke over the buffer in the
tonometer system more accurately mimics smoke filling the airspace and exposing the
lung lining fluid. The complicated nature of in vitro cigarette smoke exposure can be
evidenced by the fact that in many of the in vitro studies that observe cigarette smoke-
induced apoptosis (Aoshiba et al., 2001; Carnevali et al., 2003; Hoshino et al., 2001;
Vassier et al., 1998; Wang et al., 2001), it appears that more dilute CSC was prepared
and thus cells were exposed to lower doses of cigarette smoke than used in this thesis.
This may explain the inconsistency in results as induction of cell death by a stimulus
has been shown to be dose dependent, whereby lower doses induce apoptosis and higher
doses induce necrosis (Lennon et al., 1991). However in this thesis lower doses of
CSC did not induce apoptosis in A549, HUVEC, or Jurkat cells. In the case of cigarette
smoke exposure this dose-dependent explanation is too simplistic, due to the diverse
composition of CSC obtained by different preparation methods.
An alternative explanation can be proposed for the increased numbers of apoptotic cells
evident in the lungs of emphysema patients (Kasahara et al. 2000, 2001), and in the
bronchial epithelium of rats after smoke exposure (D'Agostini et al., 2001). The study
of apoptosis in vivo is more complex than in vitro systems as evidence of cell death does
not persist. Apoptotic cells are rarely detected in vivo due to their rapid and efficient
removal by phagocytes (Savill et al., 1993). Therefore the detection of increased
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number of apoptotic cells in diseases, like emphysema, may reflect defects in clearance
mechanisms rather than increases in cell death. Decreased phagocytic capability has
been observed after smoke exposure (Braun et al., 1998; Ortega et al., 1992, 1994;
Zappacosta et al., 2001). Moreover, phagocytosis has been demonstrated to be
depressed in individuals with COPD (Ferrara et al., 1996; Muns et al., 1995; Prieto et
al., 2000). Therefore, the observation of increased apoptotic cell death after smoke
exposure may actually result from decreased phagocytosis of apoptotic cells resulting
from normal tissue turnover, rather than increased apoptosis.
An interesting contrast between the data presented here and previous studies is that not
only did CSC not induce apoptotic cell death, it actually prevented execution of the
caspase pathway. Initial investigations provided little insight into the mechanistic
aspects of CSC-mediated caspase inhibition. Therefore there is substantial scope for
extension of these findings into this area. One of the hypothetical mechanisms for CSC-
mediated caspase inhibition was that phosphorylation of procaspase-9 prevents its
activation. However, specific kinase inhibitors had no effect on the inhibition of
caspase activation induced by CSC. Therefore it would be interesting to determine
whether phosphorylation of procaspase-9, or other components of the apoptosome,
occurs in response to CSC. This could be determined by using alkaline phosphatase to
remove any phosphate groups, which may have been added as a result of incubation
with CSC, before inducing formation of the apoptosome. Further study to elucidate the
phosphorylation target could be performed by P32 radiolabelling and
immunoprecipitation for components of the apoptosome.
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Nitric oxide (NO) acts at many stages to inhibit execution of the caspase pathway.
Caspases can be inactivated by nitrosylation of the active site thiol (Melino et al., 1999).
CSC contains high levels of NO (section 1.3.3.1), and has the potential to nitrosylate
proteins directly. However caspase activation was only prevented by incubation of cells
with CSC prior to preparation of cytoplasmic lysates. This indicates that protein
expression may be required for caspase blockade, which could be determined by
treatment of cells with CSC and the protein synthesis inhibitor, cyclohexamide. The
inducible form of the enzyme nitric oxide synthase (iNOS), which generates NO from
arginine, is elevated after smoke exposure in vivo (Chang et al., 2001). Thus CSC
treatment may prevent activation of the caspase pathway in this system by inducing
expression of iNOS. To determine whether increased iNOS expression was causative of
caspase inhibition, iNOS protein levels could be monitored. In addition, CSC treatment
in the presence of iNOS inhibitors, prior to apoptosome formation would demonstrate
whether caspase inhibition was associated with iNOS expression.
Nitric oxide can also prevent formation of a functional apoptosome complex (Zech et
al., 2003). Cigarette smoke-mediated caspase inhibition was occurring at the level of
caspase-9 (Chapter 4), activation of which requires the formation of a functional
apoptosome. Therefore it may be that CSC prevents caspase activation by preventing
apoptosome formation. Immunoprecipitation, and subsequent Western blotting for
components of the apoptosome, would determine whether these proteins still associate
after smoke exposure.
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The involvement of hydroxyl and peroxyl radicals in CSC-mediated caspase inhibition
was excluded. However, although previous studies that observed inhibition of apoptosis
have used hydrogen peroxide to induce oxidative stress, other reactive oxygen and
nitrogen radicals are released by cigarette smoke and their role in apoptosis inhibition
should be investigated. In this thesis the deleterious effects of CSC could be prevented
by the antioxidant GSH, a potent antioxidant able to quench most free radical species.
Inhibition of caspase activation and apoptosis has also been prevented by the quinone
compound menadione (2-methyl-l,4-naphthoquinone) (Samali et al., 1999), which
produces superoxide by redox cycling (Thor et al., 1982). The quinone radical system
in the tar phase of cigarette smoke also releases superoxide radicals and therefore the
possibility that superoxide is involved in CSC-mediated caspase inhibition and necrosis
should be considered. Superoxide dismutates to form hydrogen peroxide and oxygen, a
reaction that can occur spontaneously or can be catalysed by superoxide dismutase
(Cheesman and Slater, 1993). However, as discussed in section 4.12, the hydrogen
peroxide produced can further break down to form hydroxyl radicals. In the study by
Samali et al. (1999) the inhibitory effect of menadione on caspases could be prevented
by the addition of the hydrogen peroxide scavanger, catalase, but not by superoxide
dismutase. Therefore it is likely that caspase inhibition induced by menadione occurs
via hydrogen peroxide and not by superoxide itself. This would involve the hydroxyl
radical, which has been eliminated as being responsible for CSC-mediated caspase
inhibition.
The antioxidant GSH is native to the lung and forms one of the most important lung
antioxidant defences described to date (Kelly, 1999). Therefore it could be deduced that
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the effects of CSC observed in this thesis would not occur in vivo. However, previous
studies have demonstrated that in situations of acute smoking, GSH is decreased in lung
lining fluid with a subsequent rebound to levels higher than that of non-smokers (Cantin
et al., 1987; Li et al., 1994, 1996; Rahman et al., 1996). It is during this window of
antioxidant depletion that the cells of the lung may be susceptible to caspase inhibition
and necrotic cell death as a consequence of additional cigarette smoke exposure.
As with all studies into disease pathogenesis in vitro findings should be further
investigated in an in vivo model. However, there would be many problems in trying to
replicate the data obtained in this thesis in in vivo experiments. Initially it would be
important to determine the form of cell death that occurred after smoke exposure.
However, while many morphological and biochemical markers of apoptotic cell death
are detectable in vivo, it is more difficult to detect necrosis in vivo as many of the
markers used to identify necrotic cells are not suited to the study of fixed histological
sections. Theoretically, necrosis could be detected after acute smoke exposure by
monitoring levels of lactate dehydrogenase (LDH) in BAL fluid after acute smoke
exposure. However, determining whether cigarette smoke inhibits caspase activation
and apoptosis in vivo would be more complex. Whereas the presence of apoptotic cells
and activation of caspases in tissues can be easily detected, it is virtually impossible to
detect an absence of apoptosis or lack of caspase activation in vivo. In order to
adequately investigate the inhibitory effect of cigarette smoke, lung cell apoptosis
would need to be induced by instillation of an apoptotic stimulus. Therefore, this effect
may be best investigated ex vivo. Animals could be exposed to cigarette smoke prior to
the lungs being excised and relevant cell types isolated. The ability to undergo
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apoptosis in response to classical stimuli could then be determined. As discussed
earlier, damage to the type I pneumocyte layer can be repaired by proliferation and
differentiation of type II pneumocytes, therefore it would be important to determine
whether caspase activation is prevented in the type II cell.
In addition to COPD, cigarette smoking results in the development of numerous other
diseases (section 1.3.2). The data obtained in this thesis may also contribute to
elucidating the mechanism by which cigarette smoking results in lung cancer. In order
for an organism to remain healthy, a balance must exist between cellular proliferation
and death. Cancer develops when mutated cells survive and proliferate inappropriately.
Many genes have been identified that are involved in tumour development,
dysregulation of these genes often confers resistance to apoptosis resulting in
tumourigenesis. Cigarette smoke contains numerous carcinogenic compounds and thus
has the potential to transform cells and induce tumour formation. Normally,
intracellular controls "sense" the integrity of the cell and induce apoptosis if irreparable
defects are present, thereby preventing proliferation of mutated cells. The combination
of caspase inhibition, as observed in this thesis, and the tumourigenic potential of
cigarette smoke may have catastrophic consequences for the smoker. The data obtained
in this thesis demonstrates that although apoptosis is prevented, cell death still ensues;
yet this was observed after continual exposure of the cells to cigarette smoke. The lungs
of smokers are not relentlessly exposed to cigarette smoke, and in this thesis CSC-
mediated caspase inhibition occurred within 2 hours of exposure, at which time cells
remained viable. It would be interesting to investigate whether cells remain viable after
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removal of cigarette smoke; and importantly, whether caspase inhibition is maintained
after cigarette smoke is removed.
This thesis aimed to elucidate the role of cell death in the development of emphysema,
with the hypothesis that excessive cell death would result in destruction of alveolar
walls. However, the data obtained did not conform to the popular opinion that cigarette
smoking results in apoptotic cell death within the lung. Instead, cigarette smoke
exposure resulted in necrotic cell death. These two forms of cell death have different
downstream implications. Apoptosis is thought to be an anti-inflammatory process, due
to rapid phagocytic clearance before cell membrane integrity is lost, thereby preventing
release of intracellular contents which would provoke inflammation and tissue damage
(Savill et al., 1993). However it has been demonstrated that phagocytic clearance of
apoptotic bodies actively suppresses inflammation. Macrophages that ingest apoptotic
cells suppress the inflammatory response in a paracrine/autocrine fashion by releasing
soluble inhibitors, resulting in decreased expression of pro-inflammatory cytokines,
such as IL-12, IL-8 and TNF-a (Fadok et al., 1998). In contrast, exposure to necrotic
cells results in increased expression of IL-8 and TNF-a by macrophages (Fadok et al.,
2001). Interestingly, COPD is an inflammatory lung disease with increased levels of
IL-8 and TNF-a observed in the lungs and systemic circulation of COPD patients
(section 1.2.2.2). Thus these inflammatory effects may be a direct consequence of
cigarette smoke-induced necrosis.
Contrary to expectation, this thesis demonstrated that cigarette smoke did not induce
apoptotic cell death. Moreover, cigarette smoke prevented activation of the apoptotic
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machinery, and instead resulted in cell death by an alternative mechanism, necrosis.
The cell death program is important for the removal of unwanted or potentially
dangerous cells. As discussed in section 1.4 many active cell death pathways, often
with a necrotic phenotype, have been identified indicating a degree of redundancy in the
process leading to elimination of these cells. Yet, with respect to the role of cigarette
smoke in the development of emphysema, necrotic cell death would not change the
overall outcome of tissue destruction.
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Appendices
Appendix 1. Free Radical Chemistry
A. Quinone Cycling
Q + QH2 v X 2H+ + Q*
Q'" + 02 —* Q + 02"
202"+ 2H2 -► 02+ H202
B. Fenton Chemistry
H202 + Fe(II) -> -OH + HO' + Fe(III)
Fe(III) + 02" -► Fe(II) + 02
C. Peroxynitrite/peroxynitrate
H+ + 02" + NO —» H0-0N=0
H+ + 02" + N02 -> HO-ONO2
D. Lipid Peroxidation
Initiation: In* + RH —> InH + R*
Propagation: R* + 02 —> ROO*
ROO* + RH —> R* + ROOH
Termination: 2ROO* —* [ROOOOR] —* non radical products + 02
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1: known human carcinogen
2A: probable human carcinogen
2B: possible human carcinogen
3: unclassifiable as human carcinogen
1-, 2-napthylamines
ortho-, meta-, para-toludines

































Appendix 3: Reagents and Solutions
Acridine Orange Ethidium Bromide staining
Acridine Orange/Ethidium bromide staining solution
IOOjj.1 lmg/ml AcO in PBS




18.61g Na2 EDTA.2H20 (Sigma) in 70ml dH20
Adjust pH to 8 with 10M NaOH.
Add dH20 to 100ml
Store at room temperature
IOx TBE buffer
108g (890mM) Trizma Base (Sigma)
55g (890mM) Boric Acid (Sigma)
40ml 0.5M EDTA pH 8
Make up to 1L with dH20
Store at room temperature
Annexin-V/propidium Iodide staining
Attnexin-Vbinding buffer
2mM CaCl2 in Hanks balanced salt solution (HBSS, Sigma)
Store at room temperature
Propidium Iodide Solution
lmg Propidium Iodide (Molecular Probes) in 1ml dH20
Store at 4°C
DNA Laddering reagents
"CURRENT PROTOCOLS IN MOLECULAR BIOLOGY" PROTOCOL
5M NaCl
14.6g Sodium Chloride (Sigma) in 50ml ddH20
Store at room temperature
1M Tris.ClpH 7.6
24.2g Trizma Base (Sigma) in 70ml ddH20,
pH to 7.6 with HC1
make up to 100ml with ddH20.
Store at room temperature
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TE buffer (lOmM Tris CIpH 7.6, ImMEDTA)
5ml 1M Tris.CI pH 7.6 and 495ml dH20.
Add 0.185g EDTA
Store at room temperature
TTE solution (TE buffer containing 0.2% Triton X-100)
50 ml TE with lOOpl Triton X-100 (Sigma)
(store at 4°C)
IOx DNA loading buffer
lg Ficoll 400 (20%) Sigma, F-4375
lml 0.5M Na2EDTA pH 8 (0.1M)
0.5ml 10% SDS (1%)
1.25ml l%(0.01g/ml) Bromophenol blue (0.25%)
Make to 5ml with dH20
Store at room temperature
GSH Assay reagents
0.1M Phosphate Buffer with 5mM EDTA, pH 7.5 (KPE)
Make solution A by adding 6.8g KFEPO4 to 500mls dH20 - store at 4°C
Make solution B by adding 8.5g K2HP04 or 11.4g K2HP04.3H20 to 500mls dH20 -
store at 4°C
Make 0.1M phosphate buffer by adding 16mls of solution A to 84mls of solution B -
make up fresh each time
Adjust pH to 7.5, then add 0.327g of EDTA
Extraction buffer (0.1% Triton /0.6% SSA in KPE)
Add 20pl of Triton X-100 and 120mg of SSA to 20mls of 0.1M Phosphate buffer with





Store for several months at 4°C
PI staining solution
To 10ml 0.1% Triton X-100 in PBS add
2mg DNase free RNase A









make up to 100ml with CMF-PBS
Store at 4°C
Anti-protease cocktail
1 protease inhibitor tablet (Roche 1836153)
dissolve in lml RIPA buffer
1 Ox solution
Add lOOpl to 900|ol RIPA lysis buffer before use






Add 200p.l leupeptin at 5mg/ml and 200(ol aproteinin at lmg/ml
Make up to 100ml with dH20.
Store at 4°C
Immediately prior to use
Prepare lOOmM stock DTT in CEB (15.42mg/ml)
And 0.5M stock PMSF in DMSO (87. lmg/ml)

































4x Tris.ClpH 8.8 (1.5M Tris.Cl containing 0.4% SDS)
Dissolve 91 g Trizma base in 300ml H20.
Adjust to pH 8.8 with 1M HC1.
Add H20 to 500ml total volume.
Filter through 0.5micron syringe filter, add 2g SDS.
Store 4°C for up to 1 month.
4x Tris.ClpH 6.8 (0.5M Tris.Cl containing 0.4% SDS)
Dissolve 6.05g Trizma base in 40ml H20.
Adjust to pH 6.8 with 1M HC1.
Add H20 to 100ml total volume.
Filter through 0.5micron syringe filter, add 0.4g SDS.
Store 4°C for up to 1 month.




1.25ml 1M Tris.Cl pH 6.7




15. lg Trizma base
72g Glycine
5g SDS
Dissolve in 400ml dH20











Dissolve in 500ml dH20
Add 200ml methanol
Make up to 1L with dH20
Store at 4°C
lOx Tris Buffered Saline (TBS)
24.2g Trizma base
87.7g NaCl
Dissolve in 800ml dH20
Adjust pH to 7.4 with HC1 and make up to 1L with dH^O
Store at room temperature
Strip Buffer
100ml 10% SDS (10g/100ml)
400ml dH20
3.78g Trizma base
pH to 6.7 with cone HC1
Make up to 1L with dH20
Store at room temperature
Immediately prior to use add 400pi P-mercaptoethanol to 50ml strip buffer
Cigarette Smoke Prevents Apoptosis through Inhibition of Caspase
Activation and Induces Necrosis
Julie A. Wickenden, Murray C. H. Clarke, Adriano G. Rossi, Irfan Rahman, Stephen P. Faux, Kenneth Donaldson,
and William MacNee
ELEGI/Colt, Phagocyte, and MRC Laboratories, Centre for Inflammation Research, University of Edinburgh Medical School;
and Institute of Occupational Medicine, Roxburgh Place, Edinburgh, Scotland, United Kingdom
Emphysema is characterized hy enlargement of the distal air¬
spaces in the lungs due to destruction of alveolar walls, Alveolar
endothelial and epithelial cell apoptosis induced by cigarette
smoke is thought to be a possible mechanism for this cell loss.
In contrast, our studies show that cigarette smoke condensate
(CSC) induces necrosis in alveolar epithelial cells and human
umbilical vein endothelial cells. Furthermore, study of the cell
death pathway in a model system using Jurkat cells revealed
that in addition to inducing necrosis, CSC inhibited apoptosis
induced by staurosporine or Fas ligation, with both effects pre¬
vented by the antioxidants glutathione and dithiothreitol Time
course experiments revealed that CSC inhibited an early step in the
caspase cascade, whereby caspase-3 was not activated. Moreover,
cell-free reconstitution of the apoptosome in cytoplasmic extracts
from CSC-treated ceils, by addition of cytochrome-c and dATP,
did not result in activation of caspases-i or -y. ihus, smoke treat¬
ment may alter the levels of pro- arid aritiapoptogenic faclois
downstream of the mitochondria to inhibit active apoptosome
formation. Therefore, unlike previous studies, cell death in re¬
sponse to cigarette smoke by necrosis and not apoptosis may
be responsible for the loss of alveolar walls and inflammation
observed in emphysema.
Cigarette smoke is a complex mixture of chemicals con¬
taining high levels of oxidants and is the major etiologic
factor in the development of chronic obstructive pulmonaiy
disease (COPD), of which emphysema is a major compo¬
nent. Emphysema is characterized by enlargement of distal
airspaces due to destruction of alveolar wall endothelial
cells, epithelial ccll3, and connective tissue resulting from
both protcasc/antiprotcasc and oxidant/antioxidant imbal¬
ances (1,2). Recently, it has been proposed that apoptosis of
alveolar wall cells occurs in response to cigarette smoking,
resulting in progressive cell loss and emphysema (3-7).
The study of coll death, including apoptosis, has attracted
intense interest as the physiologic program for deletion
of harmful or unwanted cells in vivo. A variety of newly
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characterized forms of coll death have highlighted the com
plexity, diversity, and redundancy that exist in a cell's ability
to die (8). In general, there are two main forms of cell
death: apoptosis and necrosis. Apoptosis is a well defined
programmed response that results in characteristic morpho
logic and biochemical changes, such as cell shrinkage and
the condensation and fragmentation of nuclear material
(9). Inappropriate apoptosis has been implicated in many
pathologic conditions, such as neurodegenerative disorders
and cancer (10). Necrosis, however, is regarded as a passive
responso to extremes of environmental stimuli, such as heat
and ultraviolet light, and is characterized by cytoplasmic
swelling, the rapid loss of plasma membrane integrity, and
eventually cell lysis (11). It has been documented that the
mode of cell death may be dependent on the cell type, the
concentration of stimulus employed, and its environmental
setting (12).
The most characterized effectors of apoptotic cell death
are the caspascs, a family of cysteine proteases that interact
with each other in a hierarchical manner (13). One pathway
involves induction of apoptosis by ligation of surface death
receptors such as Fas and tumor necrosis factor. This so-called
"extrinsic" pathway results in auto activation of caspasc 8,
and the subsequent cleavage of procaspasc-3 into its active
subunits (li). The "intrinsic" mitochondria] pathway can be
activated in response to stimuli such as ultraviolet light and
oxidative stress, and results in the release of mitochondrial
cytochrome c, initiating formation of the apoptosomc com
plex (15, 16). Consisting of APAF-1, cytochrome-c, and
caspase 9, in the presence of dATP, formation of the apop
tosome results in the autoactivation of caspasc 9 and again,
activation of the effector caspasc 3 (17). Through clenvnge
of a distinct subset of cellular substrates, caspasc-3 initiates
many of the key changes witnessed during apoptosis, thus
explaining how a diverse range of stimuli manifest identical
phenotypic outcomes during cell death (13). It has been
shown that interference with one or more of these stages
may result in inhibition of the entire apoptotic process (18).
Reactive oxygen species (ROS) arc molecules that have
been implicated in mediating apoptotic processes. Depending
on the concentration, ROS have been shown to both promote
and inhibit apoptosis (12,19). Studies have also shown that
oxidants, including hydrogen peroxide (FLO,,), inhibit the
apoptotic process initiated by other stimuli (19, 20-22). Inhi¬
bition of the caspasc cascade (19 23) and activation of poly
(ADP-ribose) polymerase (PARP) (21, 22, 24) have been
proposed as mechanisms for the oxidant-mcdiatcd inhibition
of apoptosis.
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The aim of the present study was to characterize cigarette
smoke-mediated induction of cell death in epithelial and
endothelial cells. An alveolar epithelial type II cell line
(A549) and primary human umbilical vein endothelial cells
(HUVECs) were chosen as surrogate cells to represent
alveolar epithelial type II cells and pulmonary microvascu¬
lar endothelial cells. Here we demonstrate that, in contrast
to previous studies (3, 4, 25-28), cigarette smoke induced
necrosis with no evidence of apoptosis, and in addition was
able to inhibit apoptosis induced by staurosporine (SS). The
cell death machinery is ubiquitous and highly conserved; thus,
Jurkat T cells are commonly used to study the mechanisms
of cell death, given that they undergo apoptosis readily and
display classical apoptotic markers. Therefore, Jurkat cells
were used as a model system to determine the effect of ciga¬
rette smoke condensate (CSC) on their well-characterized
apoptotic pathway. Here we report that cigarette smoke expo¬




All chemicals were of analytical reagent grade and purchased from
Sigma Chemical Co. (Poole, UK) unless stated otherwise.
Cell Culture
A549 cells (ECACC; Porton Down, UK) were grown in Dulbecco's
modified Eagle's medium supplemented with 10% fetal calf serum
(LahTech International, Ringmer, UK), 100 U/ml penicillin, 100
pg/ml streptomycin (P/S; Invitrogen, Paisley, UK) and 2 mM
L-Glutamine (L-Glut; Invitrogen). A549 cells were seeded into 6-
well plates at a density of 0.3 X 1C cells per well or 96 well plates
at 9 X 104 cells per well for treatment. Cells were quiesced overnight
in serum-free media and subsequently treated under serum-free
conditions. HUVECs were grown in EBM-2 media (BioWhittaker,
Verviers, Belgium) with supplements supplied by the manufac¬
turer. HUVECs, between passages 4 and 6, were seeded into 24-
well plates at a density of 5 X 104 cells per well or 96-well plates
at 1 X 104 cells per well, and cultured overnight before treatment.
Cells were washed once in calcium magnesium-free phosphate-
buffered saline (CMF-PBS) before being exposed to varying con¬
centrations of CSC in full media. Jurkat cells (ECACC) were
grown in RPMI supplemented with 10% fetal bovme serum, P/S,
and L-Glut and treated at a cell density of 1 X 10'' cells/ml with
either normal media, 2 pM SS (Calbiochem, Nottingham, UK), 100
ng/ml anti-Fas activating antibody (CH-11; Upstate Biotechnology,
Lake Placid, NY), 10% CSC or a combination of 2 pM SS and
10% CSC or 100 ng/ml CH-11 and 10% CSC.
Preparation of CSC
CSC was prepared fresh at a concentration of 1 cigarette/ml in
CMF-PBS. Whole smoke from a king-size medium tar filter-tipped
cigarette was drawn into a glass syringe and passed over CMF-
PBS in a tonometer with agitation (29, 30). The condensate was
sterile filtered through a 0.22-mm syringe filter before use.
Determination of Apoptosis and Necrosis
Acridine orange/ethidium bromide staining was performed as pre¬
viously described (31). Briefly, treated cells were stained with 4 pg/
ml acridine orange and 4 pg/ml ethidium bromide and visualized by
epifluoresence microscopy. Viable (normal, green nuclei), early
apoptotic (condensed, green nuclei), late apoptotic (condensed,
red nuclei), and necrotic (normal, red nuclei) cells were counted.
For assessment of DNA fragmentation, 2 X lO6 cells were lysed
in 500 ml 7 M guanidine hydrochloride and applied to Wizard
SV miniprep columns (Promega, Madison, WI). Columns were
centrifuged at 10,000 X g for 2 min, column wash solution (9 mM
Tris.Cl pH 7.4, 90 mM NaCl, 2.25 mM EDTA, 55% ethanol)
was applied and the columns were re-centrifuged. The wash was
repeated before eluting DNA with 50 ml TE/RNase and per¬
forming electrophoresis on a 1.8% agarose gel. The lactate dehy¬
drogenase (LDH) assay (Roche, Lewes, UK) was performed on
cells grown in 96-well plates. Treated cells were incubated at 37°C
for times as indicated, plates centrifuged at 250 X g for 10 min
and 100 pi of supernatant transferred to a fresh 96-weil plate.
The LDH assay was performed as per manufacturer's instructions.
Jurkat cells were prepared by Cytospin (Shandon, Pittsburgh, PA),
stained with DiffQuick (Dade Behring, Marburg, Germany), and
viable, apoptotic and necrotic cells counted by brightfield micros¬
copy (Olympus, London, UK). Two Cytospins were prepared for
each treatment and at least 300 cells counted per slide.
Cell-Free Apoptosis Assay and Western Blotting
The assay was performed as previously described (32). Briefly,
Jurkat or A549 cells, were incubated in cell extract buffer (CEB,
20 mM HEPES-KOH, pll 7.5, 10 mM KC1, 1.5 mM MgCl2, 1 mM
EDTA, 1 mM EGTA, 1 mM DTT, 100 pM PMSF, 10 pg/ml
leupeptin, 2 pg/ml aprotinin) on ice for 10 min, before passing
through a 25-G needle ten times and centrifuged at 10,000 X g
for 15 min at 4°C. Supernatants were removed and stored at -70°C
until used. Cell-free apoptosis was initiated by the addition of 10
pM cytochrome-c and 1 mM dATP to the extracts, followed by
incubation at 37°C. Aliquots were removed at the time points
indicated, 4X Laemmli buffer added, and the sample heated to
96°C for 5 min. Samples equivalent to 1 x 1(1 cells were analyzed
by Western blot using a polyclonal anti-caspase-3 antibody, or
a polyclonal anti-caspase-9 antibody (Pharmingen, Oxford, UK)
recognizing both pro- and active forms. The signal was detected
using a horseradish peroxidase-conjugated secondary antibody
(Santa Cruz, Wembley, UK) and enhanced chemiluminesence
(ECL; Amersham, Little Chalfont, UK).
Assessment of Recombinant Caspase Activity
Caspase-3 activity was determined using the caspase-3 assay kit
(Calbiochem), as per manufacturer's instructions. Briefly, active
caspase-3 (30 U) was placed into a half-volume 96-well plate before
addition of inhibitor, 1, 5, 10% CSC, or 1 mM H202. The plate
was incubated at 37°C for 1 h before addition of colorimetric
caspase-3 substrate, DEVD-pNA. Caspase-3 activity was deter¬
mined by measuring the change in absorbance at 405 nm after 2.5
h at 37°C.
Measurement of Glutathione Levels
Four sets of glutathione (GSH) standards were prepared in KPE
buffer (0.1 M phosphate buffer, 5 mM EDTA, pH 7.4), CSC added
to a final concentration of 1, 5, or 10%, and solutions incubated
with agitation for 1 h at 37°C. GSH levels were measured using a
microplate assay adapted from the enzymatic method developed
by Tietze and coworkers (33) and Vandeputte and colleagues (34).
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In brief, 1.67 U/ral GSH reductase and 0.2 mg/ml dithiobisnitroben¬
zoic acid were added to the GSH standards for 30 s to enable
the conversion of GSSG to GSH before 0.2 mg/ml reduced (3-
nicotinamide adenoside diphosphate (|3-NADPH) was added. The
change in absorbance was measured over 2 min at 405 nm in a
microplate reader (MRX).
Statistical Analysis
ANOVA was performed using the MiniTab package with Tukey's
post-testing to determine significance between treatments. A P
value < 0.05 was deemed significant.
Results
CSC Induces Necrosis in Epithelial and Endothelial Cells
A significant increase in LDH release from A549 cells and
HUVECs was seen in a dose-dependent manner after a
24-h exposure to CSC (Figure 1 A). LDH release from A549
cells was also time-dependent (Figure IB). In addition, acri-
dine orange and ethidium bromide staining revealed that
CSC induced necrosis, with no evidence of apoptosis in
either A549 cells or HUVECs (Figures 2 and 3). The ab¬
sence of apoptosis in response to CSC was further confirmed
by a number of methods, including electron microscopy,
oligonucleosomal DNA fragmentation, and chromatin con¬
densation assessed by Hoechst 33342, over a range of doses
and time points (data not shown). In contrast, however,
apoptosis was induced by staurosporine in both cell types
(Figures 2E and 3E). Interestingly, A549 cells co-cultured
with SS and CSC together did not die by apoptosis, but
instead underwent necrosis (Figure 4), thereby implicating
a potential for a direct inhibitory effect of CSC on the
apoptotic machinery. These results clearly demonstrate that
epithelial and endothelial cells undergo necrosis, not apo¬
ptosis, in response to CSC.
CSC Prevents SS- and CH-ll-Induced Apoptosis,
Resulting in NecrosLs
The Jurkat cell is ubiquitously used to study the "core"
molecular machinery of cell death, thus this model was
employed to elucidate the effect of CSC on the caspase
pathway in particular. Jurkat cells treated simultaneously
with SS or CH-11 undeiwent the classical morphologic and
biochemical changes indicative of apoptosis, such as chro¬
mosomal condensation and oligonucleosomal DNA frag¬
mentation, or laddering (Figures 5A-5C). However, as ob-
Control 1%CSC 2.5% CSC 5% CSC 7.5% CSC 10% CSC
10 15
Time (hour*)
Figure 1. CSC induces necrosis in A549 alveolar epithelial cells
and HUVECs. (A) A549 cells (open bars) and HUVECs (closed
bars) were exposed to 1-10% CSC for 24 h and the percentage
ofLDH released into the culture media was determined, compared
with a total lysis control (1% Triton X-100). (B) Cytotoxicity to
A549 cells in response to 10% CSC (closed squares) was time-
dependent; control media (closed diamonds). Results are mean of











Control 1%CSC 5% CSC 10%CSC
Figure 2. CSC induces necrosis in A549 alveolar epithelial cells
with no evidence of apoptosis. A549 cells were exposed to media
alone (A), 1% CSC (B), 5% CSC (C), 10% CSC (£>), 2 p,M SS
(E), or 5 mM 11,0-. (F) for up to 24 h. Acridine orange and
ethidium bromide staining was performed, and the percentage of
viable (white bars), apoptotic (gray bars), and necrotic (black bars)
cells was determined (G, 24 h shown). Note classical apoptotic
nuclei in E (arrows) and absence of this morphology in B, C, and
D. Results are mean of three experiments ± SEM. ***P < 0.001
compared with control. Magnification: X36.
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Control 1%CSC 5%CSC 10%CSC SS
Figure 3. CSC induces necrosis in HUVECs with no evidence of
apoptosis. HUVECs were exposed to media alone (A), 1% CSC
(B), 5% CSC (C), 10% CSC (jD), 2 pM SS (E), or 5 mM H202
(F) for up to 24 h. Acridine orange and ethidium bromide staining
was performed and the percentage of viable (white bars), apoptotic
(gray bars), and necrotic (black bars) cells was determined (G,
24 h shown). Note classical apoptotic nuclei in E (arrows) and
absence of this morphology in B, C, and D. Results are mean of
three experiments ± SEM. ***/-' < 0.001 compared with control.
Magnification: X36.
served with A549 cells, apoptosis did not occur when CSC
was added to the SS- or CH-ll-treated cells or after CSC
treatment alone (Figures 5D-5G). Morphologically, the
predominant form of cell death in the presence of CSC was
necrosis. This necrotic mode of cell death was underscored
by the concurrent release of LDH from the cells treated
with CSC or a combination of SS and CSC over 24 h (Figure
6). A low level of LDH release was observed from cells
incubated with SS alone and this was attributed to secondary
necrosis given the absence of phagocytic clearance. These
results indicate that cigarette smoke prevents apoptosis in¬
duced by SS or CH-11, and instead promotes necrosis.
To ascertain more accurately the stage of apoptosis that
was inhibited, Jurkat cells were treated with SS and 10%
CSC was added at hourly intervals, after which the cells
were coincubated for the remainder of the experiment. A
higher ratio of apoptotic cells to necrotic cells was seen as
the time between SS and CSC treatment increased (Figure
7). This suggests that CSC may impede an early phase in
the apoptotic pathway, as CSC only affects apoptosis when
present in the early stages of the process.
CSC-Induced Necrosis Is Not Mediated by Oxidative Stress
Inhibition of apoptosis and induction of necrosis has been
demonstrated in response to oxidants such as H202 (20-22),
which is present in cigarette smoke (35). Therefore, to de¬
termine whether the oxidant component of cigarette smoke
was mediating inhibition of apoptosis, SS-exposed Jurkat
cells were treated with CSC in the presence of various
antioxidants and evaluated by morphology and DNA lad¬
dering. No effect was seen on the necrosis-inducing ability of
CSC in the presence of the antioxidant mannitol. However,
GSH and dithiothreitol (DTT) prevented necrosis induced
by CSC, with cells remaining viable, whereas cells cocul-
tured with SS and CSC underwent apoptosis rather than
necrosis (Table 1 and Figure 8).
An alternative role for GSH in vivo is in the detoxifica¬
tion of electrophilic compounds by direct conjugation via
the thiol group. A dose-dependent decrease in measurable
GSH was observed after incubation with CSC (results ex¬
pressed as percentage of control: 1% CSC, 80.66 ± 4.4; 5%
CSC, 17.97 ± 5.15, P < 0.001; 10% CSC, 7.11 ± 0.44, P <
0.001). The assay employed measures both reduced (GSH)
and oxidized (GSSG) glutathione. If oxidation had taken







Control 1%CSC 5% CSC 10% CSC SS 1% 5% 10% Hp2
CSC/SS CSC/SS csc/ss
Figure 4. CSC prevents apoptosis and induces necro¬
sis in A549 cells. A549 cells were incubated with either
media alone, or media containing CSC, 2 pM SS, 5
mM H202, or a combination of SS and CSC for 24 h.
The percentage of viable (white bars), apoptotic (gray
bars), and necrotic (black bars) cells was determined
following acridine orange and ethidium bromide stain¬
ing. Results expressed as the mean of three experi¬
ments ± SEM. ***P < 0.001 compared with control.
1% CSC/SS and 5% CSC/SS were significantly differ¬
ent from smoke alone treatments (P < 0.001).
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Control SS CSC SS/CSC
i*
Figure 5. CSC switches apoptosis in¬
duced by SS or CH-11 to necrosis. Jur-
kat cells were treated with SS, CH.ll,
10% CSC, or a combination as indi¬
cated. After a 6-h exposure (D) or 9-h
exposure (E), death was assessed by
morphology and the percentage of nor¬
mal (A, white bars), apoptotic (B, gray
bars), and necrotic (C, black bars) cells
was determined. Results represent
mean of three experiments ± SEM,
where at least 300 cells were counted
per slide. ***P < 0.001 compared with
control. Apoptosis was confirmed by
the presence of oligonucleosomal DNA
fragments, or so-called "ladders" (F,C).
Thus, this data implies that cigarette smoke components
may conjugate with GSH.
In addition, unlike in response to oxidants (21, 22, 24),
the presence of a PARP inhibitor, 3-aminobenzinamide,
did not alter the relative levels of apoptosis and necrosis
in response to SS and CSC (data not shown), implying that
depletion of ATP as a result of PARP activation is not
involved in CSC-mediated cell death. These data suggest
that oxidative stress induced by CSC is not responsible for
inhibition of apoptosis and induction of necrosis.
CSC Inhibits Caspase-3 Cleavage but Not Activity
Because it was established that CSC affected an early stage
of apoptosis, caspase activation was investigated. Caspases
can be inhibited by direct modification; however, CSC had
no direct effect on recombinant caspase-3 activity (data not
shown). Caspases exist as an inactive proform that is cleaved
to yield active subunits; thus, activation can be monitored
by Western blot. Assessment of caspase-3 activation in Jur-
kat cells revealed cleavage of the proform after SS treat¬
ment, but not after CSC or coculture with SS and CSC
(Figure 8), indicating that the caspase pathway may be
halted in the presence of CSC. Furthermore, when cells
were treated with SS and CSC in the presence of DTT or
GSH, caspase-3 cleavage occurred, whereas mannitol was
again not effective (Figure 8). Thus, GSH and DTT are
able to "quench" or antagonize components in CSC that
prevent caspase-3 activation.
Cell-Free Reconstitution of the Apoptosome Reveals
CSC-Mediated Inhibition of Apoptosome Formation
To ascertain how CSC affected the caspase pathway, an active
apoptosome was reconstituted in a cell-free system with
cytochrome-c and dATP, in either the presence of CSC, or
in extracts prepared from cells treated with CSC. No effect
on activation of caspase 3 was observed when CSC was added
to the lysates directly (data not shown). However, in extracts
from Jurkats exposed to CSC for 2 h before preparation,
neither caspase-3 nor caspase-9 activation occurred, in con¬
trast to the progressive processing to the active form seen
in lysates from untreated cells (Figures 9A-9D). This caspase
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Figure 6. CSC induces LDH release from Jurkat cells in a time-
dependent manner. Cells were treated with control media (dia¬
monds), 2 p,M SS (squares), 10% CSC (triangles), or a combination
of SS and CSC (open circles), and the level of released LDH
measured over 24 h was determined. Results are expressed as
percentage LDH release compared with a total lysis control. Mean
of three experiments performed in triplicate ± SEM. *P < 0.05,
**P < 0.01, ***P < 0.001 compared with untreated cells.
to the lack of effect of the inhibitor LY294002 (data not
shown). Moreover, caspase-3 was not cleaved after reconsti-
tution of the apoptosome in lysates from A549 cells treated
with CSC (Figure 9E). Thus, cigarette smoke prevents apo-
ptosis by inhibiting the formation of an active apoptosome
complex and the subsequent activation of caspase-9 and -3.
Discussion
Cigarette smoking is the major etiologic factor in the patho¬
genesis of emphysema. The gas phase of cigarette smoke
contains many free radicals and oxidant molecules, with
the potential to generate additional oxidant molecules via
redox cycling, leading to an increased oxidative burden
in the lungs of smokers (35). Therefore, cigarette smoke
inhalation leads to a depletion of antioxidants, release of
inflammatory mediators, and an increase in epithelial per¬
meability (36-39). Recent evidence has suggested that
apoptosis of lung cells may be a factor in cigarette smoke-
induced emphysema (3-5, 7, 40). In contrast, our studies
show that CSC does not induce apoptosis and in fact induces
necrosis in the alveolar epithelial type II cell line (A549)
and primary endothelial cells (HUVECs). Interestingly,
CSC also prevented apoptosis induced by SS in A549 cells.
Oxidative stress is responsible for many of the effects
of cigarette smoking. Given that oxidants, such as hydrogen
peroxide, have been shown to inhibit apoptosis and induce
necrosis (19-22) we hypothesized that CSC may function
in a similar manner. Jurkat cells, which undergo apoptosis
readily and display easily identifiable markers, treated with
CSC underwent necrosis. Moreover, Jurkat cells cocultured
with a combination of SS or CH-11 and CSC also underwent
necrosis, comparable to A549 cells, with no evidence of
apoptosis. Therefore it appeared that CSC was inhibiting
apoptosis and promoting necrosis.
An investigation into the role of oxidants demonstrated
Figure 7. Cigarette smoke can switch SS-induced apoptosis to ne¬
crosis when added after SS treatment. Jurkat cells were treated
with 2 p,M SS, followed by addition of 10% CSC at hourly intervals.
Six hours after initial SS treatment cytospins were prepared and
the percentage of normal (white bars), apoptotic (gray bars), and
necrotic (black bars) cells was determined (A). Apoptosis was
confirmed by the presence of oligonucleosomal DNA "ladders"
(B). Results are mean of three experiments ± SEM, where at
least 300 cells were counted per slide. ***P < 0.001 compared
with control.
that GSH and DTT protected against CSC-induced necro¬
sis, and prevented the inhibition of apoptosis usually seen
during SS and CSC coculture. However, the antioxidant
mannitol was ineffective. GSH is an important antioxidant
in vivo; however, it also fulfils other vital roles such as
regulation of immune function, signal transduction, metab¬
olism, and the detoxification of electrophilic compounds
(41-45). Detoxification occurs via the thiol group under the
control of GSH-S-transferases, although conjugation is also
observed in the absence of the enzyme (43, 45). A dose-
dependent decrease in measurable GSH, in the absence of
GSSG formation, after incubation with CSC was observed,
indicating that GSH may form conjugates with the many
electrophilic compounds present in cigarette smoke. Con¬
sidering that the thiol compounds GSH and DTT were both
able to prevent CSC-induced necrosis and CSC-mediated
inhibition of apoptosis, whereas mannitol was not, indicates
that electrophilic compounds, not oxidants, may be respon¬
sible for these effects.
To elucidate the mechanism of apoptosis inhibition, the
caspase pathway was studied in more detail. Western blot
analysis revealed that caspase-3 activation did not occur in
cells treated with CSC. Moreover, treatment with GSH and
DTT, and not mannitol, prevented the inhibitory effect of
CSC on caspase activation. Caspases contain a central thiol
group that is essential for function and prone to oxidation,
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TABLE 1
The antioxidants DTT and GSH prevent CSC-induced
necrosis and inhibition of apoptosis
% Apoptosis % Necrosis
Control No antioxidants 0.3 ± 0.1 0.1 ± 0.1
Mannitol 0.3 ± 0.2 0.2 -H 0.1
DTT 2.4 ± 1.3 0.7 ± 0.4
GSH 0.4 0.2 0.2 ± 0.2
SS No antioxidants 94.9 -t- 2.6* 0.4 ± 0.2
Mannitol 97.4 1.2* 0.9 0.7
DTT 90.3 -t- 4.2* 0.1 H- 0.1
GSH 93.4 ± 4.5* 0.2 0.1
CSC No antioxidants 0.0 ± 0.0 74.6 ± 5.0*
Mannitol 0.0 0.0 75.4 ± 11.8*
DTT 0.4 0.3 16.3 1.7'
GSH 12.9 ± 4.7 0.3 ± 0.3'
SS/CSC No antioxidants 0.0 -h 0.0 69.5 -t- 4.9*
Mannitol 23.2 -t- 18.4' 61.4 ± 18.5*
DTT 79.5 ± 11.4*' 0.6 -f- 0.4'
GSH 98.5 H- 0.5*' 0.3 -t- 0.2*
*P < 0.001 compared with antioxidant control.
< 0.001 compared with no antioxidant treatment.
Jurkat cells were treated as indicated with 5 mM mannitol, 1 mM dithiothreitol,
or 1 mM glutathione for 6 h. Cytospins were prepared and the percentage of
normal, apoptotic and necrotic cells were determined. Results are mean of three
experiments ± SEM where at least 300 cells were counted per slide.
alkylation, and s-nitrosylation (46). However, direct addi¬
tion of CSC to recombinant caspase-3 had no effect on the
ability of the enzyme to cleave its substrate.
The effect of CSC on caspase activation was studied
further by reconstitution of the apoptosome, in cytoplasmic
extracts of Jurkat cells, on addition of cytochrome-c and
dATP. The occurrence of caspase-3 cleavage, as determined
by Western blot, was used as a positive indicator of apopto¬
some formation and caspase-9 activation. Initially, CSC was
incubated with the extracts before addition Of cytochrome-c
and dATP, whereby caspase-3 cleavage was observed, indi¬
cating that CSC had no direct effect on formation of an
active apoptosome. Interestingly, in extracts from Jurkat
cells treated with CSC for 2 h before preparation, caspase-3
activation was prevented. Moreover, caspase-9 activation
did not occur, indicating CSC treatment prevented the for¬
mation of a functional apoplosouie. Importantly, apopto¬
some formation and caspase-3 cleavage was also pieveiiled
by CSC treatment of A549 lysates, thus underscoring this
effect on the cell death machinery to be more general and
not Juikat-specilic. Numerous inducible regulators of apo¬
ptosis exist, presenting the possibility that CSC exposure
may mediate an alteration of the intracellular balance be¬
tween pro- and autiapoptogenic factors.
Although Jurkat cells were used as a model here, the
involvement of T cells in the development of emphysema
must not be overlooked. Increased numbers of T cells are
observed in the lungs of emphysema sufferers, and their
presence is correlated with increased lung destruction (47).
Necrosis of T cells present in the lung may also contribute
to the progression of emphysema by increasing local tissue
damage by release of intracellular contents.
The data presented here are in contradiction to some
+ DTT
com SS CSC SS/CSC Cont S3 CSC SS/CSC
caspase-3
♦ GSH ♦ Mannitol
Cont SS CSC SS/CSC Cont SS CSC SS/CSC
caspase-3
FigureS. Activation of caspase-3 and subsequent DNA "lad¬
dering" does not occur in Jurkats treated with CSC or SS/CSC.
Cells were treated with 2 p-M SS and/or 10% CSC in the presence
of the thiol antioxidants DTT or GSH, or mannitol. Activation of
caspasc-3 was determined by Western blot for loss of the pro form
and the resultant DNA "laddering" was determined by agarose
gel electrophoresis. Representative of three experiments.
previous studies (3, 4, 25-28). However, a number of these
have used TUNEL nick end labeling to identify apoptotic
cells (26, 28), a method that merely detects DNA strand
breaks. Cigarette smoke exposure results in oxidant-induced
DNA 3trand breaks (18), and so these studios may have
inadvertently identified cells with oxidant-induced DNA
damage as apoptotic. Moreover, caspase activation was either
not involved (4), or not studied (27), in "cigarette smoke-
induccd apoptosis". Characterization of cell death is becom
ing increasingly complex. A number of alternative forms of
cell death have been identified with many of the "classical"
markers of apoptosis evident. However, in some cases cell
death is independent of caspaso activation (8). For this rea
son, it is becoming increasingly necessary to characterize cell
death by a number of methods. This presents a plausible
explanation as to why previous studies have purported to
observe apoptosis in response to smoke oxposure. Addition
ally, no standardized protocol for the production of CSC
exists; each procedure can isolate a slightly different spectrum
of components. Nevertheless, we believe that our method of
exposing cells to CSC replicates the situation in a smoker's
lung, whereby passing the smoke over the buffer in the to¬
nometer system more accurately mimics smoke filling the
airspace and exposing the lung fining fluid.
The key finding of this study is that cigarette smoke
induces necrosis in alveolar type II cells, endothelial cells,
and Jurkat cells. Moreover, CSC inhibited caspase activa
tion and apoptosis in A549 and Jurkat cells. From these
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Figure 9. CSC treatment inhibits apoptosome formation and sub¬
sequent activation of the caspase pathway. Jurkat cells were incu¬
bated for 2 h with either control media (A, C) or 10% CSC (B,
D ). Cytoplasmic extracts were prepared and reconstitution of the
apoptosome was initiated by addition of 10 mM cytochrome-c and
1 mM dATP. Western blotting for caspase-3 (A, B), or caspase-9
(C, D ) indicated that apoptosome formation and activation of the
caspase cascade did not occur in CSC-treated lysates. Similarly,
CSC treatment inhibited apoptosome formation and caspase-3
activation in identically prepared A549 cell lysates (E). Result is
representative of three experiments.
findings, we suggest a mechanism whereby cigarette smoke
may induce emphysema. Although initially thought to be
due to apoptosis (3-5, 7, 40), emphysema may in fact result
from loss of alveolar tissue by necrosis of lung epithelial
and endothelial cells. In these experiments, the effects of
CSC could be prevented by the presence of extracellular
thiol compounds such as GSH, which is native to the lung
and forms one of the most important lung antioxidant de¬
fenses (49). Therefore, it could be deduced that the risk of
necrosis in response to cigarette smoking is insignificant.
However, in situations of acute smoking, GSH has been
shown to be decreased in lung lining fluid with a subsequent
rebound to levels higher than those of nonsmokers (36, 38,
50, 51). During this window of antioxidant depletion, the
cells of the lung are likely to be susceptible to necrotic
cell death as a consequence of additional cigarette smoke
exposure. Moreover, local tissue damage may be amplified
by the subsequent release of intracellular enzymes and lyso¬
somal contents, resulting in recruitment of inflammatory
cells to the site of injury and further necrosis of surrounding
tissue. This scenario is supported by Retamales and cowork¬
ers (52), who observed increased inflammation in increased
severity of emphysema. Thus, although much interest has
been generated on the involvement of apoptosis, our studies
emphasize the role of necrosis and the subsequent proin¬
flammatory responses as more likely candidates in the patho¬
genesis of emphysema.
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